index	mutID	Chr	Gname	chr_gnam	ref_id	cluster	GENE	VF_gene_id	VF_name	identity	evalue	qstart	qend	query_coverage	subject_coverage	VF_category	Gene_description	Function	group	condition
1	M0000262	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00188	VFG004552	Intercellular adhesion proteins	77.4	1.5e-79	1	186	1.0	1.0054	Biofilm	ica operon transcriptional regulator IcaR	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
2	M0000263	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00188	VFG004552	Intercellular adhesion proteins	77.4	1.5e-79	1	186	1.0	1.0054	Biofilm	ica operon transcriptional regulator IcaR	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
3	M0000264	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
4	M0000264	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
5	M0000265	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
6	M0000265	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
7	M0000266	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
8	M0000266	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
9	M0000267	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
10	M0000267	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
11	M0000268	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
12	M0000268	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
13	M0000269	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
14	M0000269	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
15	M0000270	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
16	M0000270	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
17	M0000271	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
18	M0000271	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
19	M0000272	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00190	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00190	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00190	VFG004533	Intercellular adhesion proteins	78.2	4.1e-36	1	101	1.0	1	Biofilm	intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
20	M0000273	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00191	VFG004523	Intercellular adhesion proteins	71.1	4e-121	1	287	1.0	0.9931	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
21	M0000274	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00191	VFG004523	Intercellular adhesion proteins	71.1	4e-121	1	287	1.0	0.9931	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
22	M0000275	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
23	M0000275	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
24	M0000305	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
25	M0000305	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
26	M0000306	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
27	M0000306	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
28	M0000307	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
29	M0000307	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
30	M0000315	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
31	M0000315	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
32	M0000330	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00188	VFG004552	Intercellular adhesion proteins	77.4	1.5e-79	1	186	1.0	1.0054	Biofilm	ica operon transcriptional regulator IcaR	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
33	M0000331	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
34	M0000331	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
35	M0000332	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00191	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00191	VFG004523	Intercellular adhesion proteins	71.1	4e-121	1	287	1.0	0.9931	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
36	M0000333	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
37	M0000333	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
38	M0000334	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
39	M0000334	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
40	M0000335	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
41	M0000335	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
42	M0000875	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
43	M0000875	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
44	M0000876	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
45	M0000876	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
46	M0000918	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
47	M0000918	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
48	M0000919	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
49	M0000919	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
50	M0000920	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
51	M0000920	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
52	M0000934	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
53	M0000934	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
54	M0000935	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
55	M0000935	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
56	M0000936	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
57	M0000936	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
58	M0000942	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
59	M0000942	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
60	M0000943	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
61	M0000943	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
62	M0000944	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
63	M0000944	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
64	M0000945	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
65	M0000945	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
66	M0000946	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	9.9e-212	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetA	experiment
67	M0000946	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00115	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00115	VFG001314	Aureolysin	70.9	7.4e-211	1	506	1.0	0.9941	Exoenzyme	zinc metalloproteinase aureolysin	Processing the precursor of V8 protease into an active form; modifying the bacterial cell surface proteins by specific inactivation of ClfB through cleavage of the N-terminal domain, thus may promote the detachment of bacterial cells from colonized sites and facilitate the spread of infection; In vitro, aureolysin has been shown to cleave the human plasma proteinase inhibitors	SetB	prediction
68	M0001313	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
69	M0001313	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
70	M0001410	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
71	M0001410	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
72	M0001770	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
73	M0001770	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
74	M0001771	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
75	M0001771	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
76	M0001772	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
77	M0001772	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
78	M0001773	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00190	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00190	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00190	VFG004533	Intercellular adhesion proteins	78.2	4.1e-36	1	101	1.0	1	Biofilm	intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
79	M0001774	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
80	M0001774	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
81	M0001775	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG001288	Intercellular adhesion proteins	76.9	9e-151	1	350	0.9804	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
82	M0001775	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00192	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00192	VFG004513	Intercellular adhesion proteins	82.8	2.1e-167	1	354	0.9916	0.9972	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
83	M0002062	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00188	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00188	VFG004552	Intercellular adhesion proteins	77.4	1.5e-79	1	186	1.0	1.0054	Biofilm	ica operon transcriptional regulator IcaR	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
84	M0002084	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG001285	Intercellular adhesion proteins	81.3	3.2e-200	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
85	M0002084	1111525849478545_bin.16__k141_358111	IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111__IPCGDNCJ_00189	1111525849478545_bin.16__k141_358111	C1504	IPCGDNCJ_00189	VFG004542	Intercellular adhesion proteins	83.3	2.5e-204	1	412	1.0	1	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
86	M0006308	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
87	M0006309	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
88	M0006310	1111525849479042_bin.21__k141_789772	LEEGCGPK_00003	1111525849479042_bin.21__k141_789772__LEEGCGPK_00003	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00003	VFG004533	Intercellular adhesion proteins	100	1.4e-49	1	101	1.0	1	Biofilm	intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
89	M0006311	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
90	M0006311	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
91	M0006312	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
92	M0006312	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
93	M0006313	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
94	M0006313	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
95	M0006314	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
96	M0006314	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
97	M0006315	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
98	M0006315	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
99	M0006316	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
100	M0006316	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
101	M0006317	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
102	M0006317	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
103	M0006318	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
104	M0006318	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
105	M0006319	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
106	M0006319	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
107	M0006320	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
108	M0006320	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
109	M0006321	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
110	M0006321	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
111	M0006322	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
112	M0006322	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
113	M0006323	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
114	M0006323	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
115	M0006324	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
116	M0006324	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
117	M0006325	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
118	M0006325	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
119	M0006326	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
120	M0006326	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
121	M0006327	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
122	M0006327	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
123	M0006328	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
124	M0006328	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
125	M0006329	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
126	M0006329	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
127	M0006330	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
128	M0006330	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
129	M0006331	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
130	M0006331	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
131	M0006332	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
132	M0006332	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
133	M0006333	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
134	M0006333	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
135	M0006334	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
136	M0006335	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
137	M0006336	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
138	M0006337	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
139	M0006338	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
140	M0006339	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
141	M0006340	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
142	M0006341	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
143	M0006342	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
144	M0006343	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
145	M0006344	1111525849479042_bin.21__k141_789772	LEEGCGPK_00002	1111525849479042_bin.21__k141_789772__LEEGCGPK_00002	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00002	VFG004523	Intercellular adhesion proteins	100	8.3e-167	1	289	1.0	1	Biofilm	N-deacetylase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
146	M0006345	1111525849479042_bin.21__k141_789772	LEEGCGPK_00003	1111525849479042_bin.21__k141_789772__LEEGCGPK_00003	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00003	VFG004533	Intercellular adhesion proteins	100	1.4e-49	1	101	1.0	1	Biofilm	intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
147	M0006346	1111525849479042_bin.21__k141_789772	LEEGCGPK_00003	1111525849479042_bin.21__k141_789772__LEEGCGPK_00003	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00003	VFG004533	Intercellular adhesion proteins	100	1.4e-49	1	101	1.0	1	Biofilm	intercellular adhesion protein D, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
148	M0006347	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
149	M0006347	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
150	M0006348	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
151	M0006348	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
152	M0006349	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
153	M0006349	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
154	M0006350	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
155	M0006350	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
156	M0006351	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
157	M0006351	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
158	M0006352	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
159	M0006352	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
160	M0006353	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
161	M0006353	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
162	M0006354	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
163	M0006354	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
164	M0006355	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
165	M0006355	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
166	M0006356	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
167	M0006356	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
168	M0006357	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
169	M0006357	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
170	M0006358	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
171	M0006358	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
172	M0006359	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
173	M0006359	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
174	M0006360	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
175	M0006360	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
176	M0006361	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
177	M0006361	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
178	M0006362	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
179	M0006362	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
180	M0006363	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
181	M0006363	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
182	M0006364	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
183	M0006364	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
184	M0006365	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG001285	Intercellular adhesion proteins	82.8	5.5e-169	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
185	M0006365	1111525849479042_bin.21__k141_789772	LEEGCGPK_00004	1111525849479042_bin.21__k141_789772__LEEGCGPK_00004	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00004	VFG004542	Intercellular adhesion proteins	100	1.3e-198	6	349	0.9857	0.835	Biofilm	N-acetylglucosaminyltransferase, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
186	M0006366	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG001288	Intercellular adhesion proteins	74.9	1.3e-146	1	350	0.9859	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
187	M0006366	1111525849479042_bin.21__k141_789772	LEEGCGPK_00001	1111525849479042_bin.21__k141_789772__LEEGCGPK_00001	1111525849479042_bin.21__k141_789772	C1539	LEEGCGPK_00001	VFG004513	Intercellular adhesion proteins	100	4.1e-192	1	355	1.0	1	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
188	M0007917	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
189	M0007952	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
190	M0007953	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
191	M0007954	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
192	M0007955	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
193	M0007956	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
194	M0007957	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
195	M0007958	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
196	M0007959	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
197	M0007960	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
198	M0007961	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
199	M0007962	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
200	M0007963	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
201	M0007976	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
202	M0007977	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
203	M0007978	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
204	M0007979	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
205	M0007980	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
206	M0007981	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
207	M0007982	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
208	M0007983	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
209	M0007984	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
210	M0007985	1111525849480358_bin.2__k141_42315	IKAEBCDM_00004	1111525849480358_bin.2__k141_42315__IKAEBCDM_00004	1111525849480358_bin.2__k141_42315	C1582	IKAEBCDM_00004	VFG004752	Lipase	74.7	2.8e-282	1	668	1.0	0.9809	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
211	M0007986	1111525849480358_bin.2__k141_768643	MKDNEJMN_00005	1111525849480358_bin.2__k141_768643__MKDNEJMN_00005	1111525849480358_bin.2__k141_768643	C1583	MKDNEJMN_00005	VFG004481	Autolysin alt	70.3	0	8	1344	0.9948	1.0015	Adherence	bifunctional autolysin		SetB	prediction
212	M0008494	1111525849481321_bin.4__k141_87464	DFKAHJCB_00014	1111525849481321_bin.4__k141_87464__DFKAHJCB_00014	1111525849481321_bin.4__k141_87464	C1609	DFKAHJCB_00014	VFG046465	EF-Tu	77.2	1.2e-183	1	395	0.9975	1.0025	Adherence	elongation factor Tu	Surface-expressed elongation factor-Tu (EF-Tu) mediates attachment by interacting with host cell nucleolin	SetA	experiment
213	M0008494	1111525849481321_bin.4__k141_87464	DFKAHJCB_00014	1111525849481321_bin.4__k141_87464__DFKAHJCB_00014	1111525849481321_bin.4__k141_87464	C1609	DFKAHJCB_00014	VFG046467	EF-Tu	77.7	3e-183	1	395	0.9975	1.0025	Adherence	elongation factor Tu	Surface-expressed elongation factor-Tu (EF-Tu) mediates attachment by interacting with host cell nucleolin	SetB	prediction
214	M0008497	1111525849481321_bin.4__k141_87464	DFKAHJCB_00014	1111525849481321_bin.4__k141_87464__DFKAHJCB_00014	1111525849481321_bin.4__k141_87464	C1609	DFKAHJCB_00014	VFG046465	EF-Tu	77.2	1.2e-183	1	395	0.9975	1.0025	Adherence	elongation factor Tu	Surface-expressed elongation factor-Tu (EF-Tu) mediates attachment by interacting with host cell nucleolin	SetA	experiment
215	M0008497	1111525849481321_bin.4__k141_87464	DFKAHJCB_00014	1111525849481321_bin.4__k141_87464__DFKAHJCB_00014	1111525849481321_bin.4__k141_87464	C1609	DFKAHJCB_00014	VFG046467	EF-Tu	77.7	3e-183	1	395	0.9975	1.0025	Adherence	elongation factor Tu	Surface-expressed elongation factor-Tu (EF-Tu) mediates attachment by interacting with host cell nucleolin	SetB	prediction
216	M0010503	1111525849486442_bin.27__k141_310890	LGGLLPOK_00001	1111525849486442_bin.27__k141_310890__LGGLLPOK_00001	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00001	VFG002358	Flagella	91.7	5.1e-100	1	193	1.0	1	Motility	flagellar biosynthesis transcription activator FlhC	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetA	experiment
217	M0010503	1111525849486442_bin.27__k141_310890	LGGLLPOK_00001	1111525849486442_bin.27__k141_310890__LGGLLPOK_00001	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00001	VFG002358	Flagella	91.7	3.8e-99	1	193	1.0	1	Motility	flagellar biosynthesis transcription activator FlhC	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetB	prediction
218	M0010504	1111525849486442_bin.27__k141_310890	LGGLLPOK_00001	1111525849486442_bin.27__k141_310890__LGGLLPOK_00001	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00001	VFG002358	Flagella	91.7	5.1e-100	1	193	1.0	1	Motility	flagellar biosynthesis transcription activator FlhC	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetA	experiment
219	M0010504	1111525849486442_bin.27__k141_310890	LGGLLPOK_00001	1111525849486442_bin.27__k141_310890__LGGLLPOK_00001	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00001	VFG002358	Flagella	91.7	3.8e-99	1	193	1.0	1	Motility	flagellar biosynthesis transcription activator FlhC	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetB	prediction
220	M0010509	1111525849486442_bin.27__k141_310890	LGGLLPOK_00029	1111525849486442_bin.27__k141_310890__LGGLLPOK_00029	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00029	VFG000574	MgtB	73.7	0	4	898	0.9956	0.9857	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
221	M0010509	1111525849486442_bin.27__k141_310890	LGGLLPOK_00029	1111525849486442_bin.27__k141_310890__LGGLLPOK_00029	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00029	VFG021055	MgtB	73.7	0	4	898	0.9956	0.9857	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
222	M0010510	1111525849486442_bin.27__k141_310890	LGGLLPOK_00029	1111525849486442_bin.27__k141_310890__LGGLLPOK_00029	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00029	VFG000574	MgtB	73.7	0	4	898	0.9956	0.9857	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
223	M0010510	1111525849486442_bin.27__k141_310890	LGGLLPOK_00029	1111525849486442_bin.27__k141_310890__LGGLLPOK_00029	1111525849486442_bin.27__k141_310890	C1671	LGGLLPOK_00029	VFG021055	MgtB	73.7	0	4	898	0.9956	0.9857	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
224	M0014893	1111525849644360_bin.8__k141_197652	CEOJGJPB_00028	1111525849644360_bin.8__k141_197652__CEOJGJPB_00028	1111525849644360_bin.8__k141_197652	C1771	CEOJGJPB_00028	VFG001288	Intercellular adhesion proteins	74	1.1e-143	1	349	0.9803	0.9971	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetA	experiment
225	M0014893	1111525849644360_bin.8__k141_197652	CEOJGJPB_00028	1111525849644360_bin.8__k141_197652__CEOJGJPB_00028	1111525849644360_bin.8__k141_197652	C1771	CEOJGJPB_00028	VFG004513	Intercellular adhesion proteins	84.5	6.2e-164	1	353	0.9916	0.9944	Biofilm	intercellular adhesion protein C, involved in polysaccharide intercellular adhesin(PIA) synthesis	PNSG is critical to biofilm elaboration, allowing bacteria to adhere to one another, and may also promote adherence to other molecules, such as ECM components	SetB	prediction
226	M0018907	1111525849663500_bin.20__k141_1265514	KAAGILIN_00075	1111525849663500_bin.20__k141_1265514__KAAGILIN_00075	1111525849663500_bin.20__k141_1265514	C1850	KAAGILIN_00075	VFG048459	Ent	87.4	1.1e-192	1	406	0.9667	0.9831	Nutritional/Metabolic factor	enterobactin exporter EntS	May be necessary for penetration to deeper tissues	SetA	experiment
227	M0018907	1111525849663500_bin.20__k141_1265514	KAAGILIN_00075	1111525849663500_bin.20__k141_1265514__KAAGILIN_00075	1111525849663500_bin.20__k141_1265514	C1850	KAAGILIN_00075	VFG048460	Ent	87.7	2.9e-192	1	406	0.9667	0.9831	Nutritional/Metabolic factor	enterobactin exporter EntS	May be necessary for penetration to deeper tissues	SetB	prediction
228	M0018910	1111525849663500_bin.20__k141_485895	ABIGDKOG_00165	1111525849663500_bin.20__k141_485895__ABIGDKOG_00165	1111525849663500_bin.20__k141_485895	C1851	ABIGDKOG_00165	VFG043210	Flagella	82.6	3.3e-71	1	161	0.9699	0.9758	Motility	purine-binding chemotaxis protein CheW	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetA	experiment
229	M0018910	1111525849663500_bin.20__k141_485895	ABIGDKOG_00165	1111525849663500_bin.20__k141_485895__ABIGDKOG_00165	1111525849663500_bin.20__k141_485895	C1851	ABIGDKOG_00165	VFG043041	Peritrichous flagella	89.8	3.2e-78	1	166	1.0	0.994	Motility	chemotaxis protein CheW		SetB	prediction
230	M0018911	1111525849663500_bin.20__k141_485895	ABIGDKOG_00165	1111525849663500_bin.20__k141_485895__ABIGDKOG_00165	1111525849663500_bin.20__k141_485895	C1851	ABIGDKOG_00165	VFG043210	Flagella	82.6	3.3e-71	1	161	0.9699	0.9758	Motility	purine-binding chemotaxis protein CheW	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetA	experiment
231	M0018911	1111525849663500_bin.20__k141_485895	ABIGDKOG_00165	1111525849663500_bin.20__k141_485895__ABIGDKOG_00165	1111525849663500_bin.20__k141_485895	C1851	ABIGDKOG_00165	VFG043041	Peritrichous flagella	89.8	3.2e-78	1	166	1.0	0.994	Motility	chemotaxis protein CheW		SetB	prediction
232	M0018913	1111525849663500_bin.20__k141_485895	ABIGDKOG_00018	1111525849663500_bin.20__k141_485895__ABIGDKOG_00018	1111525849663500_bin.20__k141_485895	C1851	ABIGDKOG_00018	VFG041474	PAI-2 encoded	76.4	2.5e-250	17	591	0.9696	0.9762	Effector delivery system	type III secretion system outer membrane ring subunit SctC		SetB	prediction
233	M0024716	1111525849742797_bin.26__k141_325281	MIEBEGKC_00009	1111525849742797_bin.26__k141_325281__MIEBEGKC_00009	1111525849742797_bin.26__k141_325281	C2098	MIEBEGKC_00009	VFG048755	T6SS	78.3	0	108	1156	0.9074	0.9114	Effector delivery system	type VI secretion protein TssM	Antibacterial activity	SetA	experiment
234	M0024716	1111525849742797_bin.26__k141_325281	MIEBEGKC_00009	1111525849742797_bin.26__k141_325281__MIEBEGKC_00009	1111525849742797_bin.26__k141_325281	C2098	MIEBEGKC_00009	VFG048749	T6SS	82.4	0	87	1156	0.9256	0.9256	Effector delivery system	type VI secretion protein TssM	Antibacterial activity	SetB	prediction
235	M0024725	1111525849742797_bin.26__k141_325281	MIEBEGKC_00005	1111525849742797_bin.26__k141_325281__MIEBEGKC_00005	1111525849742797_bin.26__k141_325281	C2098	MIEBEGKC_00005	VFG048782	T6SS	76.1	3.6e-75	1	180	0.9945	0.9945	Effector delivery system	type VI secretion system lipoprotein TssJ	Antibacterial activity	SetB	prediction
236	M0025700	1111525849743011_bin.57__k141_477866	IDAIOMKN_00002	1111525849743011_bin.57__k141_477866__IDAIOMKN_00002	1111525849743011_bin.57__k141_477866	C2129	IDAIOMKN_00002	VFG002318	Flagella	83.4	7.2e-82	1	169	1.0	1	Motility	alternative sigma factor regulatory protein	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetA	experiment
237	M0025700	1111525849743011_bin.57__k141_477866	IDAIOMKN_00002	1111525849743011_bin.57__k141_477866__IDAIOMKN_00002	1111525849743011_bin.57__k141_477866	C2129	IDAIOMKN_00002	VFG002318	Flagella	83.4	5.4e-81	1	169	1.0	1	Motility	alternative sigma factor regulatory protein	Required for efficient cellular invasion; YplA, a phospholipase is secreted by this type III flagellum secretion system. YplA is required for survival of Y. enterocolitica in the Peyer's patches and for stimulation of the acute inflammatory response of the host to the infection; contributed to the initiation of biofilm formation	SetB	prediction
238	M0033830	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
239	M0033830	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
240	M0033831	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
241	M0033831	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
242	M0033832	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
243	M0033832	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
244	M0033833	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
245	M0033833	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
246	M0033834	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
247	M0033834	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
248	M0033835	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
249	M0033835	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
250	M0033836	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
251	M0033836	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
252	M0033837	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
253	M0033837	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
254	M0033838	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
255	M0033838	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
256	M0033839	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
257	M0033839	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
258	M0033840	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
259	M0033840	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
260	M0033841	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
261	M0033841	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
262	M0033842	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
263	M0033842	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
264	M0033843	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
265	M0033843	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
266	M0033844	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
267	M0033844	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
268	M0033845	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
269	M0033845	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
270	M0033846	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG041024	HSI-2	71.8	8.9e-58	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
271	M0033846	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG051560	HSI-2	72.5	1.8e-57	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
272	M0033849	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
273	M0033849	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
274	M0033850	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
275	M0033850	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
276	M0033851	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
277	M0033851	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
278	M0033852	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
279	M0033852	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
280	M0033853	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG041024	HSI-2	71.8	8.9e-58	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
281	M0033853	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG051560	HSI-2	72.5	1.8e-57	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
282	M0033862	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
283	M0033862	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
284	M0033863	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
285	M0033863	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
286	M0033864	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
287	M0033864	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
288	M0033865	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
289	M0033865	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
290	M0033866	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
291	M0033866	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
292	M0033867	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
293	M0033867	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
294	M0033868	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
295	M0033868	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
296	M0033869	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
297	M0033869	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
298	M0033870	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
299	M0033870	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
300	M0033871	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
301	M0033871	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
302	M0033872	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
303	M0033872	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
304	M0033905	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
305	M0033905	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
306	M0033906	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
307	M0033906	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
308	M0033907	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
309	M0033907	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
310	M0033908	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
311	M0033908	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
312	M0033909	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
313	M0033909	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
314	M0033910	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
315	M0033910	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
316	M0033911	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG041024	HSI-2	71.8	8.9e-58	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
317	M0033911	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG051560	HSI-2	72.5	1.8e-57	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
318	M0033912	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG041024	HSI-2	71.8	8.9e-58	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
319	M0033912	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG051560	HSI-2	72.5	1.8e-57	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
320	M0033913	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG041024	HSI-2	71.8	8.9e-58	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
321	M0033913	1111525849759006_bin.31__k141_214076	GJCADEND_00006	1111525849759006_bin.31__k141_214076__GJCADEND_00006	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00006	VFG051560	HSI-2	72.5	1.8e-57	1	149	0.9312	0.8869	Effector delivery system	type VI secretion system lipoprotein TssJ	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
322	M0033922	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
323	M0033922	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
324	M0033923	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	9.4e-130	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
325	M0033923	1111525849759006_bin.31__k141_214076	GJCADEND_00004	1111525849759006_bin.31__k141_214076__GJCADEND_00004	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00004	VFG041026	HSI-2	77.2	7e-129	1	285	0.9727	0.9862	Effector delivery system	type IVB secretion system protein IcmH/DotU	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
326	M0033924	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
327	M0033924	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
328	M0033925	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
329	M0033925	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
330	M0033931	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
331	M0033931	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
332	M0033932	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
333	M0033932	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
334	M0033933	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG041025	HSI-2	79.5	2.6e-208	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
335	M0033933	1111525849759006_bin.31__k141_214076	GJCADEND_00005	1111525849759006_bin.31__k141_214076__GJCADEND_00005	1111525849759006_bin.31__k141_214076	C2290	GJCADEND_00005	VFG051572	HSI-2	80.4	2.4e-213	1	443	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssK	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
336	M0035495	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
337	M0035495	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
338	M0035496	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
339	M0035496	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
340	M0035497	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
341	M0035497	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
342	M0035498	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
343	M0035498	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
344	M0035499	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
345	M0035499	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
346	M0035500	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
347	M0035500	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
348	M0035501	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
349	M0035501	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
350	M0035502	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
351	M0035502	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
352	M0035503	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
353	M0035503	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
354	M0035504	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
355	M0035504	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
356	M0035505	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048498	Ent	89.1	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetA	experiment
357	M0035505	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048497	Ent	89.2	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetB	prediction
358	M0035506	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048498	Ent	89.1	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetA	experiment
359	M0035506	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048497	Ent	89.2	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetB	prediction
360	M0035507	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048498	Ent	89.1	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetA	experiment
361	M0035507	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048497	Ent	89.2	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetB	prediction
362	M0035508	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048498	Ent	89.1	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetA	experiment
363	M0035508	1111525849760419_bin.3__k141_39468	NLFLGJIB_00009	1111525849760419_bin.3__k141_39468__NLFLGJIB_00009	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00009	VFG048497	Ent	89.2	0	1	1293	1.0	1	Nutritional/Metabolic factor	enterobactin synthase subunit F	May be necessary for penetration to deeper tissues	SetB	prediction
364	M0035509	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
365	M0035509	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
366	M0035510	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
367	M0035510	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
368	M0035511	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
369	M0035511	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
370	M0035512	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
371	M0035512	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
372	M0035513	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
373	M0035513	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
374	M0035514	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
375	M0035514	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
376	M0035515	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
377	M0035515	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
378	M0035516	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
379	M0035516	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
380	M0035517	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
381	M0035517	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
382	M0035518	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
383	M0035518	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
384	M0035519	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
385	M0035519	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
386	M0035520	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
387	M0035520	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
388	M0035521	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
389	M0035521	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
390	M0035522	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
391	M0035522	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
392	M0035523	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
393	M0035523	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
394	M0035524	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
395	M0035524	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
396	M0035525	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
397	M0035525	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
398	M0035526	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
399	M0035526	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
400	M0035527	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
401	M0035527	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
402	M0035528	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
403	M0035528	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
404	M0035529	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
405	M0035529	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
406	M0035530	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
407	M0035530	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
408	M0035531	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
409	M0035531	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
410	M0035532	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
411	M0035532	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
412	M0035533	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
413	M0035533	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
414	M0035534	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
415	M0035534	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
416	M0035535	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
417	M0035535	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
418	M0035536	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
419	M0035536	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
420	M0035537	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
421	M0035537	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
422	M0035538	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
423	M0035538	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
424	M0035539	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
425	M0035539	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
426	M0035540	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
427	M0035540	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
428	M0035541	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
429	M0035541	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
430	M0035542	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
431	M0035542	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
432	M0035543	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
433	M0035543	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
434	M0035544	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
435	M0035544	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
436	M0035545	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
437	M0035545	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
438	M0035546	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
439	M0035546	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
440	M0035547	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
441	M0035547	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
442	M0035548	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
443	M0035548	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
444	M0035549	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
445	M0035549	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
446	M0035550	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
447	M0035550	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
448	M0035551	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
449	M0035551	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
450	M0035552	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
451	M0035552	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
452	M0035553	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
453	M0035553	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
454	M0035554	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
455	M0035554	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
456	M0035555	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
457	M0035555	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
458	M0035588	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
459	M0035588	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
460	M0035589	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
461	M0035589	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
462	M0035590	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
463	M0035590	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
464	M0035591	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
465	M0035591	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
466	M0035592	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
467	M0035592	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
468	M0035593	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
469	M0035593	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
470	M0035594	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048508	Ent	75.4	1.4e-187	4	395	0.9655	0.9751	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetA	experiment
471	M0035594	1111525849760419_bin.3__k141_39468	NLFLGJIB_00011	1111525849760419_bin.3__k141_39468__NLFLGJIB_00011	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00011	VFG048500	Ent	78.6	2.6e-198	1	399	0.9828	1	Nutritional/Metabolic factor	enterobactin/ferric enterobactin esterase	May be necessary for penetration to deeper tissues	SetB	prediction
472	M0035942	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048518	Ent	93.5	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetA	experiment
473	M0035942	1111525849760419_bin.3__k141_39468	NLFLGJIB_00012	1111525849760419_bin.3__k141_39468__NLFLGJIB_00012	1111525849760419_bin.3__k141_39468	C2298	NLFLGJIB_00012	VFG048517	Ent	93.8	0	1	742	1.0	1	Nutritional/Metabolic factor	outer membrane receptor FepA	May be necessary for penetration to deeper tissues	SetB	prediction
474	M0036432	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
475	M0036433	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
476	M0036434	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
477	M0036435	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
478	M0036490	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
479	M0036491	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
480	M0036492	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
481	M0036493	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
482	M0036736	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
483	M0036737	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
484	M0036738	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
485	M0036774	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
486	M0036775	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
487	M0036776	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
488	M0036805	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
489	M0036806	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
490	M0036830	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
491	M0036831	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
492	M0036832	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
493	M0036833	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
494	M0036859	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
495	M0036860	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
496	M0036861	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
497	M0036879	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
498	M0036880	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
499	M0036888	1111525849760419_bin.7__k141_140846	IFFMMLAN_00008	1111525849760419_bin.7__k141_140846__IFFMMLAN_00008	1111525849760419_bin.7__k141_140846	C2301	IFFMMLAN_00008	VFG016402	Polysaccharide capsule	72.4	8.7e-116	1	286	0.9931	0.9761	Immune modulation	UTP--glucose-1-phosphate uridylyltransferase GalU		SetB	prediction
500	M0039842	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
501	M0039842	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
502	M0039843	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
503	M0039843	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
504	M0039844	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
505	M0039844	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
506	M0039845	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
507	M0039845	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
508	M0039846	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
509	M0039846	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
510	M0039847	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
511	M0039847	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
512	M0039848	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
513	M0039848	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
514	M0039849	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
515	M0039849	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
516	M0039850	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
517	M0039850	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
518	M0039851	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
519	M0039851	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
520	M0039852	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
521	M0039852	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
522	M0039853	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
523	M0039853	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
524	M0039854	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
525	M0039854	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
526	M0039855	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
527	M0039855	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
528	M0039856	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
529	M0039856	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
530	M0039857	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
531	M0039857	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
532	M0039858	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
533	M0039858	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
534	M0039859	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
535	M0039859	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
536	M0039860	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
537	M0039860	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
538	M0039861	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
539	M0039861	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
540	M0039862	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
541	M0039862	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
542	M0039863	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
543	M0039863	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
544	M0039864	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
545	M0039864	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
546	M0039865	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
547	M0039865	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
548	M0039866	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
549	M0039866	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
550	M0039867	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
551	M0039867	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
552	M0039868	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
553	M0039868	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
554	M0039869	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
555	M0039869	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
556	M0039870	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
557	M0039870	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
558	M0039871	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
559	M0039871	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
560	M0039872	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
561	M0039872	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
562	M0039873	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
563	M0039873	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
564	M0039874	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
565	M0039874	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
566	M0039875	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
567	M0039875	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
568	M0039876	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
569	M0039876	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
570	M0039877	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
571	M0039877	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
572	M0039878	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
573	M0039878	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
574	M0039879	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
575	M0039879	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
576	M0039880	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
577	M0039880	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
578	M0039881	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
579	M0039881	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
580	M0039882	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
581	M0039882	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
582	M0039883	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
583	M0039883	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
584	M0039884	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
585	M0039884	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
586	M0039885	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
587	M0039885	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
588	M0039886	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
589	M0039886	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
590	M0039887	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
591	M0039887	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
592	M0039888	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
593	M0039888	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
594	M0039889	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
595	M0039889	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
596	M0039890	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
597	M0039890	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
598	M0039891	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
599	M0039891	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
600	M0039892	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
601	M0039892	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
602	M0039910	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
603	M0039910	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
604	M0039911	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
605	M0039911	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
606	M0039912	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
607	M0039912	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
608	M0039913	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
609	M0039913	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
610	M0039914	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
611	M0039914	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
612	M0039915	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
613	M0039915	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
614	M0039916	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
615	M0039916	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
616	M0039917	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
617	M0039917	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
618	M0039918	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
619	M0039918	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
620	M0039919	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
621	M0039919	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
622	M0039920	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
623	M0039920	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
624	M0039921	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
625	M0039921	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
626	M0039922	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
627	M0039922	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
628	M0039923	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
629	M0039923	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
630	M0039924	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
631	M0039924	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
632	M0039925	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
633	M0039925	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
634	M0039926	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
635	M0039926	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
636	M0039927	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
637	M0039927	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
638	M0039928	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
639	M0039928	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
640	M0039929	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
641	M0039929	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
642	M0039930	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
643	M0039930	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
644	M0039931	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
645	M0039931	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
646	M0039932	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
647	M0039932	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
648	M0039933	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
649	M0039933	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
650	M0039934	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
651	M0039934	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
652	M0039935	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
653	M0039935	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
654	M0039936	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
655	M0039936	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
656	M0039937	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
657	M0039937	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
658	M0039938	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
659	M0039938	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
660	M0039939	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
661	M0039939	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
662	M0039940	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
663	M0039940	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
664	M0039941	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
665	M0039941	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
666	M0039942	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
667	M0039942	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
668	M0039943	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
669	M0039943	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
670	M0040037	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
671	M0040037	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
672	M0040038	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
673	M0040038	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
674	M0040039	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
675	M0040039	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
676	M0040040	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
677	M0040040	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
678	M0040041	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
679	M0040041	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
680	M0040042	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
681	M0040042	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
682	M0040043	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
683	M0040043	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
684	M0040044	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
685	M0040044	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
686	M0040045	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
687	M0040045	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
688	M0040046	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
689	M0040046	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
690	M0040047	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
691	M0040047	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
692	M0040061	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
693	M0040061	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
694	M0040073	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
695	M0040073	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
696	M0040074	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
697	M0040074	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
698	M0040075	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
699	M0040075	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
700	M0040076	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
701	M0040076	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
702	M0040077	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
703	M0040077	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
704	M0040078	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
705	M0040078	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
706	M0040079	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
707	M0040079	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
708	M0040080	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
709	M0040080	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
710	M0040081	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
711	M0040081	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
712	M0040082	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
713	M0040082	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
714	M0040083	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
715	M0040083	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
716	M0040084	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
717	M0040084	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
718	M0040085	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
719	M0040085	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
720	M0040086	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
721	M0040086	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
722	M0040087	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
723	M0040087	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
724	M0040088	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
725	M0040088	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
726	M0040089	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
727	M0040089	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
728	M0040090	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
729	M0040090	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
730	M0040115	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
731	M0040115	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
732	M0040116	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
733	M0040116	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
734	M0040117	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
735	M0040117	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
736	M0040118	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
737	M0040118	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
738	M0040119	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
739	M0040119	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
740	M0040120	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
741	M0040120	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
742	M0040121	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
743	M0040121	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
744	M0040122	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
745	M0040122	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
746	M0040123	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
747	M0040123	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
748	M0040124	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
749	M0040124	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
750	M0040148	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
751	M0040148	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
752	M0040149	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
753	M0040149	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
754	M0040154	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
755	M0040154	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
756	M0040155	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
757	M0040155	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
758	M0040156	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
759	M0040156	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
760	M0040157	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
761	M0040157	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
762	M0040158	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
763	M0040158	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
764	M0040159	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
765	M0040159	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
766	M0040160	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
767	M0040160	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
768	M0040161	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
769	M0040161	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
770	M0040162	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
771	M0040162	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
772	M0040163	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
773	M0040163	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
774	M0040164	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
775	M0040164	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
776	M0040165	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
777	M0040165	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
778	M0040166	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
779	M0040166	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
780	M0040167	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
781	M0040167	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
782	M0040168	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
783	M0040168	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
784	M0040169	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
785	M0040169	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
786	M0040170	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
787	M0040170	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
788	M0040171	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
789	M0040171	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
790	M0040172	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
791	M0040172	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
792	M0040173	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
793	M0040173	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
794	M0040180	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
795	M0040180	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
796	M0040185	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
797	M0040185	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
798	M0040186	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
799	M0040186	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
800	M0040187	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
801	M0040187	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
802	M0040188	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
803	M0040188	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
804	M0040197	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
805	M0040197	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
806	M0040198	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
807	M0040198	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
808	M0040219	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
809	M0040219	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
810	M0040220	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
811	M0040220	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
812	M0040236	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
813	M0040236	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
814	M0040246	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
815	M0040246	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
816	M0040247	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
817	M0040247	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
818	M0040248	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050757	T2SS	73.5	2.5e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetA	experiment
819	M0040248	1111525849767596_bin.21__k141_101207	EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207__EKOKHOOJ_00002	1111525849767596_bin.21__k141_101207	C2354	EKOKHOOJ_00002	VFG050755	T2SS	73.5	8.3e-205	28	525	0.9432	1.004	Effector delivery system	general secretion pathway protein E	Secretes multiple effectors that were shown to be required for virulence in?vivo, including the lipoyl synthases LipA and LipH as well as the protease CpaA	SetB	prediction
820	M0041272	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
821	M0041272	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
822	M0041273	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
823	M0041273	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
824	M0041274	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
825	M0041274	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
826	M0041275	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
827	M0041275	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
828	M0041276	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
829	M0041276	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
830	M0041277	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
831	M0041277	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
832	M0041278	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
833	M0041278	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
834	M0041279	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG002416	ECP	87.9	5.7e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
835	M0041279	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG018221	ECP	88.3	8.6e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
836	M0041280	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG002416	ECP	87.9	5.7e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
837	M0041280	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG018221	ECP	88.3	8.6e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
838	M0041281	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG002416	ECP	87.9	5.7e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
839	M0041281	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG018221	ECP	88.3	8.6e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
840	M0041282	1111525849768046_bin.25__k141_90932	PEAJFNCH_00020	1111525849768046_bin.25__k141_90932__PEAJFNCH_00020	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00020	VFG002417	ECP	76.2	1.5e-106	1	231	1.0	0.9788	Adherence	E. coli common pilus chaperone EcpE	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
841	M0041282	1111525849768046_bin.25__k141_90932	PEAJFNCH_00020	1111525849768046_bin.25__k141_90932__PEAJFNCH_00020	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00020	VFG034514	ECP	76.6	1.3e-106	1	231	1.0	0.9788	Adherence	E. coli common pilus chaperone EcpE	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
842	M0041283	1111525849768046_bin.25__k141_90932	PEAJFNCH_00020	1111525849768046_bin.25__k141_90932__PEAJFNCH_00020	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00020	VFG002417	ECP	76.2	1.5e-106	1	231	1.0	0.9788	Adherence	E. coli common pilus chaperone EcpE	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
843	M0041283	1111525849768046_bin.25__k141_90932	PEAJFNCH_00020	1111525849768046_bin.25__k141_90932__PEAJFNCH_00020	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00020	VFG034514	ECP	76.6	1.3e-106	1	231	1.0	0.9788	Adherence	E. coli common pilus chaperone EcpE	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
844	M0041305	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG002416	ECP	87.9	5.7e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
845	M0041305	1111525849768046_bin.25__k141_90932	PEAJFNCH_00019	1111525849768046_bin.25__k141_90932__PEAJFNCH_00019	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00019	VFG018221	ECP	88.3	8.6e-290	1	547	1.0	1	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
846	M0041326	1111525849768046_bin.25__k141_90932	PEAJFNCH_00017	1111525849768046_bin.25__k141_90932__PEAJFNCH_00017	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00017	VFG002412	ECP	82.4	1.3e-102	1	222	1.0	1	Adherence	E. coli common pilus chaperone EcpB	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
847	M0041326	1111525849768046_bin.25__k141_90932	PEAJFNCH_00017	1111525849768046_bin.25__k141_90932__PEAJFNCH_00017	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00017	VFG002412	ECP	82.4	9.4e-102	1	222	1.0	1	Adherence	E. coli common pilus chaperone EcpB	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
848	M0041327	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
849	M0041327	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
850	M0041328	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
851	M0041328	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
852	M0041329	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
853	M0041329	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
854	M0041330	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
855	M0041330	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
856	M0041331	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
857	M0041331	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
858	M0041332	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
859	M0041332	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
860	M0041333	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG002415	ECP	86.2	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
861	M0041333	1111525849768046_bin.25__k141_90932	PEAJFNCH_00018	1111525849768046_bin.25__k141_90932__PEAJFNCH_00018	1111525849768046_bin.25__k141_90932	C2360	PEAJFNCH_00018	VFG034475	ECP	86.7	0	1	841	1.0	1	Adherence	E. coli common pilus usher EcpC	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
862	M0041739	1111525849771023_bin.10__k141_481908	HIDNBCNF_00001	1111525849771023_bin.10__k141_481908__HIDNBCNF_00001	1111525849771023_bin.10__k141_481908	C2492	HIDNBCNF_00001	VFG037678	PNAG	70.5	9.2e-187	9	421	0.9741	0.9952	Biofilm	poly-beta-1,6 N-acetyl-D-glucosamine synthase	Critical for biofilm formation	SetA	experiment
863	M0041739	1111525849771023_bin.10__k141_481908	HIDNBCNF_00001	1111525849771023_bin.10__k141_481908__HIDNBCNF_00001	1111525849771023_bin.10__k141_481908	C2492	HIDNBCNF_00001	VFG037682	PNAG	70.7	5.3e-186	9	421	0.9741	0.9952	Biofilm	poly-beta-1,6 N-acetyl-D-glucosamine synthase	Critical for biofilm formation	SetB	prediction
864	M0043179	1111525849772552_bin.4__k141_121037	EJOKDIGH_00057	1111525849772552_bin.4__k141_121037__EJOKDIGH_00057	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00057	VFG037288	Acinetobactin	71.8	9.8e-164	1	373	0.9868	0.9739	Nutritional/Metabolic factor	acinetobactin biosynthesis protein BasF	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
865	M0043179	1111525849772552_bin.4__k141_121037	EJOKDIGH_00057	1111525849772552_bin.4__k141_121037__EJOKDIGH_00057	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00057	VFG044234	Pseudomonine	74.7	3.6e-170	1	372	0.9841	0.9231	Nutritional/Metabolic factor	histidine decarboxylase		SetB	prediction
866	M0043192	1111525849772552_bin.4__k141_121037	EJOKDIGH_00057	1111525849772552_bin.4__k141_121037__EJOKDIGH_00057	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00057	VFG037288	Acinetobactin	71.8	9.8e-164	1	373	0.9868	0.9739	Nutritional/Metabolic factor	acinetobactin biosynthesis protein BasF	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
867	M0043192	1111525849772552_bin.4__k141_121037	EJOKDIGH_00057	1111525849772552_bin.4__k141_121037__EJOKDIGH_00057	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00057	VFG044234	Pseudomonine	74.7	3.6e-170	1	372	0.9841	0.9231	Nutritional/Metabolic factor	histidine decarboxylase		SetB	prediction
868	M0043216	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
869	M0043216	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
870	M0043217	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
871	M0043217	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
872	M0043218	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
873	M0043218	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
874	M0043219	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
875	M0043219	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
876	M0043220	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
877	M0043220	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
878	M0043221	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
879	M0043221	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
880	M0043222	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048297	Type I fimbriae	83.2	1.8e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
881	M0043222	1111525849772552_bin.4__k141_121037	EJOKDIGH_00080	1111525849772552_bin.4__k141_121037__EJOKDIGH_00080	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00080	VFG048293	Type I fimbriae	83.9	4.6e-69	7	167	0.9641	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
882	M0043223	1111525849772552_bin.4__k141_121037	EJOKDIGH_00081	1111525849772552_bin.4__k141_121037__EJOKDIGH_00081	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00081	VFG048287	Type I fimbriae	79.3	9.4e-69	8	176	0.9602	0.9657	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetA	experiment
883	M0043223	1111525849772552_bin.4__k141_121037	EJOKDIGH_00081	1111525849772552_bin.4__k141_121037__EJOKDIGH_00081	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00081	VFG048281	Type I fimbriae	81.7	7.3e-73	2	176	0.9943	1	Adherence	type 1 fimbrial minor component	Adhering to human mucosal or epithelial surfaces	SetB	prediction
884	M0043224	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048277	Type I fimbriae	85.2	0	1	877	1.0	1.008	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetA	experiment
885	M0043224	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048270	Type I fimbriae	86.4	0	1	877	1.0	1.0023	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetB	prediction
886	M0043225	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048277	Type I fimbriae	85.2	0	1	877	1.0	1.008	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetA	experiment
887	M0043225	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048270	Type I fimbriae	86.4	0	1	877	1.0	1.0023	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetB	prediction
888	M0043226	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048277	Type I fimbriae	85.2	0	1	877	1.0	1.008	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetA	experiment
889	M0043226	1111525849772552_bin.4__k141_121037	EJOKDIGH_00082	1111525849772552_bin.4__k141_121037__EJOKDIGH_00082	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00082	VFG048270	Type I fimbriae	86.4	0	1	877	1.0	1.0023	Adherence	outer membrane usher protein 	Adhering to human mucosal or epithelial surfaces	SetB	prediction
890	M0043227	1111525849772552_bin.4__k141_121037	EJOKDIGH_00083	1111525849772552_bin.4__k141_121037__EJOKDIGH_00083	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00083	VFG048267	Type I fimbriae	87.1	6.3e-116	1	241	1.0	1	Adherence	periplasmic chaperone	Adhering to human mucosal or epithelial surfaces	SetA	experiment
891	M0043227	1111525849772552_bin.4__k141_121037	EJOKDIGH_00083	1111525849772552_bin.4__k141_121037__EJOKDIGH_00083	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00083	VFG048266	Type I fimbriae	87.6	1.6e-115	1	241	1.0	1	Adherence	periplasmic chaperone	Adhering to human mucosal or epithelial surfaces	SetB	prediction
892	M0043228	1111525849772552_bin.4__k141_121037	EJOKDIGH_00084	1111525849772552_bin.4__k141_121037__EJOKDIGH_00084	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00084	VFG048257	Type I fimbriae	79.4	2.3e-80	1	170	1.0	0.9551	Adherence	type 1 pilus biosynthesis fimbrial protein	Adhering to human mucosal or epithelial surfaces	SetA	experiment
893	M0043228	1111525849772552_bin.4__k141_121037	EJOKDIGH_00084	1111525849772552_bin.4__k141_121037__EJOKDIGH_00084	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00084	VFG048250	Type I fimbriae	81.2	3.2e-81	1	170	1.0	0.9497	Adherence	type 1 pilus biosynthesis fimbrial protein	Adhering to human mucosal or epithelial surfaces	SetB	prediction
894	M0043263	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
895	M0043263	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
896	M0043264	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
897	M0043264	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
898	M0043265	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
899	M0043265	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
900	M0043266	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
901	M0043266	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
902	M0043267	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
903	M0043267	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
904	M0043268	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
905	M0043268	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
906	M0043269	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
907	M0043269	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
908	M0043270	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
909	M0043270	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
910	M0043271	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
911	M0043271	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
912	M0043272	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
913	M0043272	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
914	M0043273	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
915	M0043273	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
916	M0043274	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
917	M0043274	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
918	M0043275	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
919	M0043275	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
920	M0043276	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
921	M0043276	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
922	M0043277	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
923	M0043277	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
924	M0043278	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
925	M0043278	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
926	M0043279	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
927	M0043279	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
928	M0043280	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
929	M0043280	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
930	M0043281	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
931	M0043281	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
932	M0043282	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
933	M0043282	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
934	M0043283	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
935	M0043283	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
936	M0043284	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
937	M0043284	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
938	M0043285	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
939	M0043285	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
940	M0043286	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
941	M0043286	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
942	M0043287	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048327	Type 3 fimbriae	70.5	6e-95	1	234	1.0	1	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
943	M0043287	1111525849772552_bin.4__k141_121037	EJOKDIGH_00112	1111525849772552_bin.4__k141_121037__EJOKDIGH_00112	1111525849772552_bin.4__k141_121037	C2521	EJOKDIGH_00112	VFG048320	Type 3 fimbriae	76.9	6.7e-98	1	234	1.0	1.0043	Biofilm	transcriptional activator	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
944	M0043473	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
945	M0043473	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
946	M0043474	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
947	M0043474	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
948	M0043475	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
949	M0043475	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
950	M0043476	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
951	M0043476	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
952	M0043477	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
953	M0043477	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
954	M0043478	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
955	M0043478	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
956	M0043479	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
957	M0043479	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
958	M0043480	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
959	M0043480	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
960	M0043481	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
961	M0043481	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
962	M0043482	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
963	M0043482	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
964	M0043483	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
965	M0043483	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
966	M0043484	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
967	M0043484	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
968	M0043485	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
969	M0043486	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
970	M0043487	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
971	M0043488	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
972	M0043489	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
973	M0043490	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
974	M0043491	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
975	M0043492	1111525849772552_bin.4__k141_321438	LGJPBMKF_00008	1111525849772552_bin.4__k141_321438__LGJPBMKF_00008	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00008	VFG049295	T6SS-III	81.6	1.5e-66	1	147	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssE		SetB	prediction
976	M0043568	1111525849772552_bin.4__k141_321438	LGJPBMKF_00003	1111525849772552_bin.4__k141_321438__LGJPBMKF_00003	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00003	VFG048632	T6SS	85.9	6.3e-75	1	163	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit VipA	Antibacterial activity	SetA	experiment
977	M0043568	1111525849772552_bin.4__k141_321438	LGJPBMKF_00003	1111525849772552_bin.4__k141_321438__LGJPBMKF_00003	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00003	VFG048624	T6SS	85.9	1.2e-74	1	163	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit VipA	Antibacterial activity	SetB	prediction
978	M0043569	1111525849772552_bin.4__k141_321438	LGJPBMKF_00004	1111525849772552_bin.4__k141_321438__LGJPBMKF_00004	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00004	VFG048643	T6SS	91.2	1.6e-278	1	510	0.998	0.9922	Effector delivery system	type VI secretion system contractile sheath large subunit VipB	Antibacterial activity	SetA	experiment
979	M0043569	1111525849772552_bin.4__k141_321438	LGJPBMKF_00004	1111525849772552_bin.4__k141_321438__LGJPBMKF_00004	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00004	VFG048635	T6SS	94.7	9.9e-288	1	510	0.998	1	Effector delivery system	type VI secretion system contractile sheath large subunit VipB	Antibacterial activity	SetB	prediction
980	M0043570	1111525849772552_bin.4__k141_321438	LGJPBMKF_00004	1111525849772552_bin.4__k141_321438__LGJPBMKF_00004	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00004	VFG048643	T6SS	91.2	1.6e-278	1	510	0.998	0.9922	Effector delivery system	type VI secretion system contractile sheath large subunit VipB	Antibacterial activity	SetA	experiment
981	M0043570	1111525849772552_bin.4__k141_321438	LGJPBMKF_00004	1111525849772552_bin.4__k141_321438__LGJPBMKF_00004	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00004	VFG048635	T6SS	94.7	9.9e-288	1	510	0.998	1	Effector delivery system	type VI secretion system contractile sheath large subunit VipB	Antibacterial activity	SetB	prediction
982	M0043571	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.5e-92	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetA	experiment
983	M0043571	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.1e-91	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetB	prediction
984	M0043572	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.5e-92	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetA	experiment
985	M0043572	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.1e-91	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetB	prediction
986	M0043573	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
987	M0043573	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
988	M0043574	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
989	M0043574	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
990	M0043575	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
991	M0043575	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
992	M0043576	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
993	M0043576	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
994	M0043577	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
995	M0043577	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
996	M0043578	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
997	M0043578	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
998	M0043579	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
999	M0043579	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1000	M0043580	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
1001	M0043580	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1002	M0043581	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
1003	M0043581	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1004	M0043582	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
1005	M0043582	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1006	M0043583	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
1007	M0043583	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1008	M0043584	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.5e-92	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetA	experiment
1009	M0043584	1111525849772552_bin.4__k141_321438	LGJPBMKF_00005	1111525849772552_bin.4__k141_321438__LGJPBMKF_00005	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00005	VFG048687	T6SS	97.5	1.1e-91	1	163	1.0	1	Effector delivery system	type VI secretion system protein, Hcp family	Antibacterial activity	SetB	prediction
1010	M0043585	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048697	T6SS	81.1	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetA	experiment
1011	M0043585	1111525849772552_bin.4__k141_321438	LGJPBMKF_00006	1111525849772552_bin.4__k141_321438__LGJPBMKF_00006	1111525849772552_bin.4__k141_321438	C2522	LGJPBMKF_00006	VFG048699	T6SS	81.2	0	1	876	0.9854	0.991	Effector delivery system	type VI secretion system ATPase TssH	Antibacterial activity	SetB	prediction
1012	M0044289	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1013	M0044289	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1014	M0044290	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1015	M0044290	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1016	M0044291	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1017	M0044291	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1018	M0044292	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1019	M0044292	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1020	M0044293	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1021	M0044293	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1022	M0044294	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1023	M0044294	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1024	M0044295	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1025	M0044295	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1026	M0044296	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1027	M0044296	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1028	M0044297	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1029	M0044297	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1030	M0044608	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1031	M0044608	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1032	M0044609	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1033	M0044609	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1034	M0044610	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1035	M0044610	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1036	M0044611	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1037	M0044611	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1038	M0044612	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1039	M0044612	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1040	M0044613	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1041	M0044613	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1042	M0044614	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1043	M0044614	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1044	M0044615	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1045	M0044615	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1046	M0044616	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1047	M0044616	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1048	M0044617	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1049	M0044617	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1050	M0044618	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG000574	MgtB	88.1	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetA	experiment
1051	M0044618	1111525849772552_bin.4__k141_350155	HKHCGNOH_00064	1111525849772552_bin.4__k141_350155__HKHCGNOH_00064	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00064	VFG018402	MgtB	88.6	0	1	910	1.0	1.0022	Nutritional/Metabolic factor	Mg2+ transport protein	Necessary for Salmonella intracellular survival under Mg2+ starvation conditions and exposure to oxidative stress	SetB	prediction
1052	M0044726	1111525849772552_bin.4__k141_350155	HKHCGNOH_00110	1111525849772552_bin.4__k141_350155__HKHCGNOH_00110	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00110	VFG002069	HSI-1	71.3	1.3e-65	1	167	0.9598	0.9709	Effector delivery system	type VI secretion system tubule-forming protein VipA	Play role in chronic P. aeruginosa infections	SetA	experiment
1053	M0044726	1111525849772552_bin.4__k141_350155	HKHCGNOH_00110	1111525849772552_bin.4__k141_350155__HKHCGNOH_00110	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00110	VFG015445	HSI-1	73	3.2e-65	6	168	0.9368	0.9532	Effector delivery system	type VI secretion system tubule-forming protein VipA	Play role in chronic P. aeruginosa infections	SetB	prediction
1054	M0044727	1111525849772552_bin.4__k141_350155	HKHCGNOH_00110	1111525849772552_bin.4__k141_350155__HKHCGNOH_00110	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00110	VFG002069	HSI-1	71.3	1.3e-65	1	167	0.9598	0.9709	Effector delivery system	type VI secretion system tubule-forming protein VipA	Play role in chronic P. aeruginosa infections	SetA	experiment
1055	M0044727	1111525849772552_bin.4__k141_350155	HKHCGNOH_00110	1111525849772552_bin.4__k141_350155__HKHCGNOH_00110	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00110	VFG015445	HSI-1	73	3.2e-65	6	168	0.9368	0.9532	Effector delivery system	type VI secretion system tubule-forming protein VipA	Play role in chronic P. aeruginosa infections	SetB	prediction
1056	M0044728	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1057	M0044728	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1058	M0044729	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1059	M0044729	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1060	M0044730	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1061	M0044730	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1062	M0044731	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1063	M0044731	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1064	M0044732	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1065	M0044732	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1066	M0044733	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1067	M0044733	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1068	M0044734	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1069	M0044734	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1070	M0044735	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1071	M0044735	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1072	M0044736	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1073	M0044736	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1074	M0044737	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1075	M0044737	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1076	M0044738	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1077	M0044738	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1078	M0044739	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1079	M0044739	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1080	M0044740	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1081	M0044740	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1082	M0044741	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1083	M0044741	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1084	M0045015	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1085	M0045015	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1086	M0045016	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1087	M0045016	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1088	M0045336	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1089	M0045336	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1090	M0045337	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041098	SCI (Salmonella centrisome island)/SPI-6 T6SS	72.6	2.3e-221	11	499	0.98	0.9741	Effector delivery system	EvpB family type VI secretion protein	Repsonsible for secreting two antibacterial effectors, Tlde1 and Tae4	SetA	experiment
1091	M0045337	1111525849772552_bin.4__k141_350155	HKHCGNOH_00111	1111525849772552_bin.4__k141_350155__HKHCGNOH_00111	1111525849772552_bin.4__k141_350155	C2523	HKHCGNOH_00111	VFG041203	CTS1	74.4	2e-229	1	495	0.992	0.992	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
1092	M0045898	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1093	M0045899	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1094	M0045900	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1095	M0045901	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1096	M0045902	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1097	M0045903	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1098	M0045904	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1099	M0045905	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1100	M0045906	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1101	M0045907	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1102	M0045916	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1103	M0045917	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1104	M0045975	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1105	M0045976	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1106	M0045977	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1107	M0045978	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1108	M0045979	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1109	M0045980	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1110	M0045981	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1111	M0045982	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1112	M0045983	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1113	M0045984	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1114	M0046033	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1115	M0046037	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1116	M0046038	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1117	M0046053	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1118	M0046054	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1119	M0046059	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1120	M0046078	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1121	M0046079	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1122	M0046080	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1123	M0046081	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1124	M0046082	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1125	M0046083	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1126	M0046084	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1127	M0046085	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1128	M0046086	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1129	M0046087	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1130	M0046125	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1131	M0046126	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1132	M0046127	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1133	M0046128	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1134	M0046129	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1135	M0046130	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1136	M0046131	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1137	M0046132	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1138	M0046133	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1139	M0046134	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1140	M0046147	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1141	M0046148	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1142	M0046149	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1143	M0046150	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1144	M0046151	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1145	M0046152	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1146	M0046153	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1147	M0046154	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1148	M0046155	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1149	M0046156	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1150	M0046157	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1151	M0046158	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1152	M0046159	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1153	M0046160	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1154	M0046161	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1155	M0046162	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1156	M0046163	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1157	M0046164	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1158	M0046165	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1159	M0046167	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1160	M0046168	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1161	M0046169	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1162	M0046170	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1163	M0046171	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1164	M0046172	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1165	M0046173	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1166	M0046174	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1167	M0046175	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1168	M0046176	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1169	M0046177	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1170	M0046178	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1171	M0046179	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1172	M0046180	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1173	M0046181	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1174	M0046182	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1175	M0046183	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1176	M0046184	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1177	M0046185	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1178	M0046186	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1179	M0046187	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1180	M0046188	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1181	M0046189	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1182	M0046190	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1183	M0046191	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1184	M0046242	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1185	M0046243	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1186	M0046244	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1187	M0046245	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1188	M0046246	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1189	M0046247	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1190	M0046248	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1191	M0046249	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1192	M0046250	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1193	M0046251	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1194	M0046252	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1195	M0046286	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1196	M0046290	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1197	M0046291	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1198	M0046292	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1199	M0046322	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1200	M0046323	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1201	M0046324	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1202	M0046325	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1203	M0046326	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1204	M0046327	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1205	M0046328	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1206	M0046329	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1207	M0046330	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1208	M0046331	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1209	M0046443	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1210	M0046444	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1211	M0046445	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1212	M0046447	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1213	M0046448	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1214	M0046449	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1215	M0046454	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1216	M0046455	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1217	M0046456	1111525849773237_bin.12__k141_84883	PEGFCOMK_00004	1111525849773237_bin.12__k141_84883__PEGFCOMK_00004	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00004	VFG044272	Staphyloferrin A	72.6	6.7e-139	1	343	1.0	1	Nutritional/Metabolic factor	iron ABC transporter permease		SetB	prediction
1218	M0046466	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1219	M0046467	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1220	M0046472	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1221	M0046473	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1222	M0046474	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1223	M0046480	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1224	M0046482	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1225	M0046483	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1226	M0046484	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1227	M0046535	1111525849773237_bin.12__k141_84883	PEGFCOMK_00003	1111525849773237_bin.12__k141_84883__PEGFCOMK_00003	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00003	VFG044271	Staphyloferrin A	78.4	8e-125	1	291	1.0	0.9037	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1228	M0046536	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1229	M0046537	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1230	M0046538	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1231	M0046539	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1232	M0046540	1111525849773237_bin.12__k141_84883	PEGFCOMK_00005	1111525849773237_bin.12__k141_84883__PEGFCOMK_00005	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00005	VFG044273	Staphyloferrin A	72.2	5e-131	1	327	0.9879	1	Nutritional/Metabolic factor	ABC transporter substrate-binding protein		SetB	prediction
1233	M0046562	1111525849773237_bin.12__k141_84883	PEGFCOMK_00008	1111525849773237_bin.12__k141_84883__PEGFCOMK_00008	1111525849773237_bin.12__k141_84883	C2534	PEGFCOMK_00008	VFG044276	Staphyloferrin A	74.9	3.1e-167	16	406	0.9583	0.9849	Nutritional/Metabolic factor	staphyloferrin A export MFS transporter		SetB	prediction
1234	M0047752	1111525849853957_bin.36__k141_973421	KGMJEOOI_00018	1111525849853957_bin.36__k141_973421__KGMJEOOI_00018	1111525849853957_bin.36__k141_973421	C2582	KGMJEOOI_00018	VFG043453	SE2319	85	2.2e-155	1	333	1.0	1.0278	Adherence	autolysin/adhesin Aae		SetB	prediction
1235	M0047757	1111525849853957_bin.36__k141_973421	KGMJEOOI_00018	1111525849853957_bin.36__k141_973421__KGMJEOOI_00018	1111525849853957_bin.36__k141_973421	C2582	KGMJEOOI_00018	VFG043453	SE2319	85	2.2e-155	1	333	1.0	1.0278	Adherence	autolysin/adhesin Aae		SetB	prediction
1236	M0047914	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1237	M0047914	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1238	M0047915	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1239	M0047915	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1240	M0047916	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1241	M0047916	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1242	M0047917	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1243	M0047917	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1244	M0047918	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1245	M0047918	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1246	M0047919	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1247	M0047919	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1248	M0047920	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1249	M0047920	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1250	M0047921	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1251	M0047921	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1252	M0047922	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1253	M0047922	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1254	M0047923	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1255	M0047923	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1256	M0047924	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1257	M0047924	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1258	M0047925	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1259	M0047925	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1260	M0047926	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1261	M0047926	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1262	M0047927	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1263	M0047927	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1264	M0047928	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1265	M0047928	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1266	M0047929	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1267	M0047929	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1268	M0047930	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1269	M0047930	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1270	M0047931	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1271	M0047931	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1272	M0047932	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1273	M0047932	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1274	M0047933	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1275	M0047933	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1276	M0047934	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1277	M0047934	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1278	M0047935	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1279	M0047935	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1280	M0047936	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1281	M0047936	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1282	M0047937	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1283	M0047937	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1284	M0047938	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1285	M0047938	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1286	M0047939	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1287	M0047939	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1288	M0047940	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1289	M0047940	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1290	M0047941	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1291	M0047941	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1292	M0047942	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1293	M0047942	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1294	M0047943	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1295	M0047943	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1296	M0047944	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1297	M0047944	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1298	M0047945	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1299	M0047945	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1300	M0047946	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1301	M0047946	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1302	M0047947	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1303	M0047947	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1304	M0047948	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1305	M0047948	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1306	M0047949	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1307	M0047949	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1308	M0047950	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1309	M0047950	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1310	M0047951	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1311	M0047951	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1312	M0047952	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1313	M0047952	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1314	M0047953	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1315	M0047953	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1316	M0047954	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1317	M0047954	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1318	M0047955	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1319	M0047955	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1320	M0047956	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1321	M0047956	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1322	M0047957	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1323	M0047957	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1324	M0047958	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1325	M0047958	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1326	M0047959	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1327	M0047959	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1328	M0047960	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1329	M0047960	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1330	M0047961	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1331	M0047961	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1332	M0047962	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1333	M0047962	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1334	M0047963	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1335	M0047963	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1336	M0048002	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1337	M0048002	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1338	M0048003	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1339	M0048003	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1340	M0048004	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1341	M0048004	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1342	M0048005	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1343	M0048005	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1344	M0048006	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1345	M0048006	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1346	M0048007	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1347	M0048007	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1348	M0048008	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1349	M0048008	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1350	M0048009	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1351	M0048009	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1352	M0048010	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1353	M0048010	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1354	M0048011	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1355	M0048011	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1356	M0048016	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1357	M0048016	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1358	M0048017	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1359	M0048017	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1360	M0048018	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1361	M0048018	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1362	M0048019	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1363	M0048019	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1364	M0048020	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1365	M0048020	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1366	M0048021	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1367	M0048021	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1368	M0048022	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1369	M0048022	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1370	M0048023	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1371	M0048023	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1372	M0048024	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1373	M0048024	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1374	M0048025	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1375	M0048025	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1376	M0048026	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1377	M0048026	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1378	M0048036	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1379	M0048036	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1380	M0048037	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1381	M0048037	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1382	M0048038	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1383	M0048038	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1384	M0048039	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1385	M0048039	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1386	M0048040	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1387	M0048040	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1388	M0048051	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1389	M0048051	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1390	M0048056	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1391	M0048056	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1392	M0048057	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1393	M0048057	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1394	M0048080	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1395	M0048080	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1396	M0048083	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1397	M0048083	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1398	M0048084	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1399	M0048084	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1400	M0048085	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1401	M0048085	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1402	M0048086	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1403	M0048086	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1404	M0048087	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1405	M0048087	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1406	M0048088	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1407	M0048088	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1408	M0048089	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1409	M0048089	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1410	M0048106	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1411	M0048106	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1412	M0048114	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1413	M0048114	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1414	M0048115	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1415	M0048115	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1416	M0048116	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1417	M0048116	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1418	M0048117	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1419	M0048117	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1420	M0048118	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1421	M0048118	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1422	M0048119	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1423	M0048119	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1424	M0048120	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1425	M0048120	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1426	M0048121	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1427	M0048121	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1428	M0048122	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1429	M0048122	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1430	M0048123	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1431	M0048123	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1432	M0048124	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1433	M0048124	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1434	M0048125	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1435	M0048125	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1436	M0048126	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1437	M0048126	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1438	M0048127	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1439	M0048127	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1440	M0048128	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1441	M0048128	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1442	M0048129	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1443	M0048129	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1444	M0048130	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1445	M0048130	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1446	M0048131	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1447	M0048131	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1448	M0048135	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1449	M0048135	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1450	M0048136	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG041016	HSI-2	86.8	3.4e-257	1	492	1.0	1.002	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1451	M0048136	1111525849854017_bin.1__k141_13121	BNLHKGKM_00009	1111525849854017_bin.1__k141_13121__BNLHKGKM_00009	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00009	VFG051523	HSI-2	89	6.9e-262	4	492	0.9939	0.998	Effector delivery system	type VI secretion system contractile sheath large subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1452	M0048137	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1453	M0048137	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1454	M0048138	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1455	M0048138	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1456	M0048139	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1457	M0048139	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1458	M0048140	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG041018	HSI-2	74.6	8.3e-242	70	596	0.8842	1.0019	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1459	M0048140	1111525849854017_bin.1__k141_13121	BNLHKGKM_00004	1111525849854017_bin.1__k141_13121__BNLHKGKM_00004	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00004	VFG051540	HSI-2	78	2.7e-284	1	596	1.0	1.0017	Effector delivery system	type VI secretion system baseplate subunit TssF	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1460	M0048141	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1461	M0048141	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1462	M0048142	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	1.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1463	M0048142	1111525849854017_bin.1__k141_13121	BNLHKGKM_00008	1111525849854017_bin.1__k141_13121__BNLHKGKM_00008	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00008	VFG041017	HSI-2	82.8	8.1e-56	1	134	0.9926	0.9926	Effector delivery system	type VI secretion system baseplate subunit TssE	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1464	M0048143	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG041019	HSI-2	79.7	1.6e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1465	M0048143	1111525849854017_bin.1__k141_13121	BNLHKGKM_00003	1111525849854017_bin.1__k141_13121__BNLHKGKM_00003	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00003	VFG051543	HSI-2	80	7e-157	1	335	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1466	M0048144	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG041020	HSI-2	78.9	0	1	863	1.0	0.984	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1467	M0048144	1111525849854017_bin.1__k141_13121	BNLHKGKM_00002	1111525849854017_bin.1__k141_13121__BNLHKGKM_00002	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00002	VFG051556	HSI-2	77.3	0	1	863	1.0	0.9751	Effector delivery system	type VI secretion system ATPase TssH	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1468	M0048146	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	4.2e-74	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetA	experiment
1469	M0048146	1111525849854017_bin.1__k141_13121	BNLHKGKM_00010	1111525849854017_bin.1__k141_13121__BNLHKGKM_00010	1111525849854017_bin.1__k141_13121	C2584	BNLHKGKM_00010	VFG041015	HSI-2	82.7	3.1e-73	1	168	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	The effectors PldA and PldB of Pseudomonas aeruginosa H2-T6SS target the Akt pathway to facilitate bacterial internalization;involved in the secretion of ModA that mediates molybdate uptake for P. aeruginosa in bacterium-bacterium competition under anaerobic conditions	SetB	prediction
1470	M0048754	1111525849857134_bin.10__k141_178378	JBFFEALM_00006	1111525849857134_bin.10__k141_178378__JBFFEALM_00006	1111525849857134_bin.10__k141_178378	C2600	JBFFEALM_00006	VFG015830	Pyoverdine	86	1.7e-179	1	336	0.997	0.997	Nutritional/Metabolic factor	acetyltransferase	Effective at acquiring iron from transferrin and lactoferrin; cytotoxic due to its ability to stimulating the production of reactive oxygen species	SetB	prediction
1471	M0049413	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1472	M0049413	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1473	M0049414	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1474	M0049414	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1475	M0049415	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1476	M0049415	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1477	M0049416	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1478	M0049416	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1479	M0049424	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1480	M0049424	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1481	M0049425	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1482	M0049425	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1483	M0049426	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1484	M0049426	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1485	M0049427	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG000133	Alginate	80.5	3.4e-230	1	473	0.9834	0.9834	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetA	experiment
1486	M0049427	1111525849858229_bin.11__k141_19080	JCMFOCHF_00003	1111525849858229_bin.11__k141_19080__JCMFOCHF_00003	1111525849858229_bin.11__k141_19080	C2620	JCMFOCHF_00003	VFG014892	Alginate	99.6	9.6e-285	1	481	1.0	1	Biofilm	phosphomannose isomerase / guanosine 5'-diphospho-D-mannose pyrophosphorylase	Allows the bacteria form biofilm; contributes to the persistence of the bacteria in the CF lung: act as an adhesin, preventing the bacteria from being expelled from the lung, and alginate slime layer makes it more difficult for phagocytes to ingest and kill the bacteria	SetB	prediction
1487	M0053174	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1488	M0053174	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1489	M0053177	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1490	M0053177	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1491	M0053178	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1492	M0053178	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1493	M0053179	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1494	M0053179	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1495	M0053180	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1496	M0053180	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1497	M0053181	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1498	M0053181	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1499	M0053182	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1500	M0053182	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1501	M0053183	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetA	experiment
1502	M0053183	1111525849861015_bin.9__k141_1406239	FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239__FMJFJDKA_00002	1111525849861015_bin.9__k141_1406239	C2704	FMJFJDKA_00002	VFG043465	PfbA	81.5	0	1	702	1.0	0.9764	Adherence	cell wall surface anchor family protein, Plasminogen- and Fibronectin-binding protein A	A surface adhesin and invasin that binds to human fibronectin and plasminogen of the host extracellular matrix	SetB	prediction
1503	M0054217	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1504	M0054217	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1505	M0054218	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1506	M0054218	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1507	M0054219	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1508	M0054219	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1509	M0054220	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1510	M0054220	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1511	M0054221	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1512	M0054221	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1513	M0054222	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1514	M0054222	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1515	M0054223	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1516	M0054223	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1517	M0054224	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1518	M0054224	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1519	M0054225	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1520	M0054225	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1521	M0054226	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1522	M0054226	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1523	M0054227	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1524	M0054227	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1525	M0054228	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1526	M0054228	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1527	M0054229	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1528	M0054229	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1529	M0054230	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1530	M0054230	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1531	M0054231	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1532	M0054231	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1533	M0054232	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1534	M0054232	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1535	M0054233	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1536	M0054233	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1537	M0054234	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1538	M0054234	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1539	M0054235	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1540	M0054235	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1541	M0054236	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1542	M0054236	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1543	M0054237	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1544	M0054237	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1545	M0054238	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1546	M0054238	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1547	M0054239	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1548	M0054239	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1549	M0054240	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1550	M0054240	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1551	M0054378	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1552	M0054378	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1553	M0054379	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1554	M0054379	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1555	M0054380	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034679	Ibes	75.7	1.4e-193	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetA	experiment
1556	M0054380	1111525849861839_bin.8__k141_38402	HDNNILPG_00005	1111525849861839_bin.8__k141_38402__HDNNILPG_00005	1111525849861839_bin.8__k141_38402	C2742	HDNNILPG_00005	VFG034663	Ibes	76.4	1.5e-194	1	461	1.0	1.0022	Invasion	Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC	Contributes to brain microvascular endothelial cells (BMECs) invasion via a ligand-receptor interaction	SetB	prediction
1557	M0059818	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG002416	ECP	96.3	5.6e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
1558	M0059818	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG018221	ECP	96.8	2.9e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
1559	M0059819	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG002416	ECP	96.3	5.6e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
1560	M0059819	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG018221	ECP	96.8	2.9e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
1561	M0059820	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG002416	ECP	96.3	5.6e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetA	experiment
1562	M0059820	CP125156.1	GHCAAKOG_01000	CP125156.1__GHCAAKOG_01000	CP125156.1	C212	GHCAAKOG_01000	VFG018221	ECP	96.8	2.9e-251	9	445	0.982	0.7989	Adherence	polymerized tip adhesin of ECP fibers	ECP, composed of a 21-kDa pilin subunit EspA, is a pilus-adherence factor that is crucial to the virulence of E. coli O157 in humans, and is also carried by commensal strains of E. coli.; It is suggested that pathogenic E. coli strains may use ECP to mimic commensal E. coli and provide themselves with an ecological advantage for host colonization and evasion of the immune system.	SetB	prediction
1563	M0063839	DP1807004395_bin.4__NODE_12_length_87200_cov_2.761955	CFDMAPGG_00053	DP1807004395_bin.4__NODE_12_length_87200_cov_2.761955__CFDMAPGG_00053	DP1807004395_bin.4__NODE_12_length_87200_cov_2.761955	C2841	CFDMAPGG_00053	VFG026575	Mycobactin	77.2	0	1	1030	1.0	0.999	Nutritional/Metabolic factor	Polyketide synthetase MbtD (polyketide synthase)	Cell-association mycobactin participates in iron internalization and/or to serve as a temporary iron-holding molecule to prevent sudden influx of excess iron if the metal suddenly becomes available after a period of iron limitation	SetB	prediction
1564	M0069114	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1565	M0069114	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1566	M0069115	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1567	M0069115	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1568	M0069116	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1569	M0069116	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1570	M0069117	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1571	M0069117	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1572	M0069118	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1573	M0069118	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1574	M0069119	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1575	M0069119	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1576	M0069120	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037720	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetA	experiment
1577	M0069120	DSKIN0031-1_bin.8__k141_19928	COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928__COFOKFAB_00016	DSKIN0031-1_bin.8__k141_19928	C2988	COFOKFAB_00016	VFG037718	AdeFGH efflux pump	70.7	0	1	1065	0.9834	1.0057	Biofilm	cation/multidrug efflux pump	Play a potential role in the synthesis and transport of autoinducer molecules during biofilm formation	SetB	prediction
1578	M0070206	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG037414	Acinetobactin	70.6	7.9e-117	23	321	0.8952	0.9708	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1579	M0070206	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG044227	Pseudomonine	74.8	1e-123	15	334	0.9581	1.0159	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1580	M0070207	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG037414	Acinetobactin	70.6	7.9e-117	23	321	0.8952	0.9708	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1581	M0070207	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG044227	Pseudomonine	74.8	1e-123	15	334	0.9581	1.0159	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1582	M0070208	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG037414	Acinetobactin	70.6	7.9e-117	23	321	0.8952	0.9708	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1583	M0070208	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG044227	Pseudomonine	74.8	1e-123	15	334	0.9581	1.0159	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1584	M0070209	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG037414	Acinetobactin	70.6	7.9e-117	23	321	0.8952	0.9708	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1585	M0070209	DSKIN0049-1_bin.26__k141_40024	FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024__FDKFKBOO_00014	DSKIN0049-1_bin.26__k141_40024	C3040	FDKFKBOO_00014	VFG044227	Pseudomonine	74.8	1e-123	15	334	0.9581	1.0159	Nutritional/Metabolic factor	iron chelate uptake ABC transporter family permease subunit		SetB	prediction
1586	M0074333	MET0114_bin.4__k81_1205	OAHCGHHK_00014	MET0114_bin.4__k81_1205__OAHCGHHK_00014	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00014	VFG044262	Staphyloferrin B	100	1.3e-152	1	254	1.0	1	Nutritional/Metabolic factor	bifunctional transcriptional regulator/O-phospho-L-serine synthase SbnI		SetB	prediction
1587	M0074334	MET0114_bin.4__k81_1205	OAHCGHHK_00014	MET0114_bin.4__k81_1205__OAHCGHHK_00014	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00014	VFG044262	Staphyloferrin B	100	1.3e-152	1	254	1.0	1	Nutritional/Metabolic factor	bifunctional transcriptional regulator/O-phospho-L-serine synthase SbnI		SetB	prediction
1588	M0074335	MET0114_bin.4__k81_1205	OAHCGHHK_00015	MET0114_bin.4__k81_1205__OAHCGHHK_00015	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00015	VFG044261	Staphyloferrin B	98.5	2.8e-237	1	400	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis decarboxylase SbnH		SetB	prediction
1589	M0074336	MET0114_bin.4__k81_1205	OAHCGHHK_00015	MET0114_bin.4__k81_1205__OAHCGHHK_00015	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00015	VFG044261	Staphyloferrin B	98.5	2.8e-237	1	400	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis decarboxylase SbnH		SetB	prediction
1590	M0074337	MET0114_bin.4__k81_1205	OAHCGHHK_00016	MET0114_bin.4__k81_1205__OAHCGHHK_00016	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00016	VFG044260	Staphyloferrin B	100	2.3e-144	1	258	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis citrate synthase SbnG		SetB	prediction
1591	M0074338	MET0114_bin.4__k81_1205	OAHCGHHK_00016	MET0114_bin.4__k81_1205__OAHCGHHK_00016	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00016	VFG044260	Staphyloferrin B	100	2.3e-144	1	258	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis citrate synthase SbnG		SetB	prediction
1592	M0074339	MET0114_bin.4__k81_1205	OAHCGHHK_00016	MET0114_bin.4__k81_1205__OAHCGHHK_00016	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00016	VFG044260	Staphyloferrin B	100	2.3e-144	1	258	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis citrate synthase SbnG		SetB	prediction
1593	M0074340	MET0114_bin.4__k81_1205	OAHCGHHK_00016	MET0114_bin.4__k81_1205__OAHCGHHK_00016	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00016	VFG044260	Staphyloferrin B	100	2.3e-144	1	258	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis citrate synthase SbnG		SetB	prediction
1594	M0074341	MET0114_bin.4__k81_1205	OAHCGHHK_00016	MET0114_bin.4__k81_1205__OAHCGHHK_00016	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00016	VFG044260	Staphyloferrin B	100	2.3e-144	1	258	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis citrate synthase SbnG		SetB	prediction
1595	M0074342	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1596	M0074343	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1597	M0074344	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1598	M0074345	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1599	M0074346	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1600	M0074347	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1601	M0074348	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1602	M0074349	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1603	M0074350	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1604	M0074351	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1605	M0074352	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1606	M0074353	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1607	M0074354	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1608	M0074355	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1609	M0074356	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1610	M0074357	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1611	M0074358	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1612	M0074359	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1613	M0074360	MET0114_bin.4__k81_1205	OAHCGHHK_00017	MET0114_bin.4__k81_1205__OAHCGHHK_00017	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00017	VFG044259	Staphyloferrin B	98.1	0	1	592	1.0	0.961	Nutritional/Metabolic factor	3-(L-alanin-3-ylcarbamoyl)-2-[(2- aminoethylcarbamoyl)methyl]-2-hydroxypropanoate synthase SbnF		SetB	prediction
1614	M0074361	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1615	M0074362	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1616	M0074363	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1617	M0074364	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1618	M0074365	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1619	M0074366	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1620	M0074367	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1621	M0074368	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1622	M0074369	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1623	M0074370	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1624	M0074371	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1625	M0074372	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1626	M0074373	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1627	M0074374	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1628	M0074375	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1629	M0074376	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1630	M0074377	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1631	M0074378	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1632	M0074379	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1633	M0074380	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1634	M0074381	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1635	M0074382	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1636	M0074383	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1637	M0074384	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1638	M0074385	MET0114_bin.4__k81_1205	OAHCGHHK_00018	MET0114_bin.4__k81_1205__OAHCGHHK_00018	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00018	VFG044258	Staphyloferrin B	98.4	0	1	578	1.0	1	Nutritional/Metabolic factor	L-2,3-diaminopropanoate--citrate ligase SbnE		SetB	prediction
1639	M0074386	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1640	M0074387	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1641	M0074388	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1642	M0074389	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1643	M0074390	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1644	M0074391	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1645	M0074392	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1646	M0074393	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1647	M0074394	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1648	M0074395	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1649	M0074396	MET0114_bin.4__k81_1205	OAHCGHHK_00020	MET0114_bin.4__k81_1205__OAHCGHHK_00020	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00020	VFG044256	Staphyloferrin B	99.3	0	1	584	1.0	1	Nutritional/Metabolic factor	staphyloferrin B biosynthesis protein SbnC		SetB	prediction
1650	M0074397	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1651	M0074398	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1652	M0074399	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1653	M0074400	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1654	M0074401	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1655	M0074402	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1656	M0074403	MET0114_bin.4__k81_1205	OAHCGHHK_00019	MET0114_bin.4__k81_1205__OAHCGHHK_00019	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00019	VFG044257	Staphyloferrin B	100	1.4e-226	1	418	1.0	1	Nutritional/Metabolic factor	staphyloferrin B export MFS transporter		SetB	prediction
1657	M0074404	MET0114_bin.4__k81_1205	OAHCGHHK_00023	MET0114_bin.4__k81_1205__OAHCGHHK_00023	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00023	VFG044253	Staphyloferrin B	100	6.6e-184	1	330	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter substrate-binding protein SirA		SetB	prediction
1658	M0074405	MET0114_bin.4__k81_1205	OAHCGHHK_00023	MET0114_bin.4__k81_1205__OAHCGHHK_00023	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00023	VFG044253	Staphyloferrin B	100	6.6e-184	1	330	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter substrate-binding protein SirA		SetB	prediction
1659	M0074406	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1660	M0074407	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1661	M0074408	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1662	M0074409	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1663	M0074410	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1664	M0074411	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1665	M0074412	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1666	M0074413	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1667	M0074414	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1668	M0074415	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1669	M0074416	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1670	M0074417	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1671	M0074418	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1672	M0074419	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1673	M0074420	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1674	M0074421	MET0114_bin.4__k81_1205	OAHCGHHK_00025	MET0114_bin.4__k81_1205__OAHCGHHK_00025	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00025	VFG044251	Staphyloferrin B	100	3.2e-170	1	332	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirC		SetB	prediction
1675	M0074422	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1676	M0074423	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1677	M0074424	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1678	M0074425	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1679	M0074426	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1680	M0074427	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1681	M0074428	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1682	M0074429	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1683	M0074430	MET0114_bin.4__k81_1205	OAHCGHHK_00021	MET0114_bin.4__k81_1205__OAHCGHHK_00021	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00021	VFG044255	Staphyloferrin B	100	3.2e-194	1	336	1.0	1	Nutritional/Metabolic factor	N-[(2S)-2-amino-2-carboxyethyl]-L-glutamate dehydrogenase SbnB		SetB	prediction
1684	M0074431	MET0114_bin.4__k81_1205	OAHCGHHK_00022	MET0114_bin.4__k81_1205__OAHCGHHK_00022	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00022	VFG044254	Staphyloferrin B	100	1.1e-188	1	326	1.0	1	Nutritional/Metabolic factor	2,3-diaminopropionate biosynthesis protein SbnA		SetB	prediction
1685	M0074432	MET0114_bin.4__k81_1205	OAHCGHHK_00022	MET0114_bin.4__k81_1205__OAHCGHHK_00022	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00022	VFG044254	Staphyloferrin B	100	1.1e-188	1	326	1.0	1	Nutritional/Metabolic factor	2,3-diaminopropionate biosynthesis protein SbnA		SetB	prediction
1686	M0074433	MET0114_bin.4__k81_1205	OAHCGHHK_00022	MET0114_bin.4__k81_1205__OAHCGHHK_00022	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00022	VFG044254	Staphyloferrin B	100	1.1e-188	1	326	1.0	1	Nutritional/Metabolic factor	2,3-diaminopropionate biosynthesis protein SbnA		SetB	prediction
1687	M0074434	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1688	M0074434	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1689	M0074435	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1690	M0074435	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1691	M0074436	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1692	M0074436	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1693	M0074437	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1694	M0074437	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1695	M0074438	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1696	M0074438	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1697	M0074439	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1698	M0074439	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1699	M0074440	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1700	M0074440	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1701	M0074441	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1702	M0074441	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1703	M0074442	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1704	M0074442	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1705	M0074443	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1706	M0074443	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1707	M0074444	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1708	M0074444	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1709	M0074445	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1710	M0074445	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1711	M0074446	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG001313	SpA	95.9	3.3e-263	13	520	0.9769	1.0325	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetA	experiment
1712	M0074446	MET0114_bin.4__k81_1205	OAHCGHHK_00027	MET0114_bin.4__k81_1205__OAHCGHHK_00027	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00027	VFG004646	SpA	98.8	9.1e-273	13	520	0.9769	1	Exotoxin	Immunoglobulin G binding protein A precursor	Bind to the Fc domain of IgG and inhibit opsonophagocytosis; can mediate attachment of S.aureus to von Willebrand factor, a protein present at sites of damage to the endothelium, and might therefore play a role as an adhesin during the initiation of intravascular infection	SetB	prediction
1713	M0074447	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1714	M0074448	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1715	M0074449	MET0114_bin.4__k81_1205	OAHCGHHK_00024	MET0114_bin.4__k81_1205__OAHCGHHK_00024	MET0114_bin.4__k81_1205	C3092	OAHCGHHK_00024	VFG044252	Staphyloferrin B	100	1.1e-167	1	331	1.0	1	Nutritional/Metabolic factor	staphyloferrin B ABC transporter permease subunit SirB		SetB	prediction
1716	M0074471	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1717	M0074471	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1718	M0074472	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1719	M0074472	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1720	M0074473	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1721	M0074473	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1722	M0074474	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1723	M0074474	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1724	M0074475	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1725	M0074475	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1726	M0074476	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1727	M0074476	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1728	M0074477	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1729	M0074477	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1730	M0074478	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1731	M0074478	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1732	M0074479	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1733	M0074479	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1734	M0074480	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1735	M0074480	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1736	M0074481	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1737	M0074481	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1738	M0074482	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1739	M0074482	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1740	M0074483	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1741	M0074483	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1742	M0074484	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1743	M0074484	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1744	M0074485	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1745	M0074485	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1746	M0074486	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1747	M0074486	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1748	M0074487	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1749	M0074487	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1750	M0074488	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1751	M0074488	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1752	M0074489	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1753	M0074489	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1754	M0074490	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1755	M0074490	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1756	M0074491	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1757	M0074491	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1758	M0074492	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1759	M0074492	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1760	M0074493	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1761	M0074493	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1762	M0074494	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1763	M0074494	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1764	M0074495	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1765	M0074495	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1766	M0074496	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1767	M0074496	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1768	M0074497	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1769	M0074497	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1770	M0074498	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1771	M0074498	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1772	M0074499	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1773	M0074499	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1774	M0074500	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1775	M0074500	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1776	M0074501	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1777	M0074501	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1778	M0074502	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1779	M0074502	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1780	M0074503	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1781	M0074503	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1782	M0074504	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1783	M0074504	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1784	M0074505	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1785	M0074505	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1786	M0074506	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1787	M0074506	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1788	M0074507	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1789	M0074507	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1790	M0074508	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1791	M0074508	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1792	M0074509	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1793	M0074509	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1794	M0074510	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1795	M0074510	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1796	M0074511	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1797	M0074511	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1798	M0074512	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1799	M0074512	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1800	M0074513	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1801	M0074513	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1802	M0074514	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1803	M0074514	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1804	M0074515	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1805	M0074515	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1806	M0074543	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetA	experiment
1807	M0074543	MET0114_bin.4__k81_3932	KFKDIIAG_00018	MET0114_bin.4__k81_3932__KFKDIIAG_00018	MET0114_bin.4__k81_3932	C3093	KFKDIIAG_00018	VFG001290	Clumping factor	96.6	0	1	877	1.0	0.9669	Adherence	Clumping factor B, adhesin	ClfA and ClfB bind to different sites in fibrinogen. ClfA binds to the gamma-chain whereas ClfB binds to the alpha-chain; ClfA through its fibrinogen-binding function is a mediator of S. aureus-induced platelet aggregation	SetB	prediction
1808	M0076748	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1809	M0076748	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1810	M0076749	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1811	M0076749	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1812	M0076750	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1813	M0076750	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1814	M0076751	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1815	M0076751	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1816	M0076752	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1817	M0076752	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1818	M0076753	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1819	M0076753	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1820	M0076754	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1821	M0076754	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1822	M0076755	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1823	M0076755	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1824	M0076756	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1825	M0076756	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1826	M0076757	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	8.6e-80	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1827	M0076757	MET0293_bin.10__k81_21916	EADHFIMK_00002	MET0293_bin.10__k81_21916__EADHFIMK_00002	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00002	VFG051056	T6SS	88	6.5e-79	1	167	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1828	M0076758	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	3.4e-92	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1829	M0076758	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	2.5e-91	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1830	M0076759	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	3.4e-92	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1831	M0076759	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	2.5e-91	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1832	M0076760	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	3.4e-92	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetA	experiment
1833	M0076760	MET0293_bin.10__k81_21916	EADHFIMK_00004	MET0293_bin.10__k81_21916__EADHFIMK_00004	MET0293_bin.10__k81_21916	C3163	EADHFIMK_00004	VFG051042	T6SS	95.2	2.5e-91	1	167	1.0	1	Effector delivery system	type VI secretion system tube protein Hcp	T6SS delivers protein effectors into host cells or competing bacteria and exists as an important virulence system in A. baumannii	SetB	prediction
1834	M0083522	MET0772_bin.10__k81_522844	HPIHMBOO_00002	MET0772_bin.10__k81_522844__HPIHMBOO_00002	MET0772_bin.10__k81_522844	C3280	HPIHMBOO_00002	VFG002093	VAS T6SS	72.9	1.6e-214	18	490	0.9575	0.9633	Effector delivery system	type VI secretion system tubule-forming protein VipB	Antibacterial and antieukaryotic activities	SetA	experiment
1835	M0083522	MET0772_bin.10__k81_522844	HPIHMBOO_00002	MET0772_bin.10__k81_522844__HPIHMBOO_00002	MET0772_bin.10__k81_522844	C3280	HPIHMBOO_00002	VFG002093	VAS T6SS	72.9	1.2e-213	18	490	0.9575	0.9633	Effector delivery system	type VI secretion system tubule-forming protein VipB	Antibacterial and antieukaryotic activities	SetB	prediction
1836	M0083523	MET0772_bin.10__k81_522844	HPIHMBOO_00002	MET0772_bin.10__k81_522844__HPIHMBOO_00002	MET0772_bin.10__k81_522844	C3280	HPIHMBOO_00002	VFG002093	VAS T6SS	72.9	1.6e-214	18	490	0.9575	0.9633	Effector delivery system	type VI secretion system tubule-forming protein VipB	Antibacterial and antieukaryotic activities	SetA	experiment
1837	M0083523	MET0772_bin.10__k81_522844	HPIHMBOO_00002	MET0772_bin.10__k81_522844__HPIHMBOO_00002	MET0772_bin.10__k81_522844	C3280	HPIHMBOO_00002	VFG002093	VAS T6SS	72.9	1.2e-213	18	490	0.9575	0.9633	Effector delivery system	type VI secretion system tubule-forming protein VipB	Antibacterial and antieukaryotic activities	SetB	prediction
1838	M0096149	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037625	Csu fimbriae	99.4	3.4e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetA	experiment
1839	M0096149	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037628	Csu fimbriae	99.7	5.2e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetB	prediction
1840	M0096150	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037625	Csu fimbriae	99.4	3.4e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetA	experiment
1841	M0096150	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037628	Csu fimbriae	99.7	5.2e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetB	prediction
1842	M0096151	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037625	Csu fimbriae	99.4	3.4e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetA	experiment
1843	M0096151	NZ_CP040085.1	HBPOFGEC_00016	NZ_CP040085.1__HBPOFGEC_00016	NZ_CP040085.1	C634	HBPOFGEC_00016	VFG037628	Csu fimbriae	99.7	5.2e-192	1	339	1.0	1	Biofilm	Csu pilus tip adhesin CsuE	Plays a role in the initial steps of biofilm formation by allowing bacterial cells to adhere to abiotic surfaces and initiate the formation of microcolonies that precede the full development of biofilm structures	SetB	prediction
1844	M0097443	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1845	M0097444	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1846	M0097445	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1847	M0097446	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1848	M0097447	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1849	M0097448	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1850	M0097449	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1851	M0097450	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1852	M0097451	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1853	M0097452	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1854	M0097453	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1855	M0097454	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1856	M0097455	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1857	M0097456	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1858	M0097457	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1859	M0097458	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1860	M0097459	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1861	M0097460	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1862	M0097461	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1863	M0097462	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1864	M0097463	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1865	M0097464	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1866	M0097465	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1867	M0097466	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1868	M0097467	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1869	M0097468	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1870	M0097469	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1871	M0097470	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1872	M0097471	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1873	M0097472	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1874	M0097473	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1875	M0097474	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1876	M0097475	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1877	M0097476	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1878	M0097477	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1879	M0097478	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1880	M0097479	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1881	M0097480	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1882	M0097481	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1883	M0097482	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1884	M0097483	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1885	M0097484	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1886	M0097485	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1887	M0097486	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1888	M0097487	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1889	M0097488	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1890	M0097489	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1891	M0097490	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1892	M0097491	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1893	M0097492	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1894	M0097493	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1895	M0097494	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1896	M0097495	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1897	M0097496	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1898	M0097497	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1899	M0097498	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1900	M0097499	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1901	M0097500	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1902	M0097501	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1903	M0097609	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1904	M0097609	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1905	M0097610	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1906	M0097610	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1907	M0097611	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1908	M0097611	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1909	M0097612	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1910	M0097612	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1911	M0097613	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1912	M0097613	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1913	M0097614	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1914	M0097614	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1915	M0097615	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1916	M0097615	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1917	M0097616	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1918	M0097616	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1919	M0097617	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1920	M0097617	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1921	M0097618	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1922	M0097618	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1923	M0097619	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1924	M0097619	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1925	M0097620	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1926	M0097620	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1927	M0097621	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1928	M0097621	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1929	M0097622	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1930	M0097622	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1931	M0097623	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1932	M0097623	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1933	M0097624	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1934	M0097624	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1935	M0097625	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1936	M0097625	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1937	M0097626	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1938	M0097626	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1939	M0097627	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1940	M0097627	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1941	M0097628	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1942	M0097628	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1943	M0097629	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	3.5e-89	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1944	M0097629	NZ_CP046561.1	MBDGPIKF_00042	NZ_CP046561.1__MBDGPIKF_00042	NZ_CP046561.1	C681	MBDGPIKF_00042	VFG000519	TTSS (SPI-2 encode)	79.9	2.6e-88	1	214	0.9953	0.9953	Effector delivery system	type III secretion system minor export apparatus protein SsaR	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1945	M0097729	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1946	M0097729	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1947	M0097730	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1948	M0097730	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1949	M0097731	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1950	M0097731	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1951	M0097732	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1952	M0097732	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1953	M0097733	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1954	M0097733	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1955	M0097734	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1956	M0097734	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1957	M0097735	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1958	M0097735	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1959	M0097736	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1960	M0097736	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1961	M0097737	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1962	M0097737	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1963	M0097738	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1964	M0097738	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1965	M0097739	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	4.9e-24	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetA	experiment
1966	M0097739	NZ_CP046561.1	MBDGPIKF_00029	NZ_CP046561.1__MBDGPIKF_00029	NZ_CP046561.1	C681	MBDGPIKF_00029	VFG000507	TTSS (SPI-2 encode)	71.8	3.6e-23	1	71	1.0	1	Effector delivery system	type III secretion system needle filament protein SsaG	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1967	M0097890	NZ_CP046561.1	MBDGPIKF_00037	NZ_CP046561.1__MBDGPIKF_00037	NZ_CP046561.1	C681	MBDGPIKF_00037	VFG003915	TTSS (SPI-2 encode)	70.2	3.6e-253	6	686	0.9927	1	Effector delivery system	type III secretion system major export apparatus protein ssaV	Required to translocate at least 28 effector proteins from vacuolar-resident bacteria into host cells; functions both in intestinal and disseminated infection and is required for growth within cells of different hosts	SetB	prediction
1968	M0101490	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1969	M0101490	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1970	M0101491	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1971	M0101491	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1972	M0101492	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1973	M0101492	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1974	M0101493	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1975	M0101493	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1976	M0101494	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1977	M0101494	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1978	M0101495	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1979	M0101495	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1980	M0101496	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1981	M0101496	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1982	M0101497	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1983	M0101497	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1984	M0101498	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1985	M0101498	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1986	M0101499	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1987	M0101499	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1988	M0101500	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1989	M0101500	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1990	M0101501	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1991	M0101501	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1992	M0101502	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1993	M0101502	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1994	M0101503	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1995	M0101503	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1996	M0101504	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1997	M0101504	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
1998	M0101505	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
1999	M0101505	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2000	M0101506	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2001	M0101506	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2002	M0101507	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2003	M0101507	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2004	M0101508	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2005	M0101508	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2006	M0101509	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2007	M0101509	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2008	M0101510	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2009	M0101510	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2010	M0101511	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2011	M0101511	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2012	M0101512	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2013	M0101512	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2014	M0101513	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2015	M0101513	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2016	M0101514	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2017	M0101514	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2018	M0101515	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2019	M0101515	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2020	M0101516	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2021	M0101516	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2022	M0101517	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2023	M0101517	NZ_CP064203.1	JJEBMEPF_00565	NZ_CP064203.1__JJEBMEPF_00565	NZ_CP064203.1	C792	JJEBMEPF_00565	VFG037442	Acinetobactin	100	0	1	615	1.0	1	Nutritional/Metabolic factor	acinetobactin biosynthesis protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2024	M0101520	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2025	M0101520	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2026	M0101521	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2027	M0101521	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2028	M0101522	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2029	M0101522	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2030	M0101523	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2031	M0101523	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2032	M0101524	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2033	M0101524	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2034	M0101525	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2035	M0101525	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2036	M0101526	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2037	M0101526	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2038	M0101527	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2039	M0101527	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2040	M0101528	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2041	M0101528	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2042	M0101529	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2043	M0101529	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2044	M0101530	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2045	M0101530	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2046	M0101531	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2047	M0101531	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2048	M0101532	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2049	M0101532	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2050	M0101533	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2051	M0101533	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2052	M0101534	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2053	M0101534	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2054	M0101535	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2055	M0101535	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2056	M0101536	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2057	M0101536	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2058	M0101537	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2059	M0101537	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2060	M0101538	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2061	M0101538	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2062	M0101539	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2063	M0101539	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2064	M0101540	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2065	M0101540	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2066	M0101541	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2067	M0101541	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2068	M0101542	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2069	M0101542	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2070	M0101543	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2071	M0101543	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2072	M0101544	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2073	M0101544	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2074	M0101545	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2075	M0101545	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2076	M0101546	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2077	M0101546	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2078	M0101547	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2079	M0101547	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2080	M0101548	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2081	M0101548	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2082	M0101549	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2083	M0101549	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2084	M0101550	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2085	M0101550	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2086	M0101551	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2087	M0101551	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2088	M0101552	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037414	Acinetobactin	100	3.9e-158	1	300	0.9585	0.974	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2089	M0101552	NZ_CP064203.1	JJEBMEPF_00569	NZ_CP064203.1__JJEBMEPF_00569	NZ_CP064203.1	C792	JJEBMEPF_00569	VFG037417	Acinetobactin	100	5.5e-164	1	313	1.0	0.9572	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauD	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2090	M0101553	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2091	M0101553	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2092	M0101554	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2093	M0101554	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2094	M0101555	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2095	M0101555	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2096	M0101556	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2097	M0101556	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2098	M0101557	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2099	M0101557	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2100	M0101558	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2101	M0101558	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2102	M0101559	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2103	M0101559	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2104	M0101560	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2105	M0101560	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2106	M0101561	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2107	M0101561	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2108	M0101562	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2109	M0101562	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2110	M0101563	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2111	M0101563	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2112	M0101564	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2113	M0101564	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2114	M0101565	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2115	M0101565	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2116	M0101566	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2117	M0101566	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2118	M0101567	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2119	M0101567	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2120	M0101568	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2.6e-170	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2121	M0101568	NZ_CP064203.1	JJEBMEPF_00570	NZ_CP064203.1__JJEBMEPF_00570	NZ_CP064203.1	C792	JJEBMEPF_00570	VFG037400	Acinetobactin	100	2e-169	1	315	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, permease protein BauC	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2122	M0101569	NZ_CP064203.1	JJEBMEPF_00571	NZ_CP064203.1__JJEBMEPF_00571	NZ_CP064203.1	C792	JJEBMEPF_00571	VFG037386	Acinetobactin	100	2.8e-146	1	256	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, ATP-binding protein BauE	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2123	M0101569	NZ_CP064203.1	JJEBMEPF_00571	NZ_CP064203.1__JJEBMEPF_00571	NZ_CP064203.1	C792	JJEBMEPF_00571	VFG037386	Acinetobactin	100	2.1e-145	1	256	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, ATP-binding protein BauE	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2124	M0101570	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	3.8e-185	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2125	M0101570	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	2.9e-184	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2126	M0101571	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	3.8e-185	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2127	M0101571	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	2.9e-184	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2128	M0101572	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	3.8e-185	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2129	M0101572	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	2.9e-184	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2130	M0101573	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	3.8e-185	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2131	M0101573	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	2.9e-184	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2132	M0101574	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	3.8e-185	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2133	M0101574	NZ_CP064203.1	JJEBMEPF_00572	NZ_CP064203.1__JJEBMEPF_00572	NZ_CP064203.1	C792	JJEBMEPF_00572	VFG037372	Acinetobactin	100	2.9e-184	1	322	1.0	1	Nutritional/Metabolic factor	ferric siderophore ABC transporter, periplasmic siderophore-binding protein	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2134	M0101575	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2135	M0101575	NZ_CP064203.1	JJEBMEPF_00566	NZ_CP064203.1__JJEBMEPF_00566	NZ_CP064203.1	C792	JJEBMEPF_00566	VFG037428	Acinetobactin	100	0	23	698	0.9685	1	Nutritional/Metabolic factor	non-ribosomal peptide synthetase with condensation and peptidyl carrier protein domains	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2136	M0101576	NZ_CP064203.1	JJEBMEPF_00573	NZ_CP064203.1__JJEBMEPF_00573	NZ_CP064203.1	C792	JJEBMEPF_00573	VFG037358	Acinetobactin	99.9	0	1	751	1.0	0.9882	Nutritional/Metabolic factor	TonB-dependent siderophore receptor BauA	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2137	M0101576	NZ_CP064203.1	JJEBMEPF_00573	NZ_CP064203.1__JJEBMEPF_00573	NZ_CP064203.1	C792	JJEBMEPF_00573	VFG037355	Acinetobactin	100	0	1	751	1.0	0.9882	Nutritional/Metabolic factor	TonB-dependent siderophore receptor BauA	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2138	M0101577	NZ_CP064203.1	JJEBMEPF_00573	NZ_CP064203.1__JJEBMEPF_00573	NZ_CP064203.1	C792	JJEBMEPF_00573	VFG037358	Acinetobactin	99.9	0	1	751	1.0	0.9882	Nutritional/Metabolic factor	TonB-dependent siderophore receptor BauA	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetA	experiment
2139	M0101577	NZ_CP064203.1	JJEBMEPF_00573	NZ_CP064203.1__JJEBMEPF_00573	NZ_CP064203.1	C792	JJEBMEPF_00573	VFG037355	Acinetobactin	100	0	1	751	1.0	0.9882	Nutritional/Metabolic factor	TonB-dependent siderophore receptor BauA	High-affinity catechol-hydroxamate siderophore competing with host cells for iron	SetB	prediction
2140	M0110565	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2141	M0110576	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2142	M0110577	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2143	M0110578	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2144	M0110579	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2145	M0110580	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2146	M0110581	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2147	M0110582	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2148	M0110583	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2149	M0110584	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2150	M0110585	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2151	M0110586	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2152	M0110587	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2153	M0110588	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2154	M0110589	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2155	M0110590	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2156	M0110591	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2157	M0110592	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2158	M0110593	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2159	M0110594	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2160	M0110595	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2161	M0110596	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2162	M0110597	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2163	M0110598	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2164	M0110599	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2165	M0110600	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2166	M0110601	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2167	M0110602	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2168	M0110603	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2169	M0110604	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2170	M0110652	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2171	M0110653	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2172	M0110654	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2173	M0110655	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2174	M0110656	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2175	M0110657	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2176	M0110658	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2177	M0110666	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2178	M0110667	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2179	M0110668	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2180	M0110669	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2181	M0111225	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2182	M0111226	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2183	M0111227	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2184	M0111228	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2185	M0111229	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2186	M0111230	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2187	M0111231	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2188	M0111232	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2189	M0111233	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2190	M0111234	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2191	M0111255	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2192	M0111256	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2193	M0111257	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2194	M0111258	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2195	M0111259	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2196	M0111260	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2197	M0111261	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2198	M0111262	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2199	M0111263	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2200	M0111264	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2201	M0111265	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2202	M0111266	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2203	M0111267	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2204	M0111268	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2205	M0111269	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2206	M0111270	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2207	M0111271	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2208	M0111272	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2209	M0111273	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2210	M0111274	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2211	M0111275	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2212	M0111276	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2213	M0111277	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2214	M0111278	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2215	M0111279	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2216	M0111280	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2217	M0111281	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2218	M0111282	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2219	M0111283	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2220	M0111284	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2221	M0111285	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2222	M0111286	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2223	M0111287	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2224	M0111288	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2225	M0111289	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2226	M0111290	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2227	M0111291	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2228	M0111292	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2229	M0111293	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2230	M0111294	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2231	M0111295	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2232	M0111296	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2233	M0111297	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2234	M0111298	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2235	M0111299	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2236	M0111300	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2237	M0111301	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2238	M0111342	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2239	M0111343	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2240	M0111376	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2241	M0111377	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2242	M0111378	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2243	M0111379	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2244	M0111380	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2245	M0111381	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2246	M0111382	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2247	M0111383	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2248	M0111384	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2249	M0111391	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2250	M0111392	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2251	M0111393	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2252	M0111417	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2253	M0111418	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2254	M0111419	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2255	M0111420	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2256	M0111421	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2257	M0111422	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2258	M0111423	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2259	M0111496	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2260	M0111497	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2261	M0111498	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2262	M0111546	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2263	M0111547	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2264	M0111548	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2265	M0111549	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2266	M0111550	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2267	M0111551	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2268	M0111552	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2269	M0111553	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2270	M0111554	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2271	M0111555	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2272	M0111556	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2273	M0111561	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2274	M0111562	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2275	M0111563	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2276	M0111564	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2277	M0111565	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2278	M0111566	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2279	M0111567	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2280	M0111596	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2281	M0111597	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2282	M0111598	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2283	M0111599	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2284	M0111899	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2285	M0111900	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2286	M0111938	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2287	M0111939	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2288	M0111942	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2289	M0111943	NZ_CP121525.1	KAOOAMGK_00189	NZ_CP121525.1__KAOOAMGK_00189	NZ_CP121525.1	C1	KAOOAMGK_00189	VFG004751	Lipase	99.8	0	1	627	1.0	0.9751	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2290	M0111967	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2291	M0111968	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2292	M0111969	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2293	M0111970	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2294	M0111971	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2295	M0111975	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2296	M0111976	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2297	M0111977	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2298	M0112063	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2299	M0112098	NZ_CP121525.1	KAOOAMGK_00188	NZ_CP121525.1__KAOOAMGK_00188	NZ_CP121525.1	C1	KAOOAMGK_00188	VFG004717	Staphopain	100	1.7e-226	1	395	1.0	1	Exoenzyme	staphopain cysteine proteinase SspB	Broad substrate specificity, unclear role in pathogenesis	SetB	prediction
2300	M0112100	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2301	M0112124	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2302	M0112256	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2303	M0112285	NZ_CP121525.1	KAOOAMGK_00041	NZ_CP121525.1__KAOOAMGK_00041	NZ_CP121525.1	C1	KAOOAMGK_00041	VFG004585	SDr	96.5	0	1	1517	0.9819	0.929	Adherence	MSCRAMM family adhesin SdrF	Binds to bone sialoprotein and fibrinogen	SetB	prediction
2304	M0112300	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2305	M0112305	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2306	M0112332	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2307	M0112335	NZ_CP121525.1	KAOOAMGK_00049	NZ_CP121525.1__KAOOAMGK_00049	NZ_CP121525.1	C1	KAOOAMGK_00049	VFG004752	Lipase	99.3	0	1	681	1.0	1	Exoenzyme	glycerol ester hydrolase	Responsible for the release of considerate amounts of fatty acids, particularly octadecenoic acid in human plasma; might contribute to virulence by enabling the bacteria to persist in the fatty secretions of the human or mammalian skin; the recent finding that the lipase GehD of S. epidermidis can bind to collagen might constitute a novel role for lipase in virulence	SetB	prediction
2308	M0142986	AP026530.1	CFLJOCJI_00444	AP026530.1__CFLJOCJI_00444	AP026530.1	C40	CFLJOCJI_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
2309	M0142987	AP026530.1	CFLJOCJI_00445	AP026530.1__CFLJOCJI_00445	AP026530.1	C40	CFLJOCJI_00445	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
2310	M0142988	AP026530.1	CFLJOCJI_00444	AP026530.1__CFLJOCJI_00444	AP026530.1	C40	CFLJOCJI_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
2311	M0142989	AP026530.1	CFLJOCJI_00444	AP026530.1__CFLJOCJI_00444	AP026530.1	C40	CFLJOCJI_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
2312	M0142990	AP026530.1	CFLJOCJI_00444	AP026530.1__CFLJOCJI_00444	AP026530.1	C40	CFLJOCJI_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
2313	M0142993	AP026530.1	CFLJOCJI_00444	AP026530.1__CFLJOCJI_00444	AP026530.1	C40	CFLJOCJI_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
2314	M0143153	CP006001.1	PFMCHKKD_00025	CP006001.1__PFMCHKKD_00025	CP006001.1	C56	PFMCHKKD_00025	VFG002039	Heat-stable toxin (ST)	98.6	9.6e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2315	M0143153	CP006001.1	PFMCHKKD_00025	CP006001.1__PFMCHKKD_00025	CP006001.1	C56	PFMCHKKD_00025	VFG002039	Heat-stable toxin (ST)	98.6	7.2e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2316	M0143161	CP006001.1	PFMCHKKD_00030	CP006001.1__PFMCHKKD_00030	CP006001.1	C56	PFMCHKKD_00030	VFG036066	Heat-labile toxin (LT)	99.1	4.5e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetA	experiment
2317	M0143161	CP006001.1	PFMCHKKD_00030	CP006001.1__PFMCHKKD_00030	CP006001.1	C56	PFMCHKKD_00030	VFG036065	Heat-labile toxin (LT)	99.5	8.9e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetB	prediction
2318	M0143162	CP006001.1	PFMCHKKD_00030	CP006001.1__PFMCHKKD_00030	CP006001.1	C56	PFMCHKKD_00030	VFG036066	Heat-labile toxin (LT)	99.1	4.5e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetA	experiment
2319	M0143162	CP006001.1	PFMCHKKD_00030	CP006001.1__PFMCHKKD_00030	CP006001.1	C56	PFMCHKKD_00030	VFG036065	Heat-labile toxin (LT)	99.5	8.9e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetB	prediction
2320	M0143163	CP006001.1	PFMCHKKD_00031	CP006001.1__PFMCHKKD_00031	CP006001.1	C56	PFMCHKKD_00031	VFG036068	Heat-labile toxin (LT)	100	4.8e-67	1	124	1.0	1	Exotoxin	enterotoxin subunit B (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetA	experiment
2321	M0143163	CP006001.1	PFMCHKKD_00031	CP006001.1__PFMCHKKD_00031	CP006001.1	C56	PFMCHKKD_00031	VFG036068	Heat-labile toxin (LT)	100	3.6e-66	1	124	1.0	1	Exotoxin	enterotoxin subunit B (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetB	prediction
2322	M0143173	CP012495.1	FBAHBPCB_00004	CP012495.1__FBAHBPCB_00004	CP012495.1	C57	FBAHBPCB_00004	VFG036030	EspI, SPATE	95.5	0	1	1363	1.0	1	Effector delivery system	serine protease autotransporter EspI		SetB	prediction
2323	M0143174	CP012495.1	FBAHBPCB_00004	CP012495.1__FBAHBPCB_00004	CP012495.1	C57	FBAHBPCB_00004	VFG036030	EspI, SPATE	95.5	0	1	1363	1.0	1	Effector delivery system	serine protease autotransporter EspI		SetB	prediction
2324	M0143240	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2325	M0143241	CP024249.1	CEBACDEP_00174	CP024249.1__CEBACDEP_00174	CP024249.1	C62	CEBACDEP_00174	VFG042514	Adhesive fimbriae	83	6.8e-64	1	147	1.0	1	Adherence	FotC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2326	M0143246	CP024249.1	CEBACDEP_00138	CP024249.1__CEBACDEP_00138	CP024249.1	C62	CEBACDEP_00138	VFG035379	AAI/SCI-II T6SS	87.1	3.7e-160	10	319	0.9718	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2327	M0143247	CP024249.1	CEBACDEP_00138	CP024249.1__CEBACDEP_00138	CP024249.1	C62	CEBACDEP_00138	VFG035379	AAI/SCI-II T6SS	87.1	3.7e-160	10	319	0.9718	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2328	M0143248	CP024249.1	CEBACDEP_00139	CP024249.1__CEBACDEP_00139	CP024249.1	C62	CEBACDEP_00139	VFG035374	AAI/SCI-II T6SS	87	0	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2329	M0143255	CP024249.1	CEBACDEP_00126	CP024249.1__CEBACDEP_00126	CP024249.1	C62	CEBACDEP_00126	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2330	M0143256	CP024249.1	CEBACDEP_00127	CP024249.1__CEBACDEP_00127	CP024249.1	C62	CEBACDEP_00127	VFG035428	AAI/SCI-II T6SS	79.8	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2331	M0143257	CP024249.1	CEBACDEP_00127	CP024249.1__CEBACDEP_00127	CP024249.1	C62	CEBACDEP_00127	VFG035428	AAI/SCI-II T6SS	79.8	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2332	M0143259	CP024249.1	CEBACDEP_00139	CP024249.1__CEBACDEP_00139	CP024249.1	C62	CEBACDEP_00139	VFG035374	AAI/SCI-II T6SS	87	0	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2333	M0143271	CP024249.1	CEBACDEP_00195	CP024249.1__CEBACDEP_00195	CP024249.1	C62	CEBACDEP_00195	VFG036068	Heat-labile toxin (LT)	100	4.8e-67	1	124	1.0	1	Exotoxin	enterotoxin subunit B (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetA	experiment
2334	M0143271	CP024249.1	CEBACDEP_00195	CP024249.1__CEBACDEP_00195	CP024249.1	C62	CEBACDEP_00195	VFG036068	Heat-labile toxin (LT)	100	3.6e-66	1	124	1.0	1	Exotoxin	enterotoxin subunit B (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetB	prediction
2335	M0143279	CP024249.1	CEBACDEP_00126	CP024249.1__CEBACDEP_00126	CP024249.1	C62	CEBACDEP_00126	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2336	M0143281	CP024249.1	CEBACDEP_00138	CP024249.1__CEBACDEP_00138	CP024249.1	C62	CEBACDEP_00138	VFG035379	AAI/SCI-II T6SS	87.1	3.7e-160	10	319	0.9718	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2337	M0143285	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2338	M0143286	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2339	M0143290	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2340	M0143291	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2341	M0143292	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2342	M0143293	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2343	M0143294	CP024249.1	CEBACDEP_00173	CP024249.1__CEBACDEP_00173	CP024249.1	C62	CEBACDEP_00173	VFG042515	Adhesive fimbriae	96.5	0	1	834	0.9988	0.9988	Adherence	FotD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2344	M0143298	CP024249.1	CEBACDEP_00175	CP024249.1__CEBACDEP_00175	CP024249.1	C62	CEBACDEP_00175	VFG042513	Adhesive fimbriae	71.9	1.6e-94	7	234	0.962	0.9913	Adherence	FotB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2345	M0143358	CP025876.1	PHNLLLNO_00069	CP025876.1__PHNLLLNO_00069	CP025876.1	C64	PHNLLLNO_00069	VFG035931	Dispersin	98.6	4.9e-232	11	424	0.9764	1	Others	AatD	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
2346	M0143359	CP025876.1	PHNLLLNO_00069	CP025876.1__PHNLLLNO_00069	CP025876.1	C64	PHNLLLNO_00069	VFG035931	Dispersin	98.6	4.9e-232	11	424	0.9764	1	Others	AatD	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
2347	M0143603	CP027641.1	BCLLCMAJ_00059	CP027641.1__BCLLCMAJ_00059	CP027641.1	C73	BCLLCMAJ_00059	VFG000842	Hemolysin	97.7	5e-99	1	171	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2348	M0143603	CP027641.1	BCLLCMAJ_00059	CP027641.1__BCLLCMAJ_00059	CP027641.1	C73	BCLLCMAJ_00059	VFG000842	Hemolysin	97.7	3.7e-98	1	171	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2349	M0143604	CP027641.1	BCLLCMAJ_00059	CP027641.1__BCLLCMAJ_00059	CP027641.1	C73	BCLLCMAJ_00059	VFG000842	Hemolysin	97.7	5e-99	1	171	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2350	M0143604	CP027641.1	BCLLCMAJ_00059	CP027641.1__BCLLCMAJ_00059	CP027641.1	C73	BCLLCMAJ_00059	VFG000842	Hemolysin	97.7	3.7e-98	1	171	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2351	M0143605	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2352	M0143605	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2353	M0143606	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2354	M0143606	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2355	M0143607	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2356	M0143607	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2357	M0143608	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2358	M0143608	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2359	M0143609	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2360	M0143609	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2361	M0143610	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2362	M0143610	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2363	M0143611	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2364	M0143611	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2365	M0143612	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2366	M0143612	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2367	M0143613	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2368	M0143613	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2369	M0143614	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2370	M0143614	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2371	M0143615	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2372	M0143615	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2373	M0143616	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2374	M0143616	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2375	M0143617	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG000840	Hemolysin	98.2	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2376	M0143617	CP027641.1	BCLLCMAJ_00060	CP027641.1__BCLLCMAJ_00060	CP027641.1	C73	BCLLCMAJ_00060	VFG033890	Hemolysin	98.3	0	1	997	1.0	0.999	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2377	M0143618	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG000841	Hemolysin	99.6	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2378	M0143618	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG033882	Hemolysin	99.7	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2379	M0143619	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG000841	Hemolysin	99.6	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2380	M0143619	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG033882	Hemolysin	99.7	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2381	M0143620	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG000841	Hemolysin	99.6	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2382	M0143620	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG033882	Hemolysin	99.7	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2383	M0143621	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG000841	Hemolysin	99.6	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2384	M0143621	CP027641.1	BCLLCMAJ_00061	CP027641.1__BCLLCMAJ_00061	CP027641.1	C73	BCLLCMAJ_00061	VFG033882	Hemolysin	99.7	0	1	705	1.0	0.9986	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2385	M0143622	CP027641.1	BCLLCMAJ_00062	CP027641.1__BCLLCMAJ_00062	CP027641.1	C73	BCLLCMAJ_00062	VFG000843	Hemolysin	99	8.6e-266	1	479	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2386	M0143622	CP027641.1	BCLLCMAJ_00062	CP027641.1__BCLLCMAJ_00062	CP027641.1	C73	BCLLCMAJ_00062	VFG000843	Hemolysin	99	6.5e-265	1	479	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2387	M0143637	CP029771.1	IKDBGMFM_00023	CP029771.1__IKDBGMFM_00023	CP029771.1	C74	IKDBGMFM_00023	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
2388	M0143637	CP029771.1	IKDBGMFM_00023	CP029771.1__IKDBGMFM_00023	CP029771.1	C74	IKDBGMFM_00023	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
2389	M0143794	CP048302.1	HELBBJNP_00032	CP048302.1__HELBBJNP_00032	CP048302.1	C85	HELBBJNP_00032	VFG043979	Colicin B	100	2.1e-290	1	511	1.0	1	Exotoxin	colicin B		SetB	prediction
2390	M0143795	CP048302.1	HELBBJNP_00032	CP048302.1__HELBBJNP_00032	CP048302.1	C85	HELBBJNP_00032	VFG043979	Colicin B	100	2.1e-290	1	511	1.0	1	Exotoxin	colicin B		SetB	prediction
2391	M0143796	CP048302.1	HELBBJNP_00032	CP048302.1__HELBBJNP_00032	CP048302.1	C85	HELBBJNP_00032	VFG043979	Colicin B	100	2.1e-290	1	511	1.0	1	Exotoxin	colicin B		SetB	prediction
2392	M0143817	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2393	M0143818	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2394	M0143819	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2395	M0143820	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2396	M0143821	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2397	M0143822	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2398	M0143823	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2399	M0143824	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2400	M0143825	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2401	M0143826	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2402	M0143827	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2403	M0143828	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2404	M0143829	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2405	M0143830	CP048872.1	LAFFOIBL_00001	CP048872.1__LAFFOIBL_00001	CP048872.1	C89	LAFFOIBL_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2406	M0143836	CP049613.1	KFOHPCMO_00026	CP049613.1__KFOHPCMO_00026	CP049613.1	C90	KFOHPCMO_00026	VFG042382	EtpA	99.7	0	1	598	1.0	0.9917	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
2407	M0143836	CP049613.1	KFOHPCMO_00026	CP049613.1__KFOHPCMO_00026	CP049613.1	C90	KFOHPCMO_00026	VFG042382	EtpA	99.7	0	1	598	1.0	0.9917	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
2408	M0143837	CP049613.1	KFOHPCMO_00027	CP049613.1__KFOHPCMO_00027	CP049613.1	C90	KFOHPCMO_00027	VFG034541	EtpA	94.8	0	1	1531	1.0	0.9948	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
2409	M0143837	CP049613.1	KFOHPCMO_00027	CP049613.1__KFOHPCMO_00027	CP049613.1	C90	KFOHPCMO_00027	VFG034541	EtpA	94.8	0	1	1531	1.0	0.9948	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
2410	M0144075	CP056497.1	LIHCGALI_00011	CP056497.1__LIHCGALI_00011	CP056497.1	C100	LIHCGALI_00011	VFG043627	Type 3 fimbriae	96	3e-103	1	202	1.0	1	Biofilm	type 3 fimbrial major pilin subunit MrkA	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2411	M0144075	CP056497.1	LIHCGALI_00011	CP056497.1__LIHCGALI_00011	CP056497.1	C100	LIHCGALI_00011	VFG048392	Type 3 fimbriae	100	1.5e-106	1	202	1.0	1	Biofilm	type 3 fimbrial major pilin subunit MrkA	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2412	M0144077	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG043625	Type 3 fimbriae	88.8	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2413	M0144077	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG048371	Type 3 fimbriae	99.2	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2414	M0144078	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG043625	Type 3 fimbriae	88.8	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2415	M0144078	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG048371	Type 3 fimbriae	99.2	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2416	M0144079	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG043625	Type 3 fimbriae	88.8	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2417	M0144079	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG048371	Type 3 fimbriae	99.2	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2418	M0144080	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG043625	Type 3 fimbriae	88.8	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2419	M0144080	CP056497.1	LIHCGALI_00013	CP056497.1__LIHCGALI_00013	CP056497.1	C100	LIHCGALI_00013	VFG048371	Type 3 fimbriae	99.2	0	1	828	1.0	1	Biofilm	fimbrial biogenesis outer membrane usher protein mrkC precursor	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2420	M0144083	CP056497.1	LIHCGALI_00015	CP056497.1__LIHCGALI_00015	CP056497.1	C100	LIHCGALI_00015	VFG043623	Type 3 fimbriae	81.9	4.5e-97	18	216	0.9213	0.9431	Biofilm	type 3 fimbrial minor pilin subunit MrkF	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2421	M0144083	CP056497.1	LIHCGALI_00015	CP056497.1__LIHCGALI_00015	CP056497.1	C100	LIHCGALI_00015	VFG042692	Type 3 fimbriae	99.1	1.5e-123	1	216	1.0	0.9774	Adherence	MrkF		SetB	prediction
2422	M0144084	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048348	Type 3 fimbriae	76.3	1.3e-108	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2423	M0144084	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048341	Type 3 fimbriae	91.1	4.5e-126	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2424	M0144085	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048348	Type 3 fimbriae	76.3	1.3e-108	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2425	M0144085	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048341	Type 3 fimbriae	91.1	4.5e-126	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2426	M0144089	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048348	Type 3 fimbriae	76.3	1.3e-108	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
2427	M0144089	CP056497.1	LIHCGALI_00016	CP056497.1__LIHCGALI_00016	CP056497.1	C100	LIHCGALI_00016	VFG048341	Type 3 fimbriae	91.1	4.5e-126	1	236	0.9916	0.9916	Biofilm	phosphodiesterase	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
2428	M0144215	CP057502.1	FEFFDEGL_00010	CP057502.1__FEFFDEGL_00010	CP057502.1	C109	FEFFDEGL_00010	VFG035354	AAI/SCI-II T6SS	93	1.6e-79	1	158	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit		SetB	prediction
2429	M0144216	CP057502.1	FEFFDEGL_00010	CP057502.1__FEFFDEGL_00010	CP057502.1	C109	FEFFDEGL_00010	VFG035354	AAI/SCI-II T6SS	93	1.6e-79	1	158	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit		SetB	prediction
2430	M0144217	CP057502.1	FEFFDEGL_00010	CP057502.1__FEFFDEGL_00010	CP057502.1	C109	FEFFDEGL_00010	VFG035354	AAI/SCI-II T6SS	93	1.6e-79	1	158	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit		SetB	prediction
2431	M0144218	CP057502.1	FEFFDEGL_00010	CP057502.1__FEFFDEGL_00010	CP057502.1	C109	FEFFDEGL_00010	VFG035354	AAI/SCI-II T6SS	93	1.6e-79	1	158	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit		SetB	prediction
2432	M0144219	CP057502.1	FEFFDEGL_00010	CP057502.1__FEFFDEGL_00010	CP057502.1	C109	FEFFDEGL_00010	VFG035354	AAI/SCI-II T6SS	93	1.6e-79	1	158	1.0	1	Effector delivery system	type VI secretion system contractile sheath small subunit		SetB	prediction
2433	M0144220	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2434	M0144221	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2435	M0144222	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2436	M0144223	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2437	M0144224	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2438	M0144225	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2439	M0144226	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2440	M0144227	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2441	M0144228	CP057502.1	FEFFDEGL_00011	CP057502.1__FEFFDEGL_00011	CP057502.1	C109	FEFFDEGL_00011	VFG035359	AAI/SCI-II T6SS	96.5	1.5e-280	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2442	M0144256	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2443	M0144257	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2444	M0144258	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2445	M0144259	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2446	M0144260	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2447	M0144261	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2448	M0144262	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2449	M0144263	CP057502.1	FEFFDEGL_00013	CP057502.1__FEFFDEGL_00013	CP057502.1	C109	FEFFDEGL_00013	VFG035369	AAI/SCI-II T6SS	89.3	7.3e-68	1	140	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
2450	M0144264	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2451	M0144265	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2452	M0144266	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2453	M0144267	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2454	M0144268	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2455	M0144269	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2456	M0144270	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2457	M0144271	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2458	M0144272	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2459	M0144273	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2460	M0144274	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2461	M0144275	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2462	M0144276	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2463	M0144277	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2464	M0144278	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2465	M0144279	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2466	M0144280	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2467	M0144281	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2468	M0144282	CP057502.1	FEFFDEGL_00014	CP057502.1__FEFFDEGL_00014	CP057502.1	C109	FEFFDEGL_00014	VFG035374	AAI/SCI-II T6SS	86.5	1.59999999999162e-313	1	600	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssF		SetB	prediction
2469	M0144283	CP057502.1	FEFFDEGL_00015	CP057502.1__FEFFDEGL_00015	CP057502.1	C109	FEFFDEGL_00015	VFG035379	AAI/SCI-II T6SS	86.5	1.8e-159	1	310	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2470	M0144284	CP057502.1	FEFFDEGL_00015	CP057502.1__FEFFDEGL_00015	CP057502.1	C109	FEFFDEGL_00015	VFG035379	AAI/SCI-II T6SS	86.5	1.8e-159	1	310	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2471	M0144285	CP057502.1	FEFFDEGL_00015	CP057502.1__FEFFDEGL_00015	CP057502.1	C109	FEFFDEGL_00015	VFG035379	AAI/SCI-II T6SS	86.5	1.8e-159	1	310	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2472	M0144286	CP057502.1	FEFFDEGL_00015	CP057502.1__FEFFDEGL_00015	CP057502.1	C109	FEFFDEGL_00015	VFG035379	AAI/SCI-II T6SS	86.5	1.8e-159	1	310	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2473	M0144287	CP057502.1	FEFFDEGL_00015	CP057502.1__FEFFDEGL_00015	CP057502.1	C109	FEFFDEGL_00015	VFG035379	AAI/SCI-II T6SS	86.5	1.8e-159	1	310	1.0	1	Effector delivery system	type VI secretion system baseplate subunit TssG		SetB	prediction
2474	M0144288	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2475	M0144289	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2476	M0144290	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2477	M0144291	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2478	M0144292	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2479	M0144293	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2480	M0144294	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2481	M0144295	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2482	M0144296	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2483	M0144297	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2484	M0144298	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2485	M0144299	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2486	M0144300	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2487	M0144301	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2488	M0144302	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2489	M0144303	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2490	M0144304	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2491	M0144305	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2492	M0144306	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2493	M0144307	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2494	M0144308	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2495	M0144309	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2496	M0144310	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2497	M0144311	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2498	M0144312	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2499	M0144313	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2500	M0144314	CP057502.1	FEFFDEGL_00016	CP057502.1__FEFFDEGL_00016	CP057502.1	C109	FEFFDEGL_00016	VFG035384	AAI/SCI-II T6SS	79.7	1.3e-306	23	679	0.9676	0.9955	Effector delivery system	type VI secretion system tip protein VgrG		SetB	prediction
2501	M0144315	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2502	M0144316	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2503	M0144317	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2504	M0144318	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2505	M0144319	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2506	M0144320	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2507	M0144321	CP057502.1	FEFFDEGL_00017	CP057502.1__FEFFDEGL_00017	CP057502.1	C109	FEFFDEGL_00017	VFG035389	AAI/SCI-II T6SS	77.1	3.1e-67	1	153	0.9871	0.9871	Effector delivery system	hypothetical protein		SetB	prediction
2508	M0144322	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2509	M0144323	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2510	M0144324	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2511	M0144325	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2512	M0144326	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2513	M0144327	CP057502.1	FEFFDEGL_00018	CP057502.1__FEFFDEGL_00018	CP057502.1	C109	FEFFDEGL_00018	VFG035394	AAI/SCI-II T6SS	89.9	6.6e-47	1	99	1.0	1	Effector delivery system	PAAR domain-containing protein		SetB	prediction
2514	M0144328	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2515	M0144329	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2516	M0144330	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2517	M0144331	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2518	M0144332	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2519	M0144333	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2520	M0144334	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2521	M0144335	CP057502.1	FEFFDEGL_00019	CP057502.1__FEFFDEGL_00019	CP057502.1	C109	FEFFDEGL_00019	VFG035399	AAI/SCI-II T6SS	85.5	6.9e-179	1	358	1.0	1	Effector delivery system	type VI secretion system protein TssA		SetB	prediction
2522	M0144336	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2523	M0144337	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2524	M0144338	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2525	M0144339	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2526	M0144340	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2527	M0144341	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2528	M0144342	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2529	M0144343	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2530	M0144344	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2531	M0144345	CP057502.1	FEFFDEGL_00020	CP057502.1__FEFFDEGL_00020	CP057502.1	C109	FEFFDEGL_00020	VFG035404	AAI/SCI-II T6SS	85.8	1.5e-89	1	183	1.0	1	Effector delivery system	type VI secretion lipoprotein TssJ		SetB	prediction
2532	M0144346	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2533	M0144347	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2534	M0144348	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2535	M0144349	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2536	M0144350	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2537	M0144351	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2538	M0144352	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2539	M0144353	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2540	M0144354	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2541	M0144355	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2542	M0144356	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2543	M0144357	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2544	M0144358	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2545	M0144359	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2546	M0144360	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2547	M0144361	CP057502.1	FEFFDEGL_00021	CP057502.1__FEFFDEGL_00021	CP057502.1	C109	FEFFDEGL_00021	VFG035409	AAI/SCI-II T6SS	85.8	2.1e-233	1	451	0.9826	0.9596	Effector delivery system	type VI secretion system baseplate subunit TssK		SetB	prediction
2548	M0144368	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2549	M0144369	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2550	M0144370	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2551	M0144371	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2552	M0144372	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2553	M0144373	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2554	M0144374	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2555	M0144375	CP057502.1	FEFFDEGL_00023	CP057502.1__FEFFDEGL_00023	CP057502.1	C109	FEFFDEGL_00023	VFG035422	AAI/SCI-II T6SS	75	1.6e-81	1	196	1.0	1	Effector delivery system	DotU family type IV/VI secretion system protein		SetB	prediction
2556	M0144382	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2557	M0144383	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2558	M0144384	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2559	M0144385	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2560	M0144386	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2561	M0144387	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2562	M0144388	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2563	M0144389	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2564	M0144390	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2565	M0144391	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2566	M0144392	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2567	M0144393	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2568	M0144394	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2569	M0144395	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2570	M0144396	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2571	M0144397	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2572	M0144398	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2573	M0144399	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2574	M0144400	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2575	M0144401	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2576	M0144402	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2577	M0144403	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2578	M0144404	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2579	M0144405	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2580	M0144406	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2581	M0144407	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2582	M0144408	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2583	M0144409	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2584	M0144410	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2585	M0144411	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2586	M0144412	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2587	M0144413	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2588	M0144414	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2589	M0144415	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2590	M0144416	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2591	M0144417	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2592	M0144418	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2593	M0144419	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2594	M0144420	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2595	M0144421	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2596	M0144422	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2597	M0144423	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2598	M0144424	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2599	M0144425	CP057502.1	FEFFDEGL_00024	CP057502.1__FEFFDEGL_00024	CP057502.1	C109	FEFFDEGL_00024	VFG035428	AAI/SCI-II T6SS	80.1	0	1	1045	1.0	0.9215	Effector delivery system	hypothetical protein		SetB	prediction
2600	M0144426	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2601	M0144427	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2602	M0144428	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2603	M0144429	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2604	M0144430	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2605	M0144431	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2606	M0144432	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2607	M0144433	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2608	M0144434	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2609	M0144435	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2610	M0144436	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2611	M0144437	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2612	M0144438	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2613	M0144439	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2614	M0144440	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2615	M0144441	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2616	M0144442	CP057502.1	FEFFDEGL_00025	CP057502.1__FEFFDEGL_00025	CP057502.1	C109	FEFFDEGL_00025	VFG035429	AAI/SCI-II T6SS	88.5	0	1	842	1.0	0.9918	Effector delivery system	type VI secretion system ATPase TssH		SetB	prediction
2617	M0144876	CP077391.1	GJEBKJHH_00002	CP077391.1__GJEBKJHH_00002	CP077391.1	C131	GJEBKJHH_00002	VFG044066	Colicin E1	93.9	3.9e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
2618	M0144901	CP088375.1	NABNMIME_00181	CP088375.1__NABNMIME_00181	CP088375.1	C134	NABNMIME_00181	VFG034596	Adhesive fimbriae	93.6	0	5	814	0.9951	0.9988	Adherence	fimbrial usher protein FaeD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2619	M0144902	CP088375.1	NABNMIME_00181	CP088375.1__NABNMIME_00181	CP088375.1	C134	NABNMIME_00181	VFG034596	Adhesive fimbriae	93.6	0	5	814	0.9951	0.9988	Adherence	fimbrial usher protein FaeD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2620	M0144903	CP088375.1	NABNMIME_00181	CP088375.1__NABNMIME_00181	CP088375.1	C134	NABNMIME_00181	VFG034596	Adhesive fimbriae	93.6	0	5	814	0.9951	0.9988	Adherence	fimbrial usher protein FaeD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2621	M0144904	CP088375.1	NABNMIME_00181	CP088375.1__NABNMIME_00181	CP088375.1	C134	NABNMIME_00181	VFG034596	Adhesive fimbriae	93.6	0	5	814	0.9951	0.9988	Adherence	fimbrial usher protein FaeD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2622	M0144905	CP088375.1	NABNMIME_00181	CP088375.1__NABNMIME_00181	CP088375.1	C134	NABNMIME_00181	VFG034596	Adhesive fimbriae	93.6	0	5	814	0.9951	0.9988	Adherence	fimbrial usher protein FaeD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2623	M0144925	CP088375.1	NABNMIME_00030	CP088375.1__NABNMIME_00030	CP088375.1	C134	NABNMIME_00030	VFG035359	AAI/SCI-II T6SS	80.1	7.6e-237	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2624	M0144926	CP088375.1	NABNMIME_00030	CP088375.1__NABNMIME_00030	CP088375.1	C134	NABNMIME_00030	VFG035359	AAI/SCI-II T6SS	80.1	7.6e-237	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
2625	M0145181	CP088535.1	DNLKCANA_00029	CP088535.1__DNLKCANA_00029	CP088535.1	C141	DNLKCANA_00029	VFG036043	AatA, AIDA-I type	97.3	0	1	1165	1.0	1	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
2626	M0146351	CP102113.1	MGGCNOKF_00005	CP102113.1__MGGCNOKF_00005	CP102113.1	C173	MGGCNOKF_00005	VFG012773	TTSS secreted effectors	99.2	3.8e-277	1	484	1.0	1	Effector delivery system	type III secretion system effector OspC2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2627	M0146351	CP102113.1	MGGCNOKF_00005	CP102113.1__MGGCNOKF_00005	CP102113.1	C173	MGGCNOKF_00005	VFG012776	TTSS secreted effectors	99.8	1.1e-277	1	484	1.0	1	Effector delivery system	type III secretion system effector OspC2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2628	M0149014	CP146553.1	AKMGNAON_00007	CP146553.1__AKMGNAON_00007	CP146553.1	C221	AKMGNAON_00007	VFG000907	Alpha-Hemolysin	98.7	0	1	707	1.0	1	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2629	M0149014	CP146553.1	AKMGNAON_00007	CP146553.1__AKMGNAON_00007	CP146553.1	C221	AKMGNAON_00007	VFG033885	Hemolysin	99.6	0	1	707	1.0	1	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2630	M0149015	CP146553.1	AKMGNAON_00008	CP146553.1__AKMGNAON_00008	CP146553.1	C221	AKMGNAON_00008	VFG000908	Alpha-Hemolysin	95.8	1.1e-247	1	478	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2631	M0149015	CP146553.1	AKMGNAON_00008	CP146553.1__AKMGNAON_00008	CP146553.1	C221	AKMGNAON_00008	VFG033877	Hemolysin	98.5	6.7e-254	1	478	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2632	M0149045	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG000906	Alpha-Hemolysin	96.4	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2633	M0149045	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG033893	Hemolysin	98.5	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2634	M0149046	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG000906	Alpha-Hemolysin	96.4	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2635	M0149046	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG033893	Hemolysin	98.5	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2636	M0149048	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2637	M0149049	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2638	M0149050	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2639	M0149051	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2640	M0149052	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2641	M0149053	CP146553.1	AKMGNAON_00080	CP146553.1__AKMGNAON_00080	CP146553.1	C221	AKMGNAON_00080	VFG033809	Vat	92.4	0	1	1364	1.0	1	Effector delivery system	vacuolating autotransporter toxin	 induced cellular damage, vacuole formation, and urothelial barrier dysregulation of bladder epithelial cells	SetB	prediction
2642	M0149056	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetA	experiment
2643	M0149056	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetB	prediction
2644	M0149057	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetA	experiment
2645	M0149057	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetB	prediction
2646	M0149058	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetA	experiment
2647	M0149058	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetB	prediction
2648	M0149059	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetA	experiment
2649	M0149059	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetB	prediction
2650	M0149060	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetA	experiment
2651	M0149060	CP146553.1	AKMGNAON_00065	CP146553.1__AKMGNAON_00065	CP146553.1	C221	AKMGNAON_00065	VFG000845	ToxB	98.5	0	1	2629	1.0	0.8296	Effector delivery system	cytotoxin	Important for full expression of adherence by affecting the production and secretion of some virulence factors required for the development of A/E lesions	SetB	prediction
2652	M0149071	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG000906	Alpha-Hemolysin	96.4	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2653	M0149071	CP146553.1	AKMGNAON_00006	CP146553.1__AKMGNAON_00006	CP146553.1	C221	AKMGNAON_00006	VFG033893	Hemolysin	98.5	0	1	1024	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2654	M0149072	CP146553.1	AKMGNAON_00007	CP146553.1__AKMGNAON_00007	CP146553.1	C221	AKMGNAON_00007	VFG000907	Alpha-Hemolysin	98.7	0	1	707	1.0	1	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
2655	M0149072	CP146553.1	AKMGNAON_00007	CP146553.1__AKMGNAON_00007	CP146553.1	C221	AKMGNAON_00007	VFG033885	Hemolysin	99.6	0	1	707	1.0	1	Exotoxin	Hemolysin B	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
2656	M0149078	CP148520.1	EIGHHGKD_00055	CP148520.1__EIGHHGKD_00055	CP148520.1	C223	EIGHHGKD_00055	VFG000846	StcE	86.8	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetA	experiment
2657	M0149078	CP148520.1	EIGHHGKD_00055	CP148520.1__EIGHHGKD_00055	CP148520.1	C223	EIGHHGKD_00055	VFG000846	StcE	86.8	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetB	prediction
2658	M0149079	CP148520.1	EIGHHGKD_00055	CP148520.1__EIGHHGKD_00055	CP148520.1	C223	EIGHHGKD_00055	VFG000846	StcE	86.8	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetA	experiment
2659	M0149079	CP148520.1	EIGHHGKD_00055	CP148520.1__EIGHHGKD_00055	CP148520.1	C223	EIGHHGKD_00055	VFG000846	StcE	86.8	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetB	prediction
2660	M0149080	CP148520.1	EIGHHGKD_00057	CP148520.1__EIGHHGKD_00057	CP148520.1	C223	EIGHHGKD_00057	VFG040932	Etp	94.7	0	1	655	0.9985	1	Effector delivery system	variant type II secretion system secretin EtpD		SetB	prediction
2661	M0149081	CP148520.1	EIGHHGKD_00057	CP148520.1__EIGHHGKD_00057	CP148520.1	C223	EIGHHGKD_00057	VFG040932	Etp	94.7	0	1	655	0.9985	1	Effector delivery system	variant type II secretion system secretin EtpD		SetB	prediction
2662	M0149087	CP148520.1	EIGHHGKD_00057	CP148520.1__EIGHHGKD_00057	CP148520.1	C223	EIGHHGKD_00057	VFG040932	Etp	94.7	0	1	655	0.9985	1	Effector delivery system	variant type II secretion system secretin EtpD		SetB	prediction
2663	M0149088	CP148520.1	EIGHHGKD_00057	CP148520.1__EIGHHGKD_00057	CP148520.1	C223	EIGHHGKD_00057	VFG040932	Etp	94.7	0	1	655	0.9985	1	Effector delivery system	variant type II secretion system secretin EtpD		SetB	prediction
2664	M0149719	LR962022.1	AKBJGEAO_00064	LR962022.1__AKBJGEAO_00064	LR962022.1	C250	AKBJGEAO_00064	VFG002162	BSH	73.8	1.9e-147	1	324	1.0	0.9969	Stress survival	bile salt hydrolase	Involved in resisting the acute toxicity of bile and bile salts, important for intestinal persistence of L. monocytogenes	SetA	experiment
2665	M0149719	LR962022.1	AKBJGEAO_00064	LR962022.1__AKBJGEAO_00064	LR962022.1	C250	AKBJGEAO_00064	VFG019385	BSH	74.4	3.3e-148	1	324	1.0	0.9969	Stress survival	bile salt hydrolase	Involved in resisting the acute toxicity of bile and bile salts, important for intestinal persistence of L. monocytogenes	SetB	prediction
2666	M0150059	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2667	M0150059	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2668	M0150060	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2669	M0150060	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2670	M0150061	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2671	M0150061	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2672	M0150062	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2673	M0150062	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2674	M0150063	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2675	M0150063	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2676	M0150064	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2677	M0150064	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2678	M0150065	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2679	M0150065	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2680	M0150066	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2681	M0150066	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2682	M0150067	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2683	M0150067	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2684	M0150068	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2685	M0150068	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2686	M0150069	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2687	M0150069	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2688	M0150070	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2689	M0150070	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2690	M0150071	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2691	M0150071	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2692	M0150072	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2693	M0150072	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2694	M0150073	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2695	M0150073	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2696	M0150074	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2697	M0150074	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2698	M0150075	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2699	M0150075	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2700	M0150076	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2701	M0150076	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2702	M0150077	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2703	M0150077	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2704	M0150078	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2705	M0150078	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2706	M0150079	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2707	M0150079	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2708	M0150080	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2709	M0150080	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2710	M0150081	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2711	M0150081	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2712	M0150082	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2713	M0150082	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2714	M0150083	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2715	M0150083	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2716	M0150084	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2717	M0150084	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2718	M0150085	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2719	M0150085	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2720	M0150086	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2721	M0150086	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2722	M0150087	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2723	M0150087	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2724	M0150088	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2725	M0150088	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2726	M0150089	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2727	M0150089	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2728	M0150090	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2729	M0150090	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2730	M0150091	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2731	M0150091	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2732	M0150092	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2733	M0150092	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2734	M0150093	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2735	M0150093	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2736	M0150094	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2737	M0150094	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2738	M0150095	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2739	M0150095	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2740	M0150096	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2741	M0150096	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2742	M0150097	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2743	M0150097	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2744	M0150098	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2745	M0150098	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2746	M0150099	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2747	M0150099	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2748	M0150100	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2749	M0150100	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2750	M0150101	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2751	M0150101	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2752	M0150102	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2753	M0150102	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2754	M0150103	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2755	M0150103	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2756	M0150104	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2757	M0150104	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2758	M0150105	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2759	M0150105	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2760	M0150106	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2761	M0150106	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2762	M0150107	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2763	M0150107	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2764	M0150108	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2765	M0150108	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2766	M0150109	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2767	M0150109	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2768	M0150110	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2769	M0150110	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2770	M0150111	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2771	M0150111	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2772	M0150112	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2773	M0150112	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2774	M0150113	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2775	M0150113	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2776	M0150114	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2777	M0150114	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2778	M0150115	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2779	M0150115	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2780	M0150116	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2781	M0150116	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2782	M0150117	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2783	M0150117	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2784	M0150118	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2785	M0150118	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2786	M0150119	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2787	M0150119	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2788	M0150120	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2789	M0150120	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2790	M0150121	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2791	M0150121	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2792	M0150122	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2793	M0150122	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2794	M0150123	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2795	M0150123	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2796	M0150124	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2797	M0150124	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2798	M0150125	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2799	M0150125	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2800	M0150126	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2801	M0150126	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2802	M0150127	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2803	M0150127	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2804	M0150128	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2805	M0150128	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2806	M0150129	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2807	M0150129	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2808	M0150130	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2809	M0150130	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2810	M0150131	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2811	M0150131	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2812	M0150132	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2813	M0150132	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2814	M0150133	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2815	M0150133	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2816	M0150134	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2817	M0150134	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2818	M0150135	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2819	M0150135	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2820	M0150136	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2821	M0150136	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2822	M0150137	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2823	M0150137	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2824	M0150138	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2825	M0150138	LR962706.1	IJJFINOL_00009	LR962706.1__IJJFINOL_00009	LR962706.1	C262	IJJFINOL_00009	VFG002164	AS	98.5	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2826	M0150520	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2827	M0150520	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2828	M0150521	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2829	M0150521	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2830	M0150522	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2831	M0150522	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2832	M0150523	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2833	M0150523	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2834	M0150524	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
2835	M0150524	LR962783.1	KAPDECLB_00009	LR962783.1__KAPDECLB_00009	LR962783.1	C264	KAPDECLB_00009	VFG002164	AS	96.2	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
2836	M0151384	NC_010660.1	CADANGIJ_00243	NC_010660.1__CADANGIJ_00243	NC_010660.1	C292	CADANGIJ_00243	VFG012773	TTSS secreted effectors	99.6	1.5e-278	1	484	1.0	1	Effector delivery system	type III secretion system effector OspC2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2837	M0151384	NC_010660.1	CADANGIJ_00243	NC_010660.1__CADANGIJ_00243	NC_010660.1	C292	CADANGIJ_00243	VFG020131	TTSS secreted effectors	100	2.3e-278	1	484	1.0	1	Effector delivery system	type III secretion system effector OspC2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2838	M0152797	NC_013507.1	HEMNDAFI_00038	NC_013507.1__HEMNDAFI_00038	NC_013507.1	C312	HEMNDAFI_00038	VFG002039	Heat-stable toxin (ST)	100	7.4e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2839	M0152797	NC_013507.1	HEMNDAFI_00038	NC_013507.1__HEMNDAFI_00038	NC_013507.1	C312	HEMNDAFI_00038	VFG002039	Heat-stable toxin (ST)	100	5.5e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2840	M0152798	NC_013507.1	HEMNDAFI_00038	NC_013507.1__HEMNDAFI_00038	NC_013507.1	C312	HEMNDAFI_00038	VFG002039	Heat-stable toxin (ST)	100	7.4e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2841	M0152798	NC_013507.1	HEMNDAFI_00038	NC_013507.1__HEMNDAFI_00038	NC_013507.1	C312	HEMNDAFI_00038	VFG002039	Heat-stable toxin (ST)	100	5.5e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2842	M0152819	NC_014233.1	PANEHBEB_00037	NC_014233.1__PANEHBEB_00037	NC_014233.1	C315	PANEHBEB_00037	VFG042768	Adhesive fimbriae	99.2	8.4e-220	1	373	1.0	1	Adherence	LngJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2843	M0152820	NC_014233.1	PANEHBEB_00049	NC_014233.1__PANEHBEB_00049	NC_014233.1	C315	PANEHBEB_00049	VFG042756	Adhesive fimbriae	100	2.4e-169	1	298	1.0	1	Adherence	LngS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2844	M0153049	NC_016833.1	GAAIMDDD_00183	NC_016833.1__GAAIMDDD_00183	NC_016833.1	C323	GAAIMDDD_00183	VFG002042	TTSS secreted effectors	99.1	1.4e-309	1	545	1.0	1	Effector delivery system	type III secretion system effector ipaH9.8, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2845	M0153049	NC_016833.1	GAAIMDDD_00183	NC_016833.1__GAAIMDDD_00183	NC_016833.1	C323	GAAIMDDD_00183	VFG012850	TTSS secreted effectors	99.4	4.40000000000002e-310	1	545	1.0	1	Effector delivery system	type III secretion system effector ipaH9.8, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2846	M0153050	NC_016833.1	GAAIMDDD_00183	NC_016833.1__GAAIMDDD_00183	NC_016833.1	C323	GAAIMDDD_00183	VFG002042	TTSS secreted effectors	99.1	1.4e-309	1	545	1.0	1	Effector delivery system	type III secretion system effector ipaH9.8, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2847	M0153050	NC_016833.1	GAAIMDDD_00183	NC_016833.1__GAAIMDDD_00183	NC_016833.1	C323	GAAIMDDD_00183	VFG012850	TTSS secreted effectors	99.4	4.40000000000002e-310	1	545	1.0	1	Effector delivery system	type III secretion system effector ipaH9.8, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2848	M0153051	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012833	TTSS secreted effectors	99.3	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2849	M0153051	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012836	TTSS secreted effectors	99.8	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2850	M0153052	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012833	TTSS secreted effectors	99.3	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2851	M0153052	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012836	TTSS secreted effectors	99.8	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2852	M0153053	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012833	TTSS secreted effectors	99.3	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2853	M0153053	NC_016833.1	GAAIMDDD_00223	NC_016833.1__GAAIMDDD_00223	NC_016833.1	C323	GAAIMDDD_00223	VFG012836	TTSS secreted effectors	99.8	0	1	575	1.0	1	Effector delivery system	type III secretion system effector ipaH1.4, E3 ubiquitin ligase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2854	M0153054	NC_016833.1	GAAIMDDD_00119	NC_016833.1__GAAIMDDD_00119	NC_016833.1	C323	GAAIMDDD_00119	VFG001002	TTSS	100	1.5e-77	1	142	1.0	1	Effector delivery system	type III secretion system pilotin MxiM	Mxi-Spa system secretes approximately 20 proteins with the four Ipas A, B,C,D and IpgD being the most abundant; Recent findings indicate that TTSS in Shigella is responsible not only for protein secretion, but that it is also involved in the control mechanisms of transcription of other target genes located on the virulence plasmid, virA and ipaH9.8, these proteins were not constitutively synthesized and stored in the bacterial cytoplasm; their expression was markedly increased after initial activation of the secretion system, virA is not required for entry;Upon contact of the tip of the needle with the plasma membrane, the injectisome secretes its protein substrates into host cells. Some of these substrates act as translocators or effectors whose functions are key to the invasion of the cytosol and the cell-to-cell spread characterizing the lifestyle of Shigella spp.	SetA	experiment
2855	M0153054	NC_016833.1	GAAIMDDD_00119	NC_016833.1__GAAIMDDD_00119	NC_016833.1	C323	GAAIMDDD_00119	VFG001002	TTSS	100	1.1e-76	1	142	1.0	1	Effector delivery system	type III secretion system pilotin MxiM	Mxi-Spa system secretes approximately 20 proteins with the four Ipas A, B,C,D and IpgD being the most abundant; Recent findings indicate that TTSS in Shigella is responsible not only for protein secretion, but that it is also involved in the control mechanisms of transcription of other target genes located on the virulence plasmid, virA and ipaH9.8, these proteins were not constitutively synthesized and stored in the bacterial cytoplasm; their expression was markedly increased after initial activation of the secretion system, virA is not required for entry;Upon contact of the tip of the needle with the plasma membrane, the injectisome secretes its protein substrates into host cells. Some of these substrates act as translocators or effectors whose functions are key to the invasion of the cytosol and the cell-to-cell spread characterizing the lifestyle of Shigella spp.	SetB	prediction
2856	M0153058	NC_016833.1	GAAIMDDD_00010	NC_016833.1__GAAIMDDD_00010	NC_016833.1	C323	GAAIMDDD_00010	VFG012793	TTSS secreted effectors	99.5	0	1	569	1.0	1	Effector delivery system	type III secretion system effector OspD2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
2857	M0153058	NC_016833.1	GAAIMDDD_00010	NC_016833.1__GAAIMDDD_00010	NC_016833.1	C323	GAAIMDDD_00010	VFG012795	TTSS secreted effectors	99.8	0	1	569	1.0	1	Effector delivery system	type III secretion system effector OspD2	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
2858	M0153197	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	7.4e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2859	M0153197	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	5.5e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2860	M0153203	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	7.4e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2861	M0153203	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	5.5e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2862	M0153204	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	7.4e-36	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetA	experiment
2863	M0153204	NC_017722.1	JAKBCPAC_00073	NC_017722.1__JAKBCPAC_00073	NC_017722.1	C331	JAKBCPAC_00073	VFG002039	Heat-stable toxin (ST)	100	5.5e-35	1	72	1.0	1	Exotoxin	heat stable enterotoxin I	STa: activates guanylate cyclase resulting in ion secretion; STb: increase intracellular calcium resulting in ion secretion	SetB	prediction
2864	M0155783	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2865	M0155784	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2866	M0155785	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2867	M0155786	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2868	M0155787	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2869	M0155788	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2870	M0155789	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2871	M0155790	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2872	M0155791	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2873	M0155792	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2874	M0155793	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2875	M0155794	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2876	M0155795	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2877	M0155796	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2878	M0155797	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2879	M0155798	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2880	M0155799	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2881	M0155800	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2882	M0155801	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2883	M0155802	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2884	M0155803	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2885	M0155804	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2886	M0155805	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2887	M0155806	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2888	M0155807	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2889	M0155808	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2890	M0155809	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2891	M0155810	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2892	M0155811	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2893	M0155812	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2894	M0155813	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2895	M0155814	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2896	M0155815	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2897	M0155816	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2898	M0155817	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2899	M0155818	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2900	M0155819	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2901	M0155820	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2902	M0155821	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2903	M0155822	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2904	M0155823	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2905	M0155824	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2906	M0155825	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2907	M0155826	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2908	M0155827	NZ_AP019857.1	NFNKEPKH_00007	NZ_AP019857.1__NFNKEPKH_00007	NZ_AP019857.1	C364	NFNKEPKH_00007	VFG042771	Adhesive fimbriae	94.7	7.1e-152	73	355	0.7972	1	Adherence	CofS	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2909	M0155828	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2910	M0155829	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2911	M0155830	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2912	M0155831	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2913	M0155832	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2914	M0155833	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2915	M0155834	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2916	M0155835	NZ_AP019857.1	NFNKEPKH_00008	NZ_AP019857.1__NFNKEPKH_00008	NZ_AP019857.1	C364	NFNKEPKH_00008	VFG042772	Adhesive fimbriae	99.3	3.9e-80	1	147	1.0	1	Adherence	CofT	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2917	M0155836	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2918	M0155837	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2919	M0155838	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2920	M0155839	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2921	M0155840	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2922	M0155841	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2923	M0155842	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2924	M0155843	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2925	M0155844	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2926	M0155845	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2927	M0155846	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2928	M0155847	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2929	M0155848	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2930	M0155849	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2931	M0155850	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2932	M0155851	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2933	M0155852	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2934	M0155853	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2935	M0155854	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2936	M0155855	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2937	M0155856	NZ_AP019857.1	NFNKEPKH_00011	NZ_AP019857.1__NFNKEPKH_00011	NZ_AP019857.1	C364	NFNKEPKH_00011	VFG042774	Adhesive fimbriae	94.5	1.4e-284	1	523	1.0	1	Adherence	CofB	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2938	M0155857	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2939	M0155858	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2940	M0155859	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2941	M0155860	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2942	M0155861	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2943	M0155862	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2944	M0155863	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2945	M0155864	NZ_AP019857.1	NFNKEPKH_00012	NZ_AP019857.1__NFNKEPKH_00012	NZ_AP019857.1	C364	NFNKEPKH_00012	VFG042775	Adhesive fimbriae	98.5	9.1e-71	1	137	1.0	1	Adherence	CofC	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2946	M0155865	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2947	M0155866	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2948	M0155867	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2949	M0155868	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2950	M0155869	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2951	M0155870	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2952	M0155871	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2953	M0155872	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2954	M0155873	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2955	M0155874	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2956	M0155875	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2957	M0155876	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2958	M0155877	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2959	M0155878	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2960	M0155879	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2961	M0155880	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2962	M0155881	NZ_AP019857.1	NFNKEPKH_00013	NZ_AP019857.1__NFNKEPKH_00013	NZ_AP019857.1	C364	NFNKEPKH_00013	VFG042776	Adhesive fimbriae	99.6	1.5e-269	1	485	1.0	1	Adherence	CofD	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2963	M0155882	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2964	M0155883	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2965	M0155884	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2966	M0155885	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2967	M0155886	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2968	M0155887	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2969	M0155888	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2970	M0155889	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2971	M0155890	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2972	M0155891	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2973	M0155892	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2974	M0155893	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2975	M0155894	NZ_AP019857.1	NFNKEPKH_00014	NZ_AP019857.1__NFNKEPKH_00014	NZ_AP019857.1	C364	NFNKEPKH_00014	VFG042777	Adhesive fimbriae	97.8	6.7e-101	1	186	1.0	1	Adherence	CofE	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2976	M0155895	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2977	M0155896	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2978	M0155897	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2979	M0155898	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2980	M0155899	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2981	M0155900	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2982	M0155901	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2983	M0155902	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2984	M0155903	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2985	M0155904	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2986	M0155905	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2987	M0155906	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2988	M0155907	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2989	M0155908	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2990	M0155909	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2991	M0155910	NZ_AP019857.1	NFNKEPKH_00015	NZ_AP019857.1__NFNKEPKH_00015	NZ_AP019857.1	C364	NFNKEPKH_00015	VFG042778	Adhesive fimbriae	97.1	1.1e-147	1	275	1.0	1	Adherence	CofF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2992	M0155911	NZ_AP019857.1	NFNKEPKH_00016	NZ_AP019857.1__NFNKEPKH_00016	NZ_AP019857.1	C364	NFNKEPKH_00016	VFG042779	Adhesive fimbriae	99.4	1e-81	1	161	1.0	1	Adherence	CofG	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2993	M0155912	NZ_AP019857.1	NFNKEPKH_00016	NZ_AP019857.1__NFNKEPKH_00016	NZ_AP019857.1	C364	NFNKEPKH_00016	VFG042779	Adhesive fimbriae	99.4	1e-81	1	161	1.0	1	Adherence	CofG	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2994	M0155913	NZ_AP019857.1	NFNKEPKH_00016	NZ_AP019857.1__NFNKEPKH_00016	NZ_AP019857.1	C364	NFNKEPKH_00016	VFG042779	Adhesive fimbriae	99.4	1e-81	1	161	1.0	1	Adherence	CofG	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2995	M0155914	NZ_AP019857.1	NFNKEPKH_00016	NZ_AP019857.1__NFNKEPKH_00016	NZ_AP019857.1	C364	NFNKEPKH_00016	VFG042779	Adhesive fimbriae	99.4	1e-81	1	161	1.0	1	Adherence	CofG	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2996	M0155915	NZ_AP019857.1	NFNKEPKH_00016	NZ_AP019857.1__NFNKEPKH_00016	NZ_AP019857.1	C364	NFNKEPKH_00016	VFG042779	Adhesive fimbriae	99.4	1e-81	1	161	1.0	1	Adherence	CofG	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2997	M0155916	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2998	M0155917	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
2999	M0155918	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3000	M0155919	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3001	M0155920	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3002	M0155921	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3003	M0155922	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3004	M0155923	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3005	M0155924	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3006	M0155925	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3007	M0155926	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3008	M0155927	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3009	M0155928	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3010	M0155929	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3011	M0155930	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3012	M0155931	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3013	M0155932	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3014	M0155933	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3015	M0155934	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3016	M0155935	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3017	M0155936	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3018	M0155937	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3019	M0155938	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3020	M0155939	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3021	M0155940	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3022	M0155941	NZ_AP019857.1	NFNKEPKH_00017	NZ_AP019857.1__NFNKEPKH_00017	NZ_AP019857.1	C364	NFNKEPKH_00017	VFG042780	Adhesive fimbriae	98.9	2.8e-258	67	510	0.8706	1	Adherence	CofH	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3023	M0155942	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3024	M0155943	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3025	M0155944	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3026	M0155945	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3027	M0155946	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3028	M0155947	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3029	M0155948	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3030	M0155949	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3031	M0155950	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3032	M0155951	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3033	M0155952	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3034	M0155953	NZ_AP019857.1	NFNKEPKH_00018	NZ_AP019857.1__NFNKEPKH_00018	NZ_AP019857.1	C364	NFNKEPKH_00018	VFG042781	Adhesive fimbriae	99.1	4.3e-186	1	341	1.0	1	Adherence	CofI	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3035	M0155972	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3036	M0155973	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3037	M0155974	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3038	M0155975	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3039	M0155976	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3040	M0155977	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3041	M0155978	NZ_AP019857.1	NFNKEPKH_00020	NZ_AP019857.1__NFNKEPKH_00020	NZ_AP019857.1	C364	NFNKEPKH_00020	VFG042783	Adhesive fimbriae	74.1	1.2e-117	1	273	1.0	1	Adherence	CofP	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3042	M0157066	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3043	M0157067	NZ_AP022262.1	FLEOIPMK_00073	NZ_AP022262.1__FLEOIPMK_00073	NZ_AP022262.1	C368	FLEOIPMK_00073	VFG035911	Dispersin	80	9.4e-177	1	400	1.0	1	Others	outer membrane protein AatA	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3044	M0157068	NZ_AP022262.1	FLEOIPMK_00073	NZ_AP022262.1__FLEOIPMK_00073	NZ_AP022262.1	C368	FLEOIPMK_00073	VFG035911	Dispersin	80	9.4e-177	1	400	1.0	1	Others	outer membrane protein AatA	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3045	M0157069	NZ_AP022262.1	FLEOIPMK_00073	NZ_AP022262.1__FLEOIPMK_00073	NZ_AP022262.1	C368	FLEOIPMK_00073	VFG035911	Dispersin	80	9.4e-177	1	400	1.0	1	Others	outer membrane protein AatA	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3046	M0157070	NZ_AP022262.1	FLEOIPMK_00073	NZ_AP022262.1__FLEOIPMK_00073	NZ_AP022262.1	C368	FLEOIPMK_00073	VFG035911	Dispersin	80	9.4e-177	1	400	1.0	1	Others	outer membrane protein AatA	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3047	M0157071	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3048	M0157072	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3049	M0157073	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3050	M0157074	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3051	M0157075	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3052	M0157076	NZ_AP022262.1	FLEOIPMK_00074	NZ_AP022262.1__FLEOIPMK_00074	NZ_AP022262.1	C368	FLEOIPMK_00074	VFG035904	Dispersin	83.2	2.1e-162	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3053	M0157077	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3054	M0157078	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3055	M0157079	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3056	M0157080	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3057	M0157081	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3058	M0157082	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3059	M0157083	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3060	M0157084	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3061	M0157087	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3062	M0157091	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3063	M0157092	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3064	M0157093	NZ_AP022262.1	FLEOIPMK_00071	NZ_AP022262.1__FLEOIPMK_00071	NZ_AP022262.1	C368	FLEOIPMK_00071	VFG035924	Dispersin	82.2	1.2e-93	1	208	1.0	1	Others	ATP-binding protein AatC	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3065	M0157094	NZ_AP022816.1	ELLPOFOG_00033	NZ_AP022816.1__ELLPOFOG_00033	NZ_AP022816.1	C369	ELLPOFOG_00033	VFG020186	VirK	99.1	3.2e-188	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3066	M0157113	NZ_AP023206.1	DKMPNCBD_00328	NZ_AP023206.1__DKMPNCBD_00328	NZ_AP023206.1	C370	DKMPNCBD_00328	VFG049917	T6SS	91.5	0	1	1257	0.8397	0.8966	Effector delivery system	Type VI secretion system protein, PAAR family	Plays a role in interbacterial competition and host colonization	SetA	experiment
3067	M0157113	NZ_AP023206.1	DKMPNCBD_00328	NZ_AP023206.1__DKMPNCBD_00328	NZ_AP023206.1	C370	DKMPNCBD_00328	VFG049917	T6SS	91.5	0	1	1257	0.8397	0.8966	Effector delivery system	Type VI secretion system protein, PAAR family	Plays a role in interbacterial competition and host colonization	SetB	prediction
3068	M0163788	NZ_CP006263.1	FHAIKJIH_00102	NZ_CP006263.1__FHAIKJIH_00102	NZ_CP006263.1	C404	FHAIKJIH_00102	VFG000840	Hemolysin	99.5	0	1	998	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3069	M0163788	NZ_CP006263.1	FHAIKJIH_00102	NZ_CP006263.1__FHAIKJIH_00102	NZ_CP006263.1	C404	FHAIKJIH_00102	VFG033891	Hemolysin	100	0	1	998	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3070	M0163789	NZ_CP006263.1	FHAIKJIH_00102	NZ_CP006263.1__FHAIKJIH_00102	NZ_CP006263.1	C404	FHAIKJIH_00102	VFG000840	Hemolysin	99.5	0	1	998	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3071	M0163789	NZ_CP006263.1	FHAIKJIH_00102	NZ_CP006263.1__FHAIKJIH_00102	NZ_CP006263.1	C404	FHAIKJIH_00102	VFG033891	Hemolysin	100	0	1	998	1.0	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3072	M0163790	NZ_CP006263.1	FHAIKJIH_00104	NZ_CP006263.1__FHAIKJIH_00104	NZ_CP006263.1	C404	FHAIKJIH_00104	VFG000843	Hemolysin	100	1.2e-267	1	479	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3073	M0163790	NZ_CP006263.1	FHAIKJIH_00104	NZ_CP006263.1__FHAIKJIH_00104	NZ_CP006263.1	C404	FHAIKJIH_00104	VFG000843	Hemolysin	100	9e-267	1	479	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3074	M0164257	NZ_CP010239.1	JPCPDEEH_00031	NZ_CP010239.1__JPCPDEEH_00031	NZ_CP010239.1	C419	JPCPDEEH_00031	VFG000908	Alpha-Hemolysin	96	6.2e-248	1	478	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3075	M0164257	NZ_CP010239.1	JPCPDEEH_00031	NZ_CP010239.1__JPCPDEEH_00031	NZ_CP010239.1	C419	JPCPDEEH_00031	VFG033877	Hemolysin	98.7	3.9e-254	1	478	1.0	1	Exotoxin	Hemolysin D	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3076	M0164270	NZ_CP010830.1	POILIOFN_00220	NZ_CP010830.1__POILIOFN_00220	NZ_CP010830.1	C421	POILIOFN_00220	VFG000986	TTSS	98.6	1.3e-181	1	363	1.0	1	Effector delivery system	type III secretion system hydrophilic translocator, pore protein IpaC	Mxi-Spa system secretes approximately 20 proteins with the four Ipas A, B,C,D and IpgD being the most abundant; Recent findings indicate that TTSS in Shigella is responsible not only for protein secretion, but that it is also involved in the control mechanisms of transcription of other target genes located on the virulence plasmid, virA and ipaH9.8, these proteins were not constitutively synthesized and stored in the bacterial cytoplasm; their expression was markedly increased after initial activation of the secretion system, virA is not required for entry;Upon contact of the tip of the needle with the plasma membrane, the injectisome secretes its protein substrates into host cells. Some of these substrates act as translocators or effectors whose functions are key to the invasion of the cytosol and the cell-to-cell spread characterizing the lifestyle of Shigella spp.	SetA	experiment
3077	M0164270	NZ_CP010830.1	POILIOFN_00220	NZ_CP010830.1__POILIOFN_00220	NZ_CP010830.1	C421	POILIOFN_00220	VFG012750	TTSS secreted effectors	100	2.1e-183	1	363	1.0	1	Effector delivery system	type III secretion system hydrophilic translocator, pore protein IpaC	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
3078	M0167548	NZ_CP024244.1	NJEBBCIH_00180	NZ_CP024244.1__NJEBBCIH_00180	NZ_CP024244.1	C504	NJEBBCIH_00180	VFG042382	EtpA	98.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3079	M0167548	NZ_CP024244.1	NJEBBCIH_00180	NZ_CP024244.1__NJEBBCIH_00180	NZ_CP024244.1	C504	NJEBBCIH_00180	VFG042382	EtpA	98.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3080	M0167553	NZ_CP024246.1	HKEEFILB_00020	NZ_CP024246.1__HKEEFILB_00020	NZ_CP024246.1	C505	HKEEFILB_00020	VFG033834	Pic	98.8	0	1	1348	0.9978	0.9868	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3081	M0167559	NZ_CP024246.1	HKEEFILB_00020	NZ_CP024246.1__HKEEFILB_00020	NZ_CP024246.1	C505	HKEEFILB_00020	VFG033834	Pic	98.8	0	1	1348	0.9978	0.9868	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3082	M0167560	NZ_CP024246.1	HKEEFILB_00020	NZ_CP024246.1__HKEEFILB_00020	NZ_CP024246.1	C505	HKEEFILB_00020	VFG033834	Pic	98.8	0	1	1348	0.9978	0.9868	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3083	M0167597	NZ_CP024480.1	JCHEPMOK_00020	NZ_CP024480.1__JCHEPMOK_00020	NZ_CP024480.1	C515	JCHEPMOK_00020	VFG000846	StcE	86.9	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetA	experiment
3084	M0167597	NZ_CP024480.1	JCHEPMOK_00020	NZ_CP024480.1__JCHEPMOK_00020	NZ_CP024480.1	C515	JCHEPMOK_00020	VFG000846	StcE	86.9	0	1	886	1.0	0.9866	Exoenzyme	metalloprotease 	Specifically cleaves the C1 esterase inhibitor (C1-INH), which is an essential regulator of classical and alternative complement, intrinsic coagulation and contact activation, therefore disrupts complement cascade and contributes to the tissue damage, intestinal oedema and thrombotic cytopenia	SetB	prediction
3085	M0167620	NZ_CP025687.1	JGLINNHK_00161	NZ_CP025687.1__JGLINNHK_00161	NZ_CP025687.1	C521	JGLINNHK_00161	VFG002197	BopD	85.1	1.1e-163	1	336	0.9912	1	Biofilm	sugar-binding transcriptional regulator, LacI family	Homologous to a sugar-binding transcriptional regulator involved in biofilm production; The actual role is unknown, but the association of enhanced biofilm formation in the presence of glucose and the possible involvement of a sugar-binding transcriptional regulator suggest a linkage to increased biofilm production in E. faecalis in the presence of specific carbohydrates	SetA	experiment
3086	M0167620	NZ_CP025687.1	JGLINNHK_00161	NZ_CP025687.1__JGLINNHK_00161	NZ_CP025687.1	C521	JGLINNHK_00161	VFG045671	BopD	89.3	1.4e-168	1	337	0.9941	0.9941	Biofilm	sugar-binding transcriptional regulator, LacI family	Homologous to a sugar-binding transcriptional regulator involved in biofilm production; The actual role is unknown, but the association of enhanced biofilm formation in the presence of glucose and the possible involvement of a sugar-binding transcriptional regulator suggest a linkage to increased biofilm production in E. faecalis in the presence of specific carbohydrates	SetB	prediction
3087	M0167643	NZ_CP025850.1	EEOKEPCI_00145	NZ_CP025850.1__EEOKEPCI_00145	NZ_CP025850.1	C524	EEOKEPCI_00145	VFG001445	TraJ	99.5	1.7e-115	1	200	0.8772	0.995	Invasion	unknown protein	Contributes to the ability of E. coli K1 to invade the central nervous system and cause meningitis in the neonatal rat; TraJ contributes to the early systemic dissemination of E. coli K1 in the oral infection process is via specific TraJ-dependent bacterial interactions with macrophages. TraJ enables the bacteria to be taken up efficiently by macrophages. In the early steps of dissemination, the intracellular environment of the phagocytes provides a protective or safe site from the initial host inflammatory defense mechanisms	SetA	experiment
3088	M0167643	NZ_CP025850.1	EEOKEPCI_00145	NZ_CP025850.1__EEOKEPCI_00145	NZ_CP025850.1	C524	EEOKEPCI_00145	VFG001445	TraJ	99.5	1.3e-114	1	200	0.8772	0.995	Invasion	unknown protein	Contributes to the ability of E. coli K1 to invade the central nervous system and cause meningitis in the neonatal rat; TraJ contributes to the early systemic dissemination of E. coli K1 in the oral infection process is via specific TraJ-dependent bacterial interactions with macrophages. TraJ enables the bacteria to be taken up efficiently by macrophages. In the early steps of dissemination, the intracellular environment of the phagocytes provides a protective or safe site from the initial host inflammatory defense mechanisms	SetB	prediction
3089	M0168083	NZ_CP027545.1	PCBKMEJD_00049	NZ_CP027545.1__PCBKMEJD_00049	NZ_CP027545.1	C538	PCBKMEJD_00049	VFG000840	Hemolysin	99.5	0	7	1004	0.994	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3090	M0168083	NZ_CP027545.1	PCBKMEJD_00049	NZ_CP027545.1__PCBKMEJD_00049	NZ_CP027545.1	C538	PCBKMEJD_00049	VFG033891	Hemolysin	100	0	7	1004	0.994	1	Exotoxin	Hemolysin A	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3091	M0168941	NZ_CP034948.1	LEMNKDED_00012	NZ_CP034948.1__LEMNKDED_00012	NZ_CP034948.1	C586	LEMNKDED_00012	VFG042989	PilA-type pili (PGS1, pilin gene clusters 1)	98.7	1.4e-124	1	223	1.0	1	Adherence	putative housekeeping sortase		SetB	prediction
3092	M0168942	NZ_CP034948.1	LEMNKDED_00013	NZ_CP034948.1__LEMNKDED_00013	NZ_CP034948.1	C586	LEMNKDED_00013	VFG042988	PilA-type pili (PGS1, pilin gene clusters 1)	99	3.8e-303	1	525	1.0	0.7979	Adherence	PilA		SetB	prediction
3093	M0168943	NZ_CP034948.1	LEMNKDED_00017	NZ_CP034948.1__LEMNKDED_00017	NZ_CP034948.1	C586	LEMNKDED_00017	VFG042984	PilA-type pili (PGS1, pilin gene clusters 1)	99.3	0	1	696	1.0	1	Adherence	minor pilin subunit		SetB	prediction
3094	M0168944	NZ_CP034948.1	LEMNKDED_00017	NZ_CP034948.1__LEMNKDED_00017	NZ_CP034948.1	C586	LEMNKDED_00017	VFG042984	PilA-type pili (PGS1, pilin gene clusters 1)	99.3	0	1	696	1.0	1	Adherence	minor pilin subunit		SetB	prediction
3095	M0169230	NZ_CP035847.1	KFLMNJPH_00033	NZ_CP035847.1__KFLMNJPH_00033	NZ_CP035847.1	C601	KFLMNJPH_00033	VFG020186	VirK	98.1	3e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3096	M0169231	NZ_CP035847.1	KFLMNJPH_00033	NZ_CP035847.1__KFLMNJPH_00033	NZ_CP035847.1	C601	KFLMNJPH_00033	VFG020186	VirK	98.1	3e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3097	M0169238	NZ_CP035847.1	KFLMNJPH_00033	NZ_CP035847.1__KFLMNJPH_00033	NZ_CP035847.1	C601	KFLMNJPH_00033	VFG020186	VirK	98.1	3e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3098	M0169274	NZ_CP035852.1	DBPBMMNC_00081	NZ_CP035852.1__DBPBMMNC_00081	NZ_CP035852.1	C603	DBPBMMNC_00081	VFG041000	AAI/SCI-II T6SS	91.5	3.1e-98	1	188	1.0	1	Effector delivery system	hypothetical protein		SetB	prediction
3099	M0169289	NZ_CP035852.1	DBPBMMNC_00060	NZ_CP035852.1__DBPBMMNC_00060	NZ_CP035852.1	C603	DBPBMMNC_00060	VFG042382	EtpA	99.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3100	M0169289	NZ_CP035852.1	DBPBMMNC_00060	NZ_CP035852.1__DBPBMMNC_00060	NZ_CP035852.1	C603	DBPBMMNC_00060	VFG042382	EtpA	99.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3101	M0169290	NZ_CP035852.1	DBPBMMNC_00060	NZ_CP035852.1__DBPBMMNC_00060	NZ_CP035852.1	C603	DBPBMMNC_00060	VFG042382	EtpA	99.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3102	M0169290	NZ_CP035852.1	DBPBMMNC_00060	NZ_CP035852.1__DBPBMMNC_00060	NZ_CP035852.1	C603	DBPBMMNC_00060	VFG042382	EtpA	99.7	0	1	603	1.0	1	Adherence	two-partner secretion transporter EtpB	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3103	M0169291	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3104	M0169291	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3105	M0169292	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3106	M0169292	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3107	M0169293	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3108	M0169293	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3109	M0169294	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3110	M0169294	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3111	M0169295	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3112	M0169295	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3113	M0169296	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3114	M0169296	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3115	M0169297	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3116	M0169297	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3117	M0169298	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3118	M0169298	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3119	M0169299	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3120	M0169299	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3121	M0169300	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3122	M0169300	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3123	M0169301	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3124	M0169301	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3125	M0169302	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3126	M0169302	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3127	M0169303	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3128	M0169303	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3129	M0169304	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3130	M0169304	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3131	M0169305	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3132	M0169305	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3133	M0169306	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3134	M0169306	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3135	M0169307	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3136	M0169307	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3137	M0169308	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3138	M0169308	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3139	M0169309	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3140	M0169309	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3141	M0169310	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3142	M0169310	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3143	M0169311	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3144	M0169311	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3145	M0169312	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3146	M0169312	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3147	M0169313	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3148	M0169313	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3149	M0169314	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3150	M0169314	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3151	M0169315	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3152	M0169315	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3153	M0169316	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3154	M0169316	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3155	M0169317	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetA	experiment
3156	M0169317	NZ_CP035852.1	DBPBMMNC_00061	NZ_CP035852.1__DBPBMMNC_00061	NZ_CP035852.1	C603	DBPBMMNC_00061	VFG034541	EtpA	93.6	0	1	1526	1.0	0.9916	Adherence	Two-partner secreted adhesin EtpA	Interacts with highly conserved regions of flagellin exposed at the tips of flagella, exploiting these long (<10~15 mm) appendages to tether EtpA adhesins that anchor bacteria on initial engagement of host cells	SetB	prediction
3157	M0169331	NZ_CP035861.1	OFMCCMOF_00039	NZ_CP035861.1__OFMCCMOF_00039	NZ_CP035861.1	C604	OFMCCMOF_00039	VFG035911	Dispersin	80.5	1.1e-177	1	400	1.0	1	Others	outer membrane protein AatA	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3158	M0169341	NZ_CP035861.1	OFMCCMOF_00040	NZ_CP035861.1__OFMCCMOF_00040	NZ_CP035861.1	C604	OFMCCMOF_00040	VFG035904	Dispersin	82.9	2.3e-161	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3159	M0169342	NZ_CP035861.1	OFMCCMOF_00040	NZ_CP035861.1__OFMCCMOF_00040	NZ_CP035861.1	C604	OFMCCMOF_00040	VFG035904	Dispersin	82.9	2.3e-161	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3160	M0169343	NZ_CP035861.1	OFMCCMOF_00040	NZ_CP035861.1__OFMCCMOF_00040	NZ_CP035861.1	C604	OFMCCMOF_00040	VFG035904	Dispersin	82.9	2.3e-161	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3161	M0169344	NZ_CP035861.1	OFMCCMOF_00040	NZ_CP035861.1__OFMCCMOF_00040	NZ_CP035861.1	C604	OFMCCMOF_00040	VFG035904	Dispersin	82.9	2.3e-161	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3162	M0169345	NZ_CP035861.1	OFMCCMOF_00040	NZ_CP035861.1__OFMCCMOF_00040	NZ_CP035861.1	C604	OFMCCMOF_00040	VFG035904	Dispersin	82.9	2.3e-161	6	377	0.9867	0.9841	Others	permease AatP	Promotes dispersal of EAEC on the intestinal mucosa to establish new foci of infection and facilitate efficient colonization via bacterial dispersal	SetB	prediction
3163	M0169381	NZ_CP035861.1	OFMCCMOF_00141	NZ_CP035861.1__OFMCCMOF_00141	NZ_CP035861.1	C604	OFMCCMOF_00141	VFG035359	AAI/SCI-II T6SS	80.1	7.6e-237	1	492	1.0	1	Effector delivery system	type VI secretion system contractile sheath large subunit		SetB	prediction
3164	M0169456	NZ_CP035868.1	KKFBMGLM_00024	NZ_CP035868.1__KKFBMGLM_00024	NZ_CP035868.1	C607	KKFBMGLM_00024	VFG036066	Heat-labile toxin (LT)	99.1	4.5e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetA	experiment
3165	M0169456	NZ_CP035868.1	KKFBMGLM_00024	NZ_CP035868.1__KKFBMGLM_00024	NZ_CP035868.1	C607	KKFBMGLM_00024	VFG036065	Heat-labile toxin (LT)	99.5	8.9e-129	1	218	1.0	0.845	Exotoxin	heat-labile enterotoxin A prepeptide (from human)	ADP ribosylates and activates adenylate cyclase resulting in ion secretion	SetB	prediction
3166	M0169665	NZ_CP035885.1	MPKKIMGJ_00165	NZ_CP035885.1__MPKKIMGJ_00165	NZ_CP035885.1	C612	MPKKIMGJ_00165	VFG033834	Pic	98.5	0	1	1364	1.0	0.9985	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3167	M0169755	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3168	M0169756	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3169	M0169757	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3170	M0169758	NZ_CP035885.1	MPKKIMGJ_00129	NZ_CP035885.1__MPKKIMGJ_00129	NZ_CP035885.1	C612	MPKKIMGJ_00129	VFG042508	Adhesive fimbriae	100	0	1	872	1.0	1	Adherence	CS17 fimbriae outer membrane usher protein	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3171	M0169759	NZ_CP035885.1	MPKKIMGJ_00131	NZ_CP035885.1__MPKKIMGJ_00131	NZ_CP035885.1	C612	MPKKIMGJ_00131	VFG042506	Adhesive fimbriae	100	1.1e-129	1	236	0.9958	0.9958	Adherence	CS17 fimbriae periplasmic chaperone	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3172	M0169760	NZ_CP035885.1	MPKKIMGJ_00131	NZ_CP035885.1__MPKKIMGJ_00131	NZ_CP035885.1	C612	MPKKIMGJ_00131	VFG042506	Adhesive fimbriae	100	1.1e-129	1	236	0.9958	0.9958	Adherence	CS17 fimbriae periplasmic chaperone	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3173	M0169761	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3174	M0169762	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3175	M0169763	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3176	M0169765	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3177	M0169766	NZ_CP035885.1	MPKKIMGJ_00128	NZ_CP035885.1__MPKKIMGJ_00128	NZ_CP035885.1	C612	MPKKIMGJ_00128	VFG042509	Adhesive fimbriae	98.9	6.7e-214	1	363	1.0	1	Adherence	CS17 fimbriae minor subunit	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3178	M0169914	NZ_CP038396.1	OEMFHIMO_00004	NZ_CP038396.1__OEMFHIMO_00004	NZ_CP038396.1	C628	OEMFHIMO_00004	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3179	M0169915	NZ_CP038396.1	OEMFHIMO_00004	NZ_CP038396.1__OEMFHIMO_00004	NZ_CP038396.1	C628	OEMFHIMO_00004	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3180	M0169916	NZ_CP038396.1	OEMFHIMO_00004	NZ_CP038396.1__OEMFHIMO_00004	NZ_CP038396.1	C628	OEMFHIMO_00004	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3181	M0169917	NZ_CP038396.1	OEMFHIMO_00004	NZ_CP038396.1__OEMFHIMO_00004	NZ_CP038396.1	C628	OEMFHIMO_00004	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3182	M0171234	NZ_CP046285.1	BCAIDBAP_00065	NZ_CP046285.1__BCAIDBAP_00065	NZ_CP046285.1	C677	BCAIDBAP_00065	VFG042215	TTSS secreted effectors	98.7	1.3e-129	1	230	1.0	1	Effector delivery system	type III secretion system effector cysteine methyltransferase OspZ	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
3183	M0171234	NZ_CP046285.1	BCAIDBAP_00065	NZ_CP046285.1__BCAIDBAP_00065	NZ_CP046285.1	C677	BCAIDBAP_00065	VFG042215	TTSS secreted effectors	98.7	9.4e-129	1	230	1.0	1	Effector delivery system	type III secretion system effector cysteine methyltransferase OspZ	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
3184	M0173092	NZ_CP049282.1	LDEBMEDG_00176	NZ_CP049282.1__LDEBMEDG_00176	NZ_CP049282.1	C704	LDEBMEDG_00176	VFG000991	TTSS secreted effectors	97.2	1.2e-278	1	494	1.0	1	Effector delivery system	type III secretion system effector IcsB, fatty acyltransferase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetA	experiment
3185	M0173092	NZ_CP049282.1	LDEBMEDG_00176	NZ_CP049282.1__LDEBMEDG_00176	NZ_CP049282.1	C704	LDEBMEDG_00176	VFG020130	TTSS secreted effectors	99.8	3.8e-284	1	494	1.0	1	Effector delivery system	type III secretion system effector IcsB, fatty acyltransferase	IcsB (Nepsilon-fatty acyltransferase. Disruption of the actin cytoskeleton in eukaryotes; evasion of autophagy. ); IpaA (Recruit focal adhesion protein vinculin to promote actin depolymerization at the site of entry. ); IpaB (Caspase-1 binding proteins. Counteracts exfoliation by binding directly to Mad2L2 to release its inhibitory effect on the anaphase-promoting complex/cyclosome, thereby causing a delayed mitotic progression or cell cycle arrest at the G2/M phase and favouring bacterial multiplication; activates Caspase-1 and induces cell death; interacts with CD44 on the epithelial cell membrane and stimulates bacterial basolateral invasion. ); IpaC (Binds the host cell-adhesion protein beta-catenin and facilitates efficient protrusion formation. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH (Possible E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH0722 (E3 ubiquitin ligase. Dampens the inflammatory response by inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2. ); IpaH1.4 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH2.5 (E3 ubiquitin ligase. Suppresses inflammatory response. ); IpaH4.5 (E3 ubiquitin ligase. Ubiquitinates the p65 subunit of NF-kappaB to modulate host inflammatory response. ); IpaH7.8 (E3 ubiquitin ligase. Induction of pyroptosis by ubiquitylating and promoting proteasome degradation. ); IpaH9.8 (E3 ubiquitin ligase. Binds to a splicing factor U2AF35 to modulate host immune responses; targets NEMO/Ikkgamma to dampen the host NF-kappaB-mediated inflammatory response; targets guanylate-binding protein GBP1 by LRR domain leads to their proteasomal degradation. ); IpaJ (Cysteine protease. Cleaves an array of N-myristoylated proteins involved in cellular growth, signal transduction, autophagasome maturation and organelle function. ); IpgB1 (GEF. Plays a pivotal role in producing membrane ruffles by exploiting the RhoG-ELMO-Dock180 pathway to stimulate Rac1 activity. ); IpgB2 (RhoA-GEF. Induces stress fiber formation. ); IpgD (Phosphoinositide 4-phosphatase. Hydrolyses phosphatidylinositol (4,5)- bisphosphate, contributes to the disruption of cortical actin structures required for efficient bacterial uptake. ); OspB (Interacts directly with the scaffolding protein IQGAP1 to activate mTORC1 and promote mTORC1-dependent cell proliferaction. ); OspC1 (Inhibition of apoptosis by preventing caspase-8 activity. ); OspC2; OspC3 (ADP-riboxanase. Inhibition of pyroptosis by inhibiting caspase-4 activation. ); OspC4; OspD1 (Anti-activator for MxiE. ); OspD2 (Inhibition of necrosis. ); OspD3/senA (Protease. Inhibition of necroptosis by degrading RIPK1 and RIPK3. ); OspE1 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspE2 (Counteracts exofoliation by interacting with integrin-liked kinase to stabilize focal adhesions and block cell detachment, thereby favouring bacterial dissemination within epithelial tissue. ); OspF (Phosphothreonine lyase. Acts as a lyase that irreversibly dephosphorylates mitogenactivated protein kinases (MAPK) in the nucleus of the host cell to suppress innate immune response; interacts with retinoblastoma protein to recruit factors such as histone deacetylase, which downregulate IL-8 production via chromatin remodelling. ); OspG (Protein kinase. Binds to ubiquitin-conjugating enzyme UbcH5 to antagonize degradation of inhibitor IkappaBalpha by blocking its ubiquitinylation, thus suppresses innate immune response. ); OspI (Glutamine deamidase. Inhibits the E2 ubiquitin-conjugating activity leading to the suppression of TRAF6-dependent inflammatory signaling. ); VirA (TBC-like GTPase-activating protein. VirA activates calpain protease by directly binding the calpain inhibitor calpastatin; hydrolyzes GTP to block Rab1 signaling so as to disrupt ER-to Golgi trafficking. ); OspZ (S-adenosyl-L-methionine-dependent methyltransferase. Binds to TAB3 to decreased IL-8 transcription through modification of TAB3. )	SetB	prediction
3186	M0173093	NZ_CP049282.1	LDEBMEDG_00182	NZ_CP049282.1__LDEBMEDG_00182	NZ_CP049282.1	C704	LDEBMEDG_00182	VFG000997	TTSS	99	2e-44	1	97	1.0	1	Effector delivery system	type III secretion system inner rod protein MxiI	Mxi-Spa system secretes approximately 20 proteins with the four Ipas A, B,C,D and IpgD being the most abundant; Recent findings indicate that TTSS in Shigella is responsible not only for protein secretion, but that it is also involved in the control mechanisms of transcription of other target genes located on the virulence plasmid, virA and ipaH9.8, these proteins were not constitutively synthesized and stored in the bacterial cytoplasm; their expression was markedly increased after initial activation of the secretion system, virA is not required for entry;Upon contact of the tip of the needle with the plasma membrane, the injectisome secretes its protein substrates into host cells. Some of these substrates act as translocators or effectors whose functions are key to the invasion of the cytosol and the cell-to-cell spread characterizing the lifestyle of Shigella spp.	SetA	experiment
3187	M0173093	NZ_CP049282.1	LDEBMEDG_00182	NZ_CP049282.1__LDEBMEDG_00182	NZ_CP049282.1	C704	LDEBMEDG_00182	VFG000997	TTSS	99	1.5e-43	1	97	1.0	1	Effector delivery system	type III secretion system inner rod protein MxiI	Mxi-Spa system secretes approximately 20 proteins with the four Ipas A, B,C,D and IpgD being the most abundant; Recent findings indicate that TTSS in Shigella is responsible not only for protein secretion, but that it is also involved in the control mechanisms of transcription of other target genes located on the virulence plasmid, virA and ipaH9.8, these proteins were not constitutively synthesized and stored in the bacterial cytoplasm; their expression was markedly increased after initial activation of the secretion system, virA is not required for entry;Upon contact of the tip of the needle with the plasma membrane, the injectisome secretes its protein substrates into host cells. Some of these substrates act as translocators or effectors whose functions are key to the invasion of the cytosol and the cell-to-cell spread characterizing the lifestyle of Shigella spp.	SetB	prediction
3188	M0173522	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3189	M0173522	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3190	M0173523	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3191	M0173523	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3192	M0173524	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3193	M0173524	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3194	M0173525	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3195	M0173525	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3196	M0173526	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3197	M0173526	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3198	M0173527	NZ_CP051689.1	IPNNCHHL_00024	NZ_CP051689.1__IPNNCHHL_00024	NZ_CP051689.1	C720	IPNNCHHL_00024	VFG012505	Salmochelin siderophore	99	2.2e-241	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3199	M0173527	NZ_CP051689.1	IPNNCHHL_00024	NZ_CP051689.1__IPNNCHHL_00024	NZ_CP051689.1	C720	IPNNCHHL_00024	VFG012505	Salmochelin siderophore	99	1.6e-240	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3200	M0173528	NZ_CP051689.1	IPNNCHHL_00024	NZ_CP051689.1__IPNNCHHL_00024	NZ_CP051689.1	C720	IPNNCHHL_00024	VFG012505	Salmochelin siderophore	99	2.2e-241	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3201	M0173528	NZ_CP051689.1	IPNNCHHL_00024	NZ_CP051689.1__IPNNCHHL_00024	NZ_CP051689.1	C720	IPNNCHHL_00024	VFG012505	Salmochelin siderophore	99	1.6e-240	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3202	M0173529	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG000935	Salmochelin siderophore	98.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3203	M0173529	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG012499	Salmochelin siderophore	98.8	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3204	M0173530	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG000935	Salmochelin siderophore	98.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3205	M0173530	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG012499	Salmochelin siderophore	98.8	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3206	M0173531	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG000935	Salmochelin siderophore	98.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3207	M0173531	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG012499	Salmochelin siderophore	98.8	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3208	M0173532	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG000935	Salmochelin siderophore	98.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3209	M0173532	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG012499	Salmochelin siderophore	98.8	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3210	M0173533	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG000935	Salmochelin siderophore	98.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3211	M0173533	NZ_CP051689.1	IPNNCHHL_00026	NZ_CP051689.1__IPNNCHHL_00026	NZ_CP051689.1	C720	IPNNCHHL_00026	VFG012499	Salmochelin siderophore	98.8	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3212	M0173542	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3213	M0173542	NZ_CP051689.1	IPNNCHHL_00023	NZ_CP051689.1__IPNNCHHL_00023	NZ_CP051689.1	C720	IPNNCHHL_00023	VFG012509	Salmochelin siderophore	99.5	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3214	M0173543	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3215	M0173544	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3216	M0173545	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3217	M0173546	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3218	M0173547	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3219	M0173548	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3220	M0173549	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3221	M0173550	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3222	M0173551	NZ_CP051704.1	DONOCFFA_00001	NZ_CP051704.1__DONOCFFA_00001	NZ_CP051704.1	C721	DONOCFFA_00001	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3223	M0177301	NZ_CP059841.1	ELFCHKLA_00098	NZ_CP059841.1__ELFCHKLA_00098	NZ_CP059841.1	C771	ELFCHKLA_00098	VFG000750	BFP	100	9.6e-74	1	133	1.0	1	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3224	M0177301	NZ_CP059841.1	ELFCHKLA_00098	NZ_CP059841.1__ELFCHKLA_00098	NZ_CP059841.1	C771	ELFCHKLA_00098	VFG000750	BFP	100	7.2e-73	1	133	1.0	1	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3225	M0177480	NZ_CP060942.1	ELIPBAAC_00009	NZ_CP060942.1__ELIPBAAC_00009	NZ_CP060942.1	C777	ELIPBAAC_00009	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3226	M0177481	NZ_CP060942.1	ELIPBAAC_00010	NZ_CP060942.1__ELIPBAAC_00010	NZ_CP060942.1	C777	ELIPBAAC_00010	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3227	M0177482	NZ_CP060942.1	ELIPBAAC_00010	NZ_CP060942.1__ELIPBAAC_00010	NZ_CP060942.1	C777	ELIPBAAC_00010	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3228	M0177483	NZ_CP060942.1	ELIPBAAC_00010	NZ_CP060942.1__ELIPBAAC_00010	NZ_CP060942.1	C777	ELIPBAAC_00010	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3229	M0177484	NZ_CP060942.1	ELIPBAAC_00010	NZ_CP060942.1__ELIPBAAC_00010	NZ_CP060942.1	C777	ELIPBAAC_00010	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3230	M0177486	NZ_CP060942.1	ELIPBAAC_00009	NZ_CP060942.1__ELIPBAAC_00009	NZ_CP060942.1	C777	ELIPBAAC_00009	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3231	M0177492	NZ_CP060942.1	ELIPBAAC_00009	NZ_CP060942.1__ELIPBAAC_00009	NZ_CP060942.1	C777	ELIPBAAC_00009	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3232	M0177495	NZ_CP060942.1	ELIPBAAC_00010	NZ_CP060942.1__ELIPBAAC_00010	NZ_CP060942.1	C777	ELIPBAAC_00010	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3233	M0177544	NZ_CP061330.1	PEFOJEJG_00020	NZ_CP061330.1__PEFOJEJG_00020	NZ_CP061330.1	C780	PEFOJEJG_00020	VFG000903	Pic	99.9	0	1	1371	1.0	1	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetA	experiment
3234	M0177544	NZ_CP061330.1	PEFOJEJG_00020	NZ_CP061330.1__PEFOJEJG_00020	NZ_CP061330.1	C780	PEFOJEJG_00020	VFG000903	Pic	99.9	0	1	1371	1.0	1	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3235	M0177545	NZ_CP061330.1	PEFOJEJG_00020	NZ_CP061330.1__PEFOJEJG_00020	NZ_CP061330.1	C780	PEFOJEJG_00020	VFG000903	Pic	99.9	0	1	1371	1.0	1	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetA	experiment
3236	M0177545	NZ_CP061330.1	PEFOJEJG_00020	NZ_CP061330.1__PEFOJEJG_00020	NZ_CP061330.1	C780	PEFOJEJG_00020	VFG000903	Pic	99.9	0	1	1371	1.0	1	Effector delivery system	Pic serine protease precursor, autotransporter	Protease, mucinase	SetB	prediction
3237	M0177564	NZ_CP061330.1	PEFOJEJG_00065	NZ_CP061330.1__PEFOJEJG_00065	NZ_CP061330.1	C780	PEFOJEJG_00065	VFG036037	Contact-dependent inhibition CDI system	96.6	0	1	588	1.0	1	Effector delivery system	ShlB/FhaC/HecB family hemolysin secretion/activation protein		SetB	prediction
3238	M0177565	NZ_CP061330.1	PEFOJEJG_00065	NZ_CP061330.1__PEFOJEJG_00065	NZ_CP061330.1	C780	PEFOJEJG_00065	VFG036037	Contact-dependent inhibition CDI system	96.6	0	1	588	1.0	1	Effector delivery system	ShlB/FhaC/HecB family hemolysin secretion/activation protein		SetB	prediction
3239	M0178451	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3240	M0178451	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3241	M0178452	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3242	M0178452	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3243	M0178453	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3244	M0178453	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3245	M0178454	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3246	M0178454	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3247	M0178455	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3248	M0178455	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3249	M0178456	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3250	M0178456	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3251	M0178457	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3252	M0178457	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3253	M0178458	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3254	M0178458	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3255	M0178459	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3256	M0178459	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3257	M0178460	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3258	M0178460	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3259	M0178461	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3260	M0178461	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3261	M0178462	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3262	M0178462	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3263	M0178463	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3264	M0178463	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3265	M0178464	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3266	M0178464	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3267	M0178465	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3268	M0178465	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3269	M0178466	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3270	M0178466	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3271	M0178467	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3272	M0178467	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3273	M0178468	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3274	M0178468	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3275	M0178469	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3276	M0178469	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3277	M0178470	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3278	M0178470	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3279	M0178471	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3280	M0178471	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3281	M0178472	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3282	M0178472	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3283	M0178473	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3284	M0178473	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3285	M0178474	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3286	M0178474	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3287	M0178475	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3288	M0178475	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3289	M0178476	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3290	M0178476	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3291	M0178477	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3292	M0178477	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3293	M0178478	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3294	M0178478	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3295	M0178479	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3296	M0178479	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3297	M0178480	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3298	M0178480	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3299	M0178481	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3300	M0178481	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3301	M0178482	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3302	M0178482	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3303	M0178483	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3304	M0178483	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3305	M0178484	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3306	M0178484	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3307	M0178485	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3308	M0178485	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3309	M0178486	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3310	M0178486	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3311	M0178487	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3312	M0178487	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3313	M0178488	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3314	M0178488	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3315	M0178489	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3316	M0178489	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3317	M0178490	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3318	M0178490	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3319	M0178491	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3320	M0178491	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3321	M0178492	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3322	M0178492	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3323	M0178493	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3324	M0178493	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3325	M0178494	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3326	M0178494	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3327	M0178495	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3328	M0178495	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3329	M0178502	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3330	M0178502	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3331	M0178503	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3332	M0178503	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3333	M0178504	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3334	M0178504	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3335	M0178505	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3336	M0178505	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3337	M0178506	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3338	M0178506	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3339	M0178507	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3340	M0178507	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3341	M0178508	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3342	M0178508	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3343	M0178509	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038365	T6SS	94.8	3.6e-97	1	172	1.0	1	Effector delivery system	HcpA-like protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetA	experiment
3344	M0178509	NZ_CP062197.1	DPAGEEAF_00234	NZ_CP062197.1__DPAGEEAF_00234	NZ_CP062197.1	C784	DPAGEEAF_00234	VFG038370	T6SS	95.3	7.1e-97	1	172	1.0	1	Effector delivery system	hemolysin co-regulated protein	A phagetail-spike-like injectisome to translocate virulence determinants directly into the host cell cytoplasm; Four effectors of the T6SS have so far been characterized, Hcp1, Vgr1, Vgr2 and Vgr3; Hcp is a powerful effector substrate and once translocated into the targeted host cell cytoplasm, apoptosis ensues following caspase 3 activation; Hcp paralyzes macrophages to prevent phagocytosis;Vgr1 is an ADP-ribosylating toxin capable of interrupting the host cell cytoskeleton and inducing apoptosis	SetB	prediction
3345	M0178566	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038367	T6SS secreted effectors	77	7.19999999993757e-314	1	669	0.9926	0.7217	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetA	experiment
3346	M0178566	NZ_CP062197.1	DPAGEEAF_00233	NZ_CP062197.1__DPAGEEAF_00233	NZ_CP062197.1	C784	DPAGEEAF_00233	VFG038368	T6SS secreted effectors	78.2	0	1	669	0.9926	0.7225	Effector delivery system	Type VI secretion system effector VgrG1, ADP-ribosyltransferase 	VgrG1 (ADPRT. Disruption of the actin cytoskeleton. )	SetB	prediction
3347	M0180513	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3348	M0180513	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3349	M0180514	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3350	M0180514	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3351	M0180515	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3352	M0180515	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3353	M0180516	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3354	M0180516	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3355	M0180517	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3356	M0180517	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3357	M0180518	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3358	M0180518	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3359	M0180519	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3360	M0180519	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3361	M0180520	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3362	M0180520	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3363	M0180521	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3364	M0180521	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3365	M0180522	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3366	M0180522	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3367	M0180523	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3368	M0180523	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3369	M0180524	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3370	M0180524	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3371	M0180525	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3372	M0180525	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3373	M0180526	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3374	M0180526	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3375	M0180527	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3376	M0180527	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3377	M0180528	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3378	M0180528	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3379	M0180529	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3380	M0180529	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3381	M0180530	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3382	M0180530	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3383	M0180531	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3384	M0180531	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3385	M0180532	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3386	M0180532	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3387	M0180533	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3388	M0180533	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3389	M0180534	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3390	M0180534	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3391	M0180535	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3392	M0180535	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3393	M0180536	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3394	M0180536	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3395	M0180537	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3396	M0180537	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3397	M0180538	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3398	M0180538	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3399	M0180539	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3400	M0180539	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3401	M0180540	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3402	M0180540	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3403	M0180541	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3404	M0180541	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3405	M0180561	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3406	M0180561	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3407	M0180577	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3408	M0180577	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3409	M0180578	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3410	M0180578	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3411	M0183104	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3412	M0183104	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3413	M0183105	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3414	M0183105	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3415	M0183106	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3416	M0183106	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3417	M0183107	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3418	M0183107	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3419	M0183108	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3420	M0183108	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3421	M0183109	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3422	M0183109	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3423	M0183110	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3424	M0183110	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3425	M0183111	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3426	M0183111	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3427	M0183112	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3428	M0183112	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3429	M0183113	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3430	M0183113	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3431	M0183114	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3432	M0183114	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3433	M0183115	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3434	M0183115	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3435	M0183116	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3436	M0183116	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3437	M0183117	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3438	M0183117	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3439	M0183118	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3440	M0183118	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3441	M0183167	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037028	KatA	72.5	2.8e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetA	experiment
3442	M0183167	NZ_CP062197.1	DPAGEEAF_00133	NZ_CP062197.1__DPAGEEAF_00133	NZ_CP062197.1	C784	DPAGEEAF_00133	VFG037029	KatA	72.7	5.5e-211	12	483	0.9593	0.9365	Stress survival	catalase	Detoxifies H2O2; Protects against ROS (Reactive oxygen species), a family of chemical that are oxidized version of molecular oxygen, including hydrogen peroxide, superoxide and hydroxyl radicals	SetB	prediction
3443	M0183634	NZ_CP062915.1	GKMCEMGI_00031	NZ_CP062915.1__GKMCEMGI_00031	NZ_CP062915.1	C786	GKMCEMGI_00031	VFG012505	Salmochelin siderophore	100	7.9e-244	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3444	M0183634	NZ_CP062915.1	GKMCEMGI_00031	NZ_CP062915.1__GKMCEMGI_00031	NZ_CP062915.1	C786	GKMCEMGI_00031	VFG012505	Salmochelin siderophore	100	5.9e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3445	M0183635	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3446	M0183635	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3447	M0183636	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3448	M0183636	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3449	M0183637	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3450	M0183637	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3451	M0183638	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3452	M0183638	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3453	M0183639	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3454	M0183639	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3455	M0183640	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3456	M0183640	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3457	M0183641	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3458	M0183641	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3459	M0183642	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3460	M0183642	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3461	M0183643	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3462	M0183643	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3463	M0183644	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3464	M0183644	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3465	M0183645	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3466	M0183645	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3467	M0183646	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3468	M0183646	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3469	M0183647	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3470	M0183647	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3471	M0183648	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3472	M0183648	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3473	M0183649	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3474	M0183649	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3475	M0183650	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3476	M0183650	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3477	M0183651	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3478	M0183651	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3479	M0183652	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3480	M0183652	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3481	M0183653	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3482	M0183653	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3483	M0183654	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3484	M0183654	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3485	M0183655	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3486	M0183655	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3487	M0183656	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3488	M0183656	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3489	M0183657	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3490	M0183657	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3491	M0183658	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3492	M0183658	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3493	M0183659	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3494	M0183659	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3495	M0183660	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3496	M0183660	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3497	M0183661	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3498	M0183661	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3499	M0183662	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG012509	Salmochelin siderophore	99.7	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3500	M0183662	NZ_CP062915.1	GKMCEMGI_00030	NZ_CP062915.1__GKMCEMGI_00030	NZ_CP062915.1	C786	GKMCEMGI_00030	VFG033929	Salmochelin siderophore	100	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3501	M0183663	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3502	M0183663	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3503	M0183664	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3504	M0183664	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3505	M0183665	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3506	M0183665	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3507	M0183666	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3508	M0183666	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3509	M0183667	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3510	M0183667	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3511	M0183668	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3512	M0183668	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3513	M0183669	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3514	M0183669	NZ_CP062915.1	GKMCEMGI_00033	NZ_CP062915.1__GKMCEMGI_00033	NZ_CP062915.1	C786	GKMCEMGI_00033	VFG012499	Salmochelin siderophore	99.7	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3515	M0184537	NZ_CP069561.1	JHNCPHAJ_00050	NZ_CP069561.1__JHNCPHAJ_00050	NZ_CP069561.1	C839	JHNCPHAJ_00050	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
3516	M0184537	NZ_CP069561.1	JHNCPHAJ_00050	NZ_CP069561.1__JHNCPHAJ_00050	NZ_CP069561.1	C839	JHNCPHAJ_00050	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
3517	M0184605	NZ_CP069896.1	EAAOCPIC_00003	NZ_CP069896.1__EAAOCPIC_00003	NZ_CP069896.1	C845	EAAOCPIC_00003	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3518	M0184627	NZ_CP069991.1	JHCCKBNG_00040	NZ_CP069991.1__JHCCKBNG_00040	NZ_CP069991.1	C848	JHCCKBNG_00040	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
3519	M0184627	NZ_CP069991.1	JHCCKBNG_00040	NZ_CP069991.1__JHCCKBNG_00040	NZ_CP069991.1	C848	JHCCKBNG_00040	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
3520	M0185136	NZ_CP070163.1	MKJHKIJA_00015	NZ_CP070163.1__MKJHKIJA_00015	NZ_CP070163.1	C854	MKJHKIJA_00015	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
3521	M0185136	NZ_CP070163.1	MKJHKIJA_00015	NZ_CP070163.1__MKJHKIJA_00015	NZ_CP070163.1	C854	MKJHKIJA_00015	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
3522	M0188210	NZ_CP074490.1	NGKHKGFP_00005	NZ_CP074490.1__NGKHKGFP_00005	NZ_CP074490.1	C898	NGKHKGFP_00005	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3523	M0188273	NZ_CP075666.1	MNDMKIOB_00085	NZ_CP075666.1__MNDMKIOB_00085	NZ_CP075666.1	C903	MNDMKIOB_00085	VFG012633	Iron-regulated element	98.8	0	1	682	1.0	1	Nutritional/Metabolic factor	TonB-dependent siderophore receptor IreA		SetB	prediction
3524	M0188495	NZ_CP077321.1	KIPGOOKF_00049	NZ_CP077321.1__KIPGOOKF_00049	NZ_CP077321.1	C914	KIPGOOKF_00049	VFG042988	PilA-type pili (PGS1, pilin gene clusters 1)	99.5	0	1	658	1.0	1	Adherence	PilA		SetB	prediction
3525	M0188496	NZ_CP077321.1	KIPGOOKF_00049	NZ_CP077321.1__KIPGOOKF_00049	NZ_CP077321.1	C914	KIPGOOKF_00049	VFG042988	PilA-type pili (PGS1, pilin gene clusters 1)	99.5	0	1	658	1.0	1	Adherence	PilA		SetB	prediction
3526	M0188552	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3527	M0188553	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3528	M0188554	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3529	M0188555	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3530	M0188556	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3531	M0188557	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3532	M0188558	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3533	M0188559	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3534	M0188560	NZ_CP080135.1	GHBCHELO_00077	NZ_CP080135.1__GHBCHELO_00077	NZ_CP080135.1	C925	GHBCHELO_00077	VFG036043	AatA, AIDA-I type	96.6	0	1	1171	1.0	1.0052	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3535	M0189282	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3536	M0189282	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3537	M0189287	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3538	M0189287	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3539	M0189288	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3540	M0189288	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3541	M0189289	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3542	M0189289	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3543	M0189290	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3544	M0189290	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3545	M0189291	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3546	M0189291	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3547	M0189292	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3548	M0189292	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3549	M0189293	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3550	M0189293	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3551	M0189294	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3552	M0189294	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3553	M0189295	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3554	M0189295	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3555	M0189296	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3556	M0189296	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3557	M0189297	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3558	M0189297	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3559	M0189298	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012513	Salmochelin siderophore	99.7	2.8e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3560	M0189298	NZ_CP082078.1	CELFONND_00067	NZ_CP082078.1__CELFONND_00067	NZ_CP082078.1	C940	CELFONND_00067	VFG012514	Salmochelin siderophore	100	9.2e-219	1	371	1.0	1	Nutritional/Metabolic factor	glucosyltransferase IroB	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3561	M0189302	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3562	M0189302	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3563	M0189303	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3564	M0189303	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3565	M0189304	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3566	M0189304	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3567	M0189305	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3568	M0189305	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3569	M0189306	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3570	M0189306	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3571	M0189307	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3572	M0189307	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3573	M0189308	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3574	M0189308	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3575	M0189309	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3576	M0189309	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3577	M0189310	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3578	M0189310	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3579	M0189311	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3580	M0189311	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3581	M0189312	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3582	M0189312	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3583	M0189313	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3584	M0189313	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3585	M0189314	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3586	M0189314	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3587	M0189315	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3588	M0189315	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3589	M0189316	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3590	M0189316	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3591	M0189317	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3592	M0189317	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3593	M0189318	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3594	M0189318	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3595	M0189319	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3596	M0189319	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3597	M0189320	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3598	M0189320	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3599	M0189321	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3600	M0189321	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3601	M0189322	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3602	M0189322	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3603	M0189323	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3604	M0189323	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3605	M0189324	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3606	M0189324	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3607	M0189325	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012501	Salmochelin siderophore	99.4	2.2e-188	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3608	M0189325	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012503	Salmochelin siderophore	99.4	1.6e-187	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3609	M0189326	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012501	Salmochelin siderophore	99.4	2.2e-188	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3610	M0189326	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012503	Salmochelin siderophore	99.4	1.6e-187	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3611	M0189327	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012501	Salmochelin siderophore	99.4	2.2e-188	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3612	M0189327	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012503	Salmochelin siderophore	99.4	1.6e-187	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3613	M0189328	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012501	Salmochelin siderophore	99.4	2.2e-188	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3614	M0189328	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012503	Salmochelin siderophore	99.4	1.6e-187	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3615	M0189329	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3616	M0189329	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3617	M0189330	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3618	M0189330	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3619	M0189331	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3620	M0189331	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3621	M0189332	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3622	M0189332	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3623	M0189333	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3624	M0189333	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3625	M0189334	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3626	M0189334	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3627	M0189335	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3628	M0189335	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3629	M0189336	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3630	M0189336	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3631	M0189337	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3632	M0189337	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3633	M0189338	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3634	M0189338	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3635	M0189339	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3636	M0189339	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3637	M0189340	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3638	M0189340	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3639	M0189341	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3640	M0189341	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3641	M0189342	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3642	M0189342	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3643	M0189343	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3644	M0189343	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3645	M0189344	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3646	M0189344	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3647	M0189345	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3648	M0189345	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3649	M0189346	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3650	M0189346	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3651	M0189347	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3652	M0189347	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3653	M0189348	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3654	M0189348	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3655	M0189349	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3656	M0189349	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3657	M0189350	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3658	M0189350	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3659	M0189351	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3660	M0189351	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3661	M0189352	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3662	M0189352	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3663	M0189353	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3664	M0189353	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3665	M0189354	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3666	M0189354	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3667	M0189355	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3668	M0189355	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3669	M0189356	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3670	M0189356	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3671	M0189357	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3672	M0189357	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3673	M0189358	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3674	M0189358	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3675	M0189359	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3676	M0189359	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3677	M0189360	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3678	M0189360	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3679	M0189361	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG012509	Salmochelin siderophore	99.4	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3680	M0189361	NZ_CP082078.1	CELFONND_00068	NZ_CP082078.1__CELFONND_00068	NZ_CP082078.1	C940	CELFONND_00068	VFG033929	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3681	M0189362	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3682	M0189362	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3683	M0189364	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3684	M0189364	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3685	M0189365	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	1e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3686	M0189365	NZ_CP082078.1	CELFONND_00069	NZ_CP082078.1__CELFONND_00069	NZ_CP082078.1	C940	CELFONND_00069	VFG012505	Salmochelin siderophore	99.8	7.7e-243	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3687	M0189366	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012501	Salmochelin siderophore	99.4	2.2e-188	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3688	M0189366	NZ_CP082078.1	CELFONND_00070	NZ_CP082078.1__CELFONND_00070	NZ_CP082078.1	C940	CELFONND_00070	VFG012503	Salmochelin siderophore	99.4	1.6e-187	1	318	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3689	M0189367	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3690	M0189367	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3691	M0189368	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG000935	Salmochelin siderophore	99.3	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
3692	M0189368	NZ_CP082078.1	CELFONND_00071	NZ_CP082078.1__CELFONND_00071	NZ_CP082078.1	C940	CELFONND_00071	VFG033911	Salmochelin siderophore	100	0	1	725	1.0	1	Nutritional/Metabolic factor	salmochelin receptor IroN	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
3693	M0189447	NZ_CP082800.1	NDGHDONL_00161	NZ_CP082800.1__NDGHDONL_00161	NZ_CP082800.1	C943	NDGHDONL_00161	VFG043624	Type 3 fimbriae	99.1	9.7e-184	1	331	1.0	1	Biofilm	fimbrial adhesin protein precursor MrkD	Mediating the formation of biofilms on biotic and abiotic surfaces	SetA	experiment
3694	M0189447	NZ_CP082800.1	NDGHDONL_00161	NZ_CP082800.1__NDGHDONL_00161	NZ_CP082800.1	C943	NDGHDONL_00161	VFG043624	Type 3 fimbriae	99.1	7.3e-183	1	331	1.0	1	Biofilm	fimbrial adhesin protein precursor MrkD	Mediating the formation of biofilms on biotic and abiotic surfaces	SetB	prediction
3695	M0191842	NZ_CP095504.1	GALLLKKE_00112	NZ_CP095504.1__GALLLKKE_00112	NZ_CP095504.1	C1017	GALLLKKE_00112	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
3696	M0191842	NZ_CP095504.1	GALLLKKE_00112	NZ_CP095504.1__GALLLKKE_00112	NZ_CP095504.1	C1017	GALLLKKE_00112	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
3697	M0196984	NZ_CP117958.1	GPEFHNOM_00117	NZ_CP117958.1__GPEFHNOM_00117	NZ_CP117958.1	C1121	GPEFHNOM_00117	VFG001445	TraJ	73.7	1.6e-76	2	191	0.8444	0.9453	Invasion	unknown protein	Contributes to the ability of E. coli K1 to invade the central nervous system and cause meningitis in the neonatal rat; TraJ contributes to the early systemic dissemination of E. coli K1 in the oral infection process is via specific TraJ-dependent bacterial interactions with macrophages. TraJ enables the bacteria to be taken up efficiently by macrophages. In the early steps of dissemination, the intracellular environment of the phagocytes provides a protective or safe site from the initial host inflammatory defense mechanisms	SetA	experiment
3698	M0196984	NZ_CP117958.1	GPEFHNOM_00117	NZ_CP117958.1__GPEFHNOM_00117	NZ_CP117958.1	C1121	GPEFHNOM_00117	VFG001445	TraJ	73.7	1.2e-75	2	191	0.8444	0.9453	Invasion	unknown protein	Contributes to the ability of E. coli K1 to invade the central nervous system and cause meningitis in the neonatal rat; TraJ contributes to the early systemic dissemination of E. coli K1 in the oral infection process is via specific TraJ-dependent bacterial interactions with macrophages. TraJ enables the bacteria to be taken up efficiently by macrophages. In the early steps of dissemination, the intracellular environment of the phagocytes provides a protective or safe site from the initial host inflammatory defense mechanisms	SetB	prediction
3699	M0199174	NZ_CP127305.1	PPPLKLJG_00002	NZ_CP127305.1__PPPLKLJG_00002	NZ_CP127305.1	C1171	PPPLKLJG_00002	VFG043979	Colicin B	80.4	1.6e-168	1	382	0.5481	0.7476	Exotoxin	colicin B		SetB	prediction
3700	M0199177	NZ_CP127305.1	PPPLKLJG_00011	NZ_CP127305.1__PPPLKLJG_00011	NZ_CP127305.1	C1171	PPPLKLJG_00011	VFG043979	Colicin B	80.4	1.6e-168	1	382	0.5481	0.7476	Exotoxin	colicin B		SetB	prediction
3701	M0199206	NZ_CP128591.1	IDHOFOKN_00113	NZ_CP128591.1__IDHOFOKN_00113	NZ_CP128591.1	C1176	IDHOFOKN_00113	VFG000905	Alpha-Hemolysin	95.3	1.9e-98	1	170	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetA	experiment
3702	M0199206	NZ_CP128591.1	IDHOFOKN_00113	NZ_CP128591.1__IDHOFOKN_00113	NZ_CP128591.1	C1176	IDHOFOKN_00113	VFG033901	Hemolysin	99.4	1.4e-100	1	170	1.0	1	Exotoxin	Hemolysin C	Cytotoxic to many types of cells: erythrocytes, granulocytes, monocytes, endothelial cells and renal epithelial cells; stimulating the release of IL-1beta and TNF	SetB	prediction
3703	M0199275	NZ_CP128951.1	LOGDOBML_00444	NZ_CP128951.1__LOGDOBML_00444	NZ_CP128951.1	C1179	LOGDOBML_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3704	M0199276	NZ_CP128951.1	LOGDOBML_00445	NZ_CP128951.1__LOGDOBML_00445	NZ_CP128951.1	C1179	LOGDOBML_00445	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3705	M0199277	NZ_CP128951.1	LOGDOBML_00444	NZ_CP128951.1__LOGDOBML_00444	NZ_CP128951.1	C1179	LOGDOBML_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3706	M0199288	NZ_CP128951.1	LOGDOBML_00444	NZ_CP128951.1__LOGDOBML_00444	NZ_CP128951.1	C1179	LOGDOBML_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3707	M0199289	NZ_CP128951.1	LOGDOBML_00444	NZ_CP128951.1__LOGDOBML_00444	NZ_CP128951.1	C1179	LOGDOBML_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3708	M0199290	NZ_CP128951.1	LOGDOBML_00444	NZ_CP128951.1__LOGDOBML_00444	NZ_CP128951.1	C1179	LOGDOBML_00444	VFG013087	MsbB2	97.1	1.2e-182	1	314	1.0	1	Others	lauroyl-Kdo(2)-lipid IV(A) myristoyltransferase		SetB	prediction
3709	M0199296	NZ_CP128951.1	LOGDOBML_00445	NZ_CP128951.1__LOGDOBML_00445	NZ_CP128951.1	C1179	LOGDOBML_00445	VFG020186	VirK	98.1	1e-186	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction
3710	M0199500	NZ_CP134806.1	BGHFBFCE_00086	NZ_CP134806.1__BGHFBFCE_00086	NZ_CP134806.1	C1206	BGHFBFCE_00086	VFG036037	Contact-dependent inhibition CDI system	96.4	0	1	588	1.0	1	Effector delivery system	ShlB/FhaC/HecB family hemolysin secretion/activation protein		SetB	prediction
3711	M0199501	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3712	M0199502	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3713	M0199503	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3714	M0199504	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3715	M0199505	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3716	M0199506	NZ_CP134806.1	BGHFBFCE_00086	NZ_CP134806.1__BGHFBFCE_00086	NZ_CP134806.1	C1206	BGHFBFCE_00086	VFG036037	Contact-dependent inhibition CDI system	96.4	0	1	588	1.0	1	Effector delivery system	ShlB/FhaC/HecB family hemolysin secretion/activation protein		SetB	prediction
3717	M0199507	NZ_CP134806.1	BGHFBFCE_00086	NZ_CP134806.1__BGHFBFCE_00086	NZ_CP134806.1	C1206	BGHFBFCE_00086	VFG036037	Contact-dependent inhibition CDI system	96.4	0	1	588	1.0	1	Effector delivery system	ShlB/FhaC/HecB family hemolysin secretion/activation protein		SetB	prediction
3718	M0199508	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3719	M0199509	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3720	M0199510	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3721	M0199511	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3722	M0199512	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3723	M0199513	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3724	M0199514	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3725	M0199515	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3726	M0199516	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3727	M0199517	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3728	M0199518	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3729	M0199519	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3730	M0199520	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3731	M0199521	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3732	M0199522	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3733	M0199523	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3734	M0199524	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3735	M0199525	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3736	M0199526	NZ_CP134806.1	BGHFBFCE_00087	NZ_CP134806.1__BGHFBFCE_00087	NZ_CP134806.1	C1206	BGHFBFCE_00087	VFG036031	Contact-dependent inhibition CDI system	94.3	0	1	3095	0.9503	0.9624	Effector delivery system	contact-dependent inhibition effector tRNA nuclease		SetB	prediction
3737	M0200099	NZ_CP137437.1	FOIMFDJB_00051	NZ_CP137437.1__FOIMFDJB_00051	NZ_CP137437.1	C1225	FOIMFDJB_00051	VFG017870	Icm/dot type IVB locus	77.9	1.6e-90	1	208	0.9905	0.9952	Effector delivery system	ParA family protein		SetB	prediction
3738	M0200623	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3739	M0200624	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3740	M0200625	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3741	M0200626	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3742	M0200627	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3743	M0200628	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3744	M0200629	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3745	M0200630	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3746	M0200631	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3747	M0200632	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3748	M0200633	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3749	M0200634	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3750	M0200635	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3751	M0200636	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3752	M0200637	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3753	M0200638	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3754	M0200639	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3755	M0200640	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3756	M0200641	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3757	M0200642	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3758	M0200643	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3759	M0200644	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3760	M0200645	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3761	M0200646	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3762	M0200647	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3763	M0200648	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3764	M0200649	NZ_CP141737.1	JFCGFDMB_00015	NZ_CP141737.1__JFCGFDMB_00015	NZ_CP141737.1	C1244	JFCGFDMB_00015	VFG043643	CS31A capsule-like antigen	97.7	1.4e-144	1	263	1.0	1	Adherence	unknown protein		SetB	prediction
3765	M0200651	NZ_CP141737.1	JFCGFDMB_00016	NZ_CP141737.1__JFCGFDMB_00016	NZ_CP141737.1	C1244	JFCGFDMB_00016	VFG034598	Adhesive fimbriae	92.6	1.7e-76	1	163	1.0	1	Adherence	fimbrial protein FaeF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3766	M0200652	NZ_CP141737.1	JFCGFDMB_00016	NZ_CP141737.1__JFCGFDMB_00016	NZ_CP141737.1	C1244	JFCGFDMB_00016	VFG034598	Adhesive fimbriae	92.6	1.7e-76	1	163	1.0	1	Adherence	fimbrial protein FaeF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3767	M0200653	NZ_CP141737.1	JFCGFDMB_00016	NZ_CP141737.1__JFCGFDMB_00016	NZ_CP141737.1	C1244	JFCGFDMB_00016	VFG034598	Adhesive fimbriae	92.6	1.7e-76	1	163	1.0	1	Adherence	fimbrial protein FaeF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3768	M0200654	NZ_CP141737.1	JFCGFDMB_00016	NZ_CP141737.1__JFCGFDMB_00016	NZ_CP141737.1	C1244	JFCGFDMB_00016	VFG034598	Adhesive fimbriae	92.6	1.7e-76	1	163	1.0	1	Adherence	fimbrial protein FaeF	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3769	M0200662	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3770	M0200663	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3771	M0200664	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3772	M0200665	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3773	M0200666	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3774	M0200667	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3775	M0200668	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3776	M0200669	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3777	M0200670	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3778	M0200671	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3779	M0200672	NZ_CP141737.1	JFCGFDMB_00018	NZ_CP141737.1__JFCGFDMB_00018	NZ_CP141737.1	C1244	JFCGFDMB_00018	VFG043647	CS31A capsule-like antigen	92.5	4.4e-138	1	265	1.0	0.9962	Adherence	fimbrial protein		SetB	prediction
3780	M0200673	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3781	M0200674	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3782	M0200675	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3783	M0200676	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3784	M0200677	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3785	M0200678	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3786	M0200679	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3787	M0200680	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3788	M0200681	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3789	M0200682	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3790	M0200683	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3791	M0200684	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3792	M0200685	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3793	M0200686	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3794	M0200687	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3795	M0200688	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3796	M0200807	NZ_CP141737.1	JFCGFDMB_00013	NZ_CP141737.1__JFCGFDMB_00013	NZ_CP141737.1	C1244	JFCGFDMB_00013	VFG042533	CS31A capsule-like antigen	88.9	9.9e-86	1	178	1.0	0.9889	Adherence	ClpC		SetB	prediction
3797	M0200808	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3798	M0200809	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3799	M0200810	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3800	M0200811	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3801	M0200812	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3802	M0200813	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3803	M0200814	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3804	M0200815	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3805	M0200816	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3806	M0200817	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3807	M0200818	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3808	M0200819	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3809	M0200820	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3810	M0200821	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3811	M0200822	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3812	M0200823	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3813	M0200824	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3814	M0200825	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3815	M0200826	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3816	M0200827	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3817	M0200828	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3818	M0200829	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3819	M0200830	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3820	M0200831	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3821	M0200832	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3822	M0200833	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3823	M0200834	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3824	M0200835	NZ_CP141737.1	JFCGFDMB_00014	NZ_CP141737.1__JFCGFDMB_00014	NZ_CP141737.1	C1244	JFCGFDMB_00014	VFG042494	Adhesive fimbriae	95.1	0	15	814	0.9828	1	Adherence	cshB porin (usher)	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3825	M0200839	NZ_CP141737.1	JFCGFDMB_00019	NZ_CP141737.1__JFCGFDMB_00019	NZ_CP141737.1	C1244	JFCGFDMB_00019	VFG043644	CS31A capsule-like antigen	96.5	9e-141	1	254	1.0	1	Adherence	CS31A minor subunit		SetB	prediction
3826	M0200840	NZ_CP141737.1	JFCGFDMB_00019	NZ_CP141737.1__JFCGFDMB_00019	NZ_CP141737.1	C1244	JFCGFDMB_00019	VFG043644	CS31A capsule-like antigen	96.5	9e-141	1	254	1.0	1	Adherence	CS31A minor subunit		SetB	prediction
3827	M0200841	NZ_CP141737.1	JFCGFDMB_00019	NZ_CP141737.1__JFCGFDMB_00019	NZ_CP141737.1	C1244	JFCGFDMB_00019	VFG043644	CS31A capsule-like antigen	96.5	9e-141	1	254	1.0	1	Adherence	CS31A minor subunit		SetB	prediction
3828	M0200842	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3829	M0200843	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3830	M0200844	NZ_CP141737.1	JFCGFDMB_00020	NZ_CP141737.1__JFCGFDMB_00020	NZ_CP141737.1	C1244	JFCGFDMB_00020	VFG034602	Adhesive fimbriae	94.9	7.5e-143	1	257	1.0	1	Adherence	fimbrial protein FaeJ	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
3831	M0205686	NZ_CP147589.1	KAHNJDHJ_00005	NZ_CP147589.1__KAHNJDHJ_00005	NZ_CP147589.1	C1282	KAHNJDHJ_00005	VFG044066	Colicin E1	94	1.7e-255	1	521	1.0	1	Exotoxin	colicin-like pore-forming protein		SetB	prediction
3832	M0205739	NZ_CP147609.1	EMGPEAKN_00057	NZ_CP147609.1__EMGPEAKN_00057	NZ_CP147609.1	C1283	EMGPEAKN_00057	VFG001827	ShET2	99.7	7.9e-225	1	391	1.0	1	Exotoxin	enterotoxin	May account for the early diarrheal phase often observed during shigellosis	SetA	experiment
3833	M0205739	NZ_CP147609.1	EMGPEAKN_00057	NZ_CP147609.1__EMGPEAKN_00057	NZ_CP147609.1	C1283	EMGPEAKN_00057	VFG036084	Enterotoxin SenB/TieB	100	1.2e-224	1	391	1.0	1	Exotoxin	enterotoxin production-related protein TieB		SetB	prediction
3834	M0205813	NZ_CP148410.1	PHGBKDAH_00005	NZ_CP148410.1__PHGBKDAH_00005	NZ_CP148410.1	C1294	PHGBKDAH_00005	VFG036043	AatA, AIDA-I type	97.2	0	1	1165	1.0	1	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3835	M0205814	NZ_CP148410.1	PHGBKDAH_00005	NZ_CP148410.1__PHGBKDAH_00005	NZ_CP148410.1	C1294	PHGBKDAH_00005	VFG036043	AatA, AIDA-I type	97.2	0	1	1165	1.0	1	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
3836	M0205858	NZ_CP148580.1	GCMNJFDC_00015	NZ_CP148580.1__GCMNJFDC_00015	NZ_CP148580.1	C1300	GCMNJFDC_00015	VFG000765	Per	95.5	1e-42	1	89	1.0	1	Regulation	BfpW	Up-regulates the expression of BFP and intimin and regulates Esps secretion in response to different environmental cues; activates the expression of ler, which then activates the expression of LEE2, LEE3, tir and LEE4 in a cascade fashion	SetA	experiment
3837	M0205858	NZ_CP148580.1	GCMNJFDC_00015	NZ_CP148580.1__GCMNJFDC_00015	NZ_CP148580.1	C1300	GCMNJFDC_00015	VFG000765	Per	95.5	7.5e-42	1	89	1.0	1	Regulation	BfpW	Up-regulates the expression of BFP and intimin and regulates Esps secretion in response to different environmental cues; activates the expression of ler, which then activates the expression of LEE2, LEE3, tir and LEE4 in a cascade fashion	SetB	prediction
3838	M0205924	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3839	M0205924	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3840	M0205925	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3841	M0205925	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3842	M0205926	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3843	M0205926	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3844	M0205927	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3845	M0205927	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3846	M0205928	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3847	M0205928	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3848	M0205929	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3849	M0205929	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3850	M0205930	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3851	M0205930	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3852	M0205931	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3853	M0205931	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3854	M0205932	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3855	M0205932	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3856	M0205933	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3857	M0205933	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3858	M0205934	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3859	M0205934	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3860	M0205935	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3861	M0205935	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3862	M0205936	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3863	M0205936	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3864	M0205937	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3865	M0205937	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3866	M0205938	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3867	M0205938	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3868	M0205939	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3869	M0205939	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3870	M0205940	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3871	M0205940	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3872	M0205941	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3873	M0205941	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3874	M0205942	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3875	M0205942	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3876	M0205943	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3877	M0205943	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3878	M0205944	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3879	M0205944	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3880	M0205945	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3881	M0205945	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3882	M0205946	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3883	M0205946	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3884	M0205947	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3885	M0205947	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3886	M0205948	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3887	M0205948	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3888	M0205949	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3889	M0205949	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3890	M0205950	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3891	M0205950	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3892	M0205951	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3893	M0205951	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3894	M0205952	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3895	M0205952	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3896	M0205953	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3897	M0205953	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3898	M0205954	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3899	M0205954	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3900	M0205955	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3901	M0205955	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3902	M0205956	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3903	M0205956	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3904	M0205957	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3905	M0205957	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3906	M0205958	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3907	M0205958	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3908	M0205959	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	8.1e-68	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3909	M0205959	NZ_CP148747.1	CIGMFIEK_00093	NZ_CP148747.1__CIGMFIEK_00093	NZ_CP148747.1	C1301	CIGMFIEK_00093	VFG000750	BFP	96.1	6.1e-67	11	137	0.927	0.9549	Adherence	BFP biogenesis protein BfpG	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3910	M0205960	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3911	M0205960	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3912	M0205961	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3913	M0205961	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3914	M0205962	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3915	M0205962	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3916	M0205963	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3917	M0205963	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3918	M0205964	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3919	M0205964	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3920	M0205965	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3921	M0205965	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3922	M0205966	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3923	M0205966	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3924	M0205967	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3925	M0205967	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3926	M0205968	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3927	M0205968	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3928	M0205969	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3929	M0205969	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3930	M0205970	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3931	M0205970	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3932	M0205971	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3933	M0205971	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3934	M0205972	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3935	M0205972	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3936	M0205973	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3937	M0205973	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3938	M0205974	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3939	M0205974	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3940	M0205975	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3941	M0205975	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3942	M0205976	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.5e-298	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3943	M0205976	NZ_CP148747.1	CIGMFIEK_00094	NZ_CP148747.1__CIGMFIEK_00094	NZ_CP148747.1	C1301	CIGMFIEK_00094	VFG000751	BFP	98.7	1.1e-297	1	552	1.0	1	Adherence	BfpB secretin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3944	M0205977	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3945	M0205977	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3946	M0205978	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3947	M0205978	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3948	M0205979	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3949	M0205979	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3950	M0205980	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3951	M0205980	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3952	M0205981	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3953	M0205981	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3954	M0205982	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3955	M0205982	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3956	M0205983	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3957	M0205983	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3958	M0205984	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3959	M0205984	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3960	M0205985	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3961	M0205985	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3962	M0205986	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3963	M0205986	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3964	M0205987	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3965	M0205987	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3966	M0205988	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3967	M0205988	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3968	M0205989	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3969	M0205989	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3970	M0205990	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3971	M0205990	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3972	M0205991	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3973	M0205991	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3974	M0205992	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3975	M0205992	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3976	M0205993	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3977	M0205993	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3978	M0205994	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3979	M0205994	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3980	M0205995	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3981	M0205995	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3982	M0205996	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3983	M0205996	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3984	M0205997	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	3.3e-198	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3985	M0205997	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	2.5e-197	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3986	M0205998	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	3.3e-198	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3987	M0205998	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	2.5e-197	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3988	M0205999	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	3.3e-198	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3989	M0205999	NZ_CP148747.1	CIGMFIEK_00097	NZ_CP148747.1__CIGMFIEK_00097	NZ_CP148747.1	C1301	CIGMFIEK_00097	VFG000755	BFP	100	2.5e-197	1	352	1.0	1	Adherence	BfpE, polytopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3990	M0206000	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	9.1e-179	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3991	M0206000	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	6.8e-178	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3992	M0206001	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	9.1e-179	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3993	M0206001	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	6.8e-178	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3994	M0206002	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	9.1e-179	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3995	M0206002	NZ_CP148747.1	CIGMFIEK_00098	NZ_CP148747.1__CIGMFIEK_00098	NZ_CP148747.1	C1301	CIGMFIEK_00098	VFG042791	BFP	99.7	6.8e-178	1	318	1.0	0.9607	Adherence	retraction ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3996	M0206003	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	5.7e-144	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3997	M0206003	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	4.2e-143	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
3998	M0206004	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	5.7e-144	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
3999	M0206004	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	4.2e-143	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4000	M0206005	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	5.7e-144	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4001	M0206005	NZ_CP148747.1	CIGMFIEK_00099	NZ_CP148747.1__CIGMFIEK_00099	NZ_CP148747.1	C1301	CIGMFIEK_00099	VFG000757	BFP	99.2	4.2e-143	1	249	1.0	1	Adherence	prepilin peptidase BfpP	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4002	M0206006	NZ_CP148747.1	CIGMFIEK_00100	NZ_CP148747.1__CIGMFIEK_00100	NZ_CP148747.1	C1301	CIGMFIEK_00100	VFG042793	BFP	98.6	1.6e-82	1	148	1.0	1	Adherence	lipoprotein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4003	M0206006	NZ_CP148747.1	CIGMFIEK_00100	NZ_CP148747.1__CIGMFIEK_00100	NZ_CP148747.1	C1301	CIGMFIEK_00100	VFG042793	BFP	98.6	1.2e-81	1	148	1.0	1	Adherence	lipoprotein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4004	M0206007	NZ_CP148747.1	CIGMFIEK_00100	NZ_CP148747.1__CIGMFIEK_00100	NZ_CP148747.1	C1301	CIGMFIEK_00100	VFG042793	BFP	98.6	1.6e-82	1	148	1.0	1	Adherence	lipoprotein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4005	M0206007	NZ_CP148747.1	CIGMFIEK_00100	NZ_CP148747.1__CIGMFIEK_00100	NZ_CP148747.1	C1301	CIGMFIEK_00100	VFG042793	BFP	98.6	1.2e-81	1	148	1.0	1	Adherence	lipoprotein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4006	M0206008	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	2.5e-96	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4007	M0206008	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	1.8e-95	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4008	M0206009	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	2.5e-96	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4009	M0206009	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	1.8e-95	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4010	M0206010	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	2.5e-96	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4011	M0206010	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	1.8e-95	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4012	M0206011	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	2.5e-96	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4013	M0206011	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	1.8e-95	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4014	M0206012	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	2.5e-96	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4015	M0206012	NZ_CP148747.1	CIGMFIEK_00101	NZ_CP148747.1__CIGMFIEK_00101	NZ_CP148747.1	C1301	CIGMFIEK_00101	VFG042794	BFP	98.3	1.8e-95	1	181	1.0	1	Adherence	minor pilin subunit BfpI	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4016	M0206013	NZ_CP148747.1	CIGMFIEK_00102	NZ_CP148747.1__CIGMFIEK_00102	NZ_CP148747.1	C1301	CIGMFIEK_00102	VFG000760	BFP	100	8.8e-102	1	183	1.0	1	Adherence	minor pilin subunit BfpJ	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4017	M0206013	NZ_CP148747.1	CIGMFIEK_00102	NZ_CP148747.1__CIGMFIEK_00102	NZ_CP148747.1	C1301	CIGMFIEK_00102	VFG000760	BFP	100	6.6e-101	1	183	1.0	1	Adherence	minor pilin subunit BfpJ	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4018	M0206014	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.6e-86	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4019	M0206014	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.2e-85	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4020	M0206015	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.6e-86	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4021	M0206015	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.2e-85	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4022	M0206016	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.6e-86	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4023	M0206016	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.2e-85	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4024	M0206017	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.6e-86	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4025	M0206017	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.2e-85	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4026	M0206018	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.6e-86	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4027	M0206018	NZ_CP148747.1	CIGMFIEK_00103	NZ_CP148747.1__CIGMFIEK_00103	NZ_CP148747.1	C1301	CIGMFIEK_00103	VFG042796	BFP	98.8	1.2e-85	1	162	1.0	1	Adherence	minor pilin subunit BfpK	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4028	M0206019	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	4.5e-80	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4029	M0206019	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	3.4e-79	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4030	M0206020	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	4.5e-80	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4031	M0206020	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	3.4e-79	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4032	M0206021	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	4.5e-80	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4033	M0206021	NZ_CP148747.1	CIGMFIEK_00104	NZ_CP148747.1__CIGMFIEK_00104	NZ_CP148747.1	C1301	CIGMFIEK_00104	VFG000762	BFP	98.7	3.4e-79	1	149	1.0	1	Adherence	BFP biogenesis protein BfpL	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4034	M0206028	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	3.4e-80	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4035	M0206028	NZ_CP148747.1	CIGMFIEK_00092	NZ_CP148747.1__CIGMFIEK_00092	NZ_CP148747.1	C1301	CIGMFIEK_00092	VFG042784	BFP	85.6	2.6e-79	1	193	1.0	1	Adherence	major pilin structural unit bundlin	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4036	M0206029	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4037	M0206029	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4038	M0206030	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.6e-239	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4039	M0206030	NZ_CP148747.1	CIGMFIEK_00095	NZ_CP148747.1__CIGMFIEK_00095	NZ_CP148747.1	C1301	CIGMFIEK_00095	VFG000752	BFP	99.5	1.2e-238	1	400	0.7156	0.995	Adherence	BfpC, bitopic inner membrane protein	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4040	M0206031	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	6.8e-293	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4041	M0206031	NZ_CP148747.1	CIGMFIEK_00096	NZ_CP148747.1__CIGMFIEK_00096	NZ_CP148747.1	C1301	CIGMFIEK_00096	VFG042789	BFP	99.4	5.1e-292	10	515	0.9825	0.9458	Adherence	assembly ATPase	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4042	M0206032	NZ_CP148747.1	CIGMFIEK_00102	NZ_CP148747.1__CIGMFIEK_00102	NZ_CP148747.1	C1301	CIGMFIEK_00102	VFG000760	BFP	100	8.8e-102	1	183	1.0	1	Adherence	minor pilin subunit BfpJ	Required for the localized adherence and autoaggregation phenotype	SetA	experiment
4043	M0206032	NZ_CP148747.1	CIGMFIEK_00102	NZ_CP148747.1__CIGMFIEK_00102	NZ_CP148747.1	C1301	CIGMFIEK_00102	VFG000760	BFP	100	6.6e-101	1	183	1.0	1	Adherence	minor pilin subunit BfpJ	Required for the localized adherence and autoaggregation phenotype	SetB	prediction
4044	M0207081	NZ_LR882979.1	NMGHAECM_00105	NZ_LR882979.1__NMGHAECM_00105	NZ_LR882979.1	C1353	NMGHAECM_00105	VFG042477	Adhesive fimbriae	95.5	0	1	815	1.0	1.0012	Adherence	hypothetical protein	Adhesin, receptor is the oligosaccharide components of glycolipids and glycoproteins	SetB	prediction
4045	M0208329	NZ_LT985321.1	NHIPIFPM_00028	NZ_LT985321.1__NHIPIFPM_00028	NZ_LT985321.1	C1369	NHIPIFPM_00028	VFG043980	Colicin Ib	98.7	4.5e-247	1	463	1.0	0.7396	Exotoxin	colicin-like pore-forming protein		SetB	prediction
4046	M0208330	NZ_LT985321.1	NHIPIFPM_00028	NZ_LT985321.1__NHIPIFPM_00028	NZ_LT985321.1	C1369	NHIPIFPM_00028	VFG043980	Colicin Ib	98.7	4.5e-247	1	463	1.0	0.7396	Exotoxin	colicin-like pore-forming protein		SetB	prediction
4047	M0208909	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4048	M0208909	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4049	M0208910	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4050	M0208910	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4051	M0208911	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4052	M0208911	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4053	M0208912	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4054	M0208912	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4055	M0208913	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4056	M0208913	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4057	M0208914	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4058	M0208914	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4059	M0208915	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4060	M0208915	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4061	M0208916	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4062	M0208916	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4063	M0208917	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4064	M0208917	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4065	M0208918	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4066	M0208918	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4067	M0208919	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4068	M0208919	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4069	M0208920	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4070	M0208920	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4071	M0208921	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4072	M0208921	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4073	M0208922	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4074	M0208922	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4075	M0208923	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4076	M0208923	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4077	M0208924	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4078	M0208924	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4079	M0208925	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4080	M0208925	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4081	M0208926	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4082	M0208926	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4083	M0208927	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4084	M0208927	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4085	M0208928	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4086	M0208928	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4087	M0208929	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4088	M0208929	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4089	M0208930	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4090	M0208930	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4091	M0208931	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4092	M0208931	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4093	M0208932	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4094	M0208932	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4095	M0208933	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4096	M0208933	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4097	M0208934	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4098	M0208934	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4099	M0208935	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4100	M0208935	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4101	M0208936	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4102	M0208936	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4103	M0208937	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4104	M0208937	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4105	M0208938	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4106	M0208938	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4107	M0208939	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4108	M0208939	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4109	M0208940	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4110	M0208940	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4111	M0208941	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4112	M0208941	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4113	M0208942	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4114	M0208942	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4115	M0208943	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4116	M0208943	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4117	M0208944	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4118	M0208944	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4119	M0208945	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4120	M0208945	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4121	M0208946	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4122	M0208946	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4123	M0208947	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4124	M0208947	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4125	M0208948	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4126	M0208948	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4127	M0208949	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4128	M0208949	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4129	M0208950	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4130	M0208950	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4131	M0208951	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetA	experiment
4132	M0208951	NZ_OM574792.1	EFCKFNBJ_00010	NZ_OM574792.1__EFCKFNBJ_00010	NZ_OM574792.1	C1402	EFCKFNBJ_00010	VFG002164	AS	96.8	0	1	1305	1.0	1	Adherence	aggregation substance PrgB/Asc10	Contributes to pathogenicity by enhancing cell adhesion to cultured renal tubular cells and intestinal epithelial cells and may involve in internalization into enterocytes; promoting direct, opsonin-independent binding of E. faecalis to human neutrophils via a complement receptor-mediated mechanism, and thus protecting E. faecalis from killing the polymorphonuclear leukocytes, an important urinary tract defense element. But AS has not been directly assessed as a urovirulence factor. A role in urovirulence has been directly demonstrated only for Esp;Asc10 and Asa1 have been implicated in binding to components of the extracellular matrix such as fibrin, fibronectin, thrombospondin, vitronectin and collagen type I.	SetB	prediction
4133	M0209551	NZ_OR345929.1	DBEGKALA_00036	NZ_OR345929.1__DBEGKALA_00036	NZ_OR345929.1	C1414	DBEGKALA_00036	VFG048621	Aerobactin	99.6	0	1	733	1.0	1	Nutritional/Metabolic factor	ferric aerobactin receptor IutA	Citrate-hydroxamate siderophore aerobactin is needed for successful infection by hypervirulent K. pneumoniae in pneumonic infections	SetA	experiment
4134	M0209551	NZ_OR345929.1	DBEGKALA_00036	NZ_OR345929.1__DBEGKALA_00036	NZ_OR345929.1	C1414	DBEGKALA_00036	VFG033945	Aerobactin	100	0	1	733	1.0	1	Nutritional/Metabolic factor	ferric aerobactin receptor precusor IutA	Iron uptake	SetB	prediction
4135	M0209552	NZ_OR345929.1	DBEGKALA_00038	NZ_OR345929.1__DBEGKALA_00038	NZ_OR345929.1	C1414	DBEGKALA_00038	VFG000617	Aerobactin	99.3	0	1	580	1.0	1	Nutritional/Metabolic factor	aerobactin synthesis protein IucC	Iron uptake, critical for intracellular growth	SetA	experiment
4136	M0209552	NZ_OR345929.1	DBEGKALA_00038	NZ_OR345929.1__DBEGKALA_00038	NZ_OR345929.1	C1414	DBEGKALA_00038	VFG033972	Aerobactin	100	0	1	580	1.0	1	Nutritional/Metabolic factor	aerobactin siderophore biosynthesis protein IucC	Iron uptake	SetB	prediction
4137	M0209557	NZ_OW967796.1	KPCGJMHB_00037	NZ_OW967796.1__KPCGJMHB_00037	NZ_OW967796.1	C1417	KPCGJMHB_00037	VFG012509	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
4138	M0209557	NZ_OW967796.1	KPCGJMHB_00037	NZ_OW967796.1__KPCGJMHB_00037	NZ_OW967796.1	C1417	KPCGJMHB_00037	VFG012509	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
4139	M0209558	NZ_OW967796.1	KPCGJMHB_00037	NZ_OW967796.1__KPCGJMHB_00037	NZ_OW967796.1	C1417	KPCGJMHB_00037	VFG012509	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
4140	M0209558	NZ_OW967796.1	KPCGJMHB_00037	NZ_OW967796.1__KPCGJMHB_00037	NZ_OW967796.1	C1417	KPCGJMHB_00037	VFG012509	Salmochelin siderophore	99.6	0	1	1219	1.0	1	Nutritional/Metabolic factor	ATP binding cassette transporter	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
4141	M0209559	NZ_OW967796.1	KPCGJMHB_00038	NZ_OW967796.1__KPCGJMHB_00038	NZ_OW967796.1	C1417	KPCGJMHB_00038	VFG012505	Salmochelin siderophore	99	7.4e-242	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetA	experiment
4142	M0209559	NZ_OW967796.1	KPCGJMHB_00038	NZ_OW967796.1__KPCGJMHB_00038	NZ_OW967796.1	C1417	KPCGJMHB_00038	VFG012508	Salmochelin siderophore	99.5	5e-242	1	409	1.0	1	Nutritional/Metabolic factor	esterase	Catecholate siderophore receptor, mediates utilization of the siderophore enterobactin	SetB	prediction
4143	M0209580	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG000884	P fimbriae	73.1	0	11	819	0.9878	0.9677	Adherence	usher protein PapC	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4144	M0209580	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG042585	Sfp fimbriae	91.8	0	1	819	1.0	0.9808	Adherence	PapC/FimD family outer membrane usher protein		SetB	prediction
4145	M0209581	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG000884	P fimbriae	73.1	0	11	819	0.9878	0.9677	Adherence	usher protein PapC	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4146	M0209581	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG042585	Sfp fimbriae	91.8	0	1	819	1.0	0.9808	Adherence	PapC/FimD family outer membrane usher protein		SetB	prediction
4147	M0209582	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG000884	P fimbriae	73.1	0	11	819	0.9878	0.9677	Adherence	usher protein PapC	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4148	M0209582	NZ_OW967796.1	KPCGJMHB_00007	NZ_OW967796.1__KPCGJMHB_00007	NZ_OW967796.1	C1417	KPCGJMHB_00007	VFG042585	Sfp fimbriae	91.8	0	1	819	1.0	0.9808	Adherence	PapC/FimD family outer membrane usher protein		SetB	prediction
4149	M0209609	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG000885	P fimbriae	73.7	1.2e-104	25	267	0.9101	0.9959	Adherence	chaperone protein PapD	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4150	M0209609	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG042586	Sfp fimbriae	95.1	4.4e-130	25	267	0.9101	1	Adherence	fimbria/pilus periplasmic chaperone		SetB	prediction
4151	M0209610	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG000885	P fimbriae	73.7	1.2e-104	25	267	0.9101	0.9959	Adherence	chaperone protein PapD	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4152	M0209610	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG042586	Sfp fimbriae	95.1	4.4e-130	25	267	0.9101	1	Adherence	fimbria/pilus periplasmic chaperone		SetB	prediction
4153	M0209611	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG000885	P fimbriae	73.7	1.2e-104	25	267	0.9101	0.9959	Adherence	chaperone protein PapD	PapG mediates binding to the alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranoside (Galalpha(1,4)Gal) moiety present in a globoseries of glycolipids found on host cells lining the upper urinary tract and erythrocytes; three adhesin variants of PapG-G-I, G-II, G-III recognize three different but related Galalpha(1,4)Gal receptors; PapG-mediated interactions with its Galalpha(1,4)Gal-containing glycolipid receptor can activate specific responses in the bacteria and in the epithelial cell that promote virulence: activating the UPEC iron-acquisition system and triggering the intracellular release from receptor glycolipids of ceramide, an important second messenger that can activate cytokine production, through the activation of serine/threonine protein kinases and phosphatase	SetA	experiment
4154	M0209611	NZ_OW967796.1	KPCGJMHB_00152	NZ_OW967796.1__KPCGJMHB_00152	NZ_OW967796.1	C1417	KPCGJMHB_00152	VFG042586	Sfp fimbriae	95.1	4.4e-130	25	267	0.9101	1	Adherence	fimbria/pilus periplasmic chaperone		SetB	prediction
4155	M0210977	NZ_OY754359.1	MIHLNACH_00021	NZ_OY754359.1__MIHLNACH_00021	NZ_OY754359.1	C1440	MIHLNACH_00021	VFG036043	AatA, AIDA-I type	97.4	0	1	1165	1.0	1	Adherence	autotransporter outer membrane beta-barrel domain-containing protein		SetB	prediction
4156	M0211048	NZ_PP261911.1	AMAGDCAB_00019	NZ_PP261911.1__AMAGDCAB_00019	NZ_PP261911.1	C1450	AMAGDCAB_00019	VFG020186	VirK	99.1	3.2e-188	1	316	1.0	1	Others	virulence factor VirK		SetB	prediction